细胞株Cell Lines 54-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV54
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID L2
AC CVCL_0383
SY L-2
DR CLO; CLO_0007169
DR CLO; CLO_0007170
DR MCCL; MCC:0000278
DR CLDB; cl3079
DR ATCC; CCL-149
DR BCRC; 60276
DR ECACC; 90112811
DR IZSLER; BS CL 180
DR JCRB; JCRB9053
DR KCLB; 10149
RX PubMed=4616002;
RX PubMed=7065527;
CC Breed/subspecies: Lewis.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Spontaneously immortalized cell line
//
ID L2-1GC
AC CVCL_W600
DR SKIP; SKIP000300
RX PubMed=23472874;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W601 ! L2-1Mut
OI CVCL_W602 ! L2-2GC
OI CVCL_W603 ! L2-2Mut
OI CVCL_W604 ! L2-3GC
OI CVCL_W605 ! L2-3Mut
SX Female
CA Induced pluripotent stem cell
//
ID L2-1Mut
AC CVCL_W601
DR SKIP; SKIP000297
RX PubMed=23472874;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W600 ! L2-1GC
OI CVCL_W602 ! L2-2GC
OI CVCL_W603 ! L2-2Mut
OI CVCL_W604 ! L2-3GC
OI CVCL_W605 ! L2-3Mut
SX Female
CA Induced pluripotent stem cell
//
ID L2-2GC
AC CVCL_W602
DR SKIP; SKIP000301
RX PubMed=23472874;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W600 ! L2-1GC
OI CVCL_W601 ! L2-1Mut
OI CVCL_W603 ! L2-2Mut
OI CVCL_W604 ! L2-3GC
OI CVCL_W605 ! L2-3Mut
SX Female
CA Induced pluripotent stem cell
//
ID L2-2Mut
AC CVCL_W603
DR SKIP; SKIP000298
RX PubMed=23472874;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W600 ! L2-1GC
OI CVCL_W601 ! L2-1Mut
OI CVCL_W602 ! L2-2GC
OI CVCL_W604 ! L2-3GC
OI CVCL_W605 ! L2-3Mut
SX Female
CA Induced pluripotent stem cell
//
ID L2-3GC
AC CVCL_W604
DR SKIP; SKIP000302
RX PubMed=23472874;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W600 ! L2-1GC
OI CVCL_W601 ! L2-1Mut
OI CVCL_W602 ! L2-2GC
OI CVCL_W603 ! L2-2Mut
OI CVCL_W605 ! L2-3Mut
SX Female
CA Induced pluripotent stem cell
//
ID L2-3Mut
AC CVCL_W605
DR SKIP; SKIP000299
RX PubMed=23472874;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W600 ! L2-1GC
OI CVCL_W601 ! L2-1Mut
OI CVCL_W602 ! L2-2GC
OI CVCL_W603 ! L2-2Mut
OI CVCL_W604 ! L2-3GC
SX Female
CA Induced pluripotent stem cell
//
ID L2-RYC
AC CVCL_3534
SY L2; L2-Rat Yolk sac Carcinoma
DR CLO; CLO_0007183
DR ATCC; CRL-2180
RX PubMed=7141105;
CC Breed/subspecies: Lewis.
DI NCIt; C60530; Rat yolk sac carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID L201.15
AC CVCL_V105
DR CLO; CLO_0007172
DR CLDB; cl3125
DR IHW; IHW8045
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID L203
AC CVCL_J015
DR CLO; CLO_0007173
DR ATCC; HB-171
RX PubMed=6966655;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID L21.3
AC CVCL_V106
DR CLO; CLO_0007174
DR CLDB; cl3126
DR IHW; IHW8204
RX PubMed=1429033;
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_V055 ! DAP.3
SX Male
CA Spontaneously immortalized cell line
//
ID L227
AC CVCL_J016
DR CLO; CLO_0007175
DR ATCC; HB-96
RX PubMed=6966655;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID L23
AC CVCL_3829
SY B1 subline L23
DR CLO; CLO_0007176
DR CLDB; cl3127
DR ECACC; 91012318
RX PubMed=2394515;
RX PubMed=7951345;
CC Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC Breed/subspecies: Miniature boar (d/d haplotype).
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_F749 ! B1 [Pig]
SX Male
CA Transformed cell line
//
ID L231
AC CVCL_3830
DR CLO; CLO_0007178
DR CLDB; cl3128
DR ECACC; 92040118
RX PubMed=1667778;
RX PubMed=7951345;
CC Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC Discontinued: ECACC; 92040118; probable.
CC Breed/subspecies: Miniature boar (d/d haplotype).
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_3829 ! L23
SX Male
CA Transformed cell line
//
ID L23immo
AC CVCL_U661
DR CLO; CLO_0050063
DR BioSample; SAMN03471933
DR RCB; RCB2833
CC Transformant: Unknown.
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 14
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Transformed cell line
//
ID L243
AC CVCL_4533
SY L 243
DR CLO; CLO_0007142
DR CLO; CLO_0007180
DR CLDB; cl5218
DR ATCC; HB-55
DR IZSLER; BS Hy 17
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID L25.4
AC CVCL_V107
DR CLO; CLO_0007181
DR CLDB; cl3129
DR IHW; IHW8305
RX PubMed=1429033;
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID L266
AC CVCL_0C35
DR Cosmic; 2239102
RX PubMed=9559344;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID L27
AC CVCL_W926
DR Cosmic; 1154604
DR Cosmic; 1571727
RX PubMed=11891209;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID L282F-hiPSC
AC CVCL_IJ22
RX PubMed=27789396;
CC From: Bioneer A/S; Denmark.
CC Characteristics: Heterozygous for the PSEN1 p.Leu282Phe mutation.
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID L2975
AC CVCL_D706
DR Cosmic; 1602481
DR Cosmic; 1755115
RX PubMed=22057234;
RX PubMed=22928481;
CC Characteristics: Heterozygous for the IDH2 p.Arg132Trp mutation.
CC Omics: Array-based CGH.
CC Miscellaneous: STR profile from personal communication of Cleton-Jansen A.-M.
CC Derived from metastatic site: Spine.
ST Source(s): Direct_author_submission
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 12
ST D16S539: 11
ST D21S11: 28,29
ST D5S818: 12
ST D7S820: 9
ST TH01: 7
ST TPOX: 8
ST vWA: 14
DI NCIt; C6476; Dedifferentiated chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID L2987
AC CVCL_H586
DR ChEMBL-Cells; CHEMBL3307776
DR ChEMBL-Targets; CHEMBL614650
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID L2C
AC CVCL_2547
DR IFO; IFO50210
RX PubMed=4550467;
OX NCBI_TaxID=10141; ! Cavia porcellus
CA Cancer cell line
//
ID L2I-6
AC CVCL_4532
SY L 21.6
DR CLO; CLO_0007141
DR CLO; CLO_0007182
DR CLDB; cl5217
DR ATCC; HB-8705
DR IZSLER; BS Hy 28
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID L3 [Human A-T patient lymphoblastoid]
AC CVCL_M915
RX PubMed=9168117;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID L3 [Mouse hybridoma]
AC CVCL_K217
DR ATCC; HB-8626
RX Patent=US4737579;
CC Discontinued: ATCC; HB-8626; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID L3-5
AC CVCL_Z624
SY L35
RX PubMed=23382679;
WW http://www.mr4.org/MR4ReagentsSearch/hybridomaCellLines/MRA-920.aspx
WW https://www.vectorbase.org/data/anopheles-gambiae-l3-5-cell-line-avcl
CC Group: Insect cell line.
CC Registration: BEI Resources Repository, Malaria Research and Reference Reagent Resource Center; MRA-920.
CC Omics: Deep RNAseq analysis.
CC Breed/subspecies: L3-5.
OX NCBI_TaxID=7165; ! Anopheles gambiae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID L3-5-3
AC CVCL_Z625
DR BTO; BTO:0002634
RX PubMed=12626708;
CC Group: Insect cell line.
CC Breed/subspecies: L3-5.
OX NCBI_TaxID=7165; ! Anopheles gambiae
HI CVCL_Z624 ! L3-5
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID L3.1
AC CVCL_8149
RX PubMed=1544114;
RX PubMed=15235133;
CC Derived from metastatic site: Celiac axis lymph node.
DI NCIt; C5721; Pancreatic adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8196 ! COLO 357/FG
SX Female
CA Cancer cell line
//
ID L3.2
AC CVCL_8148
RX PubMed=1544114;
RX PubMed=15235133;
CC Derived from metastatic site: Celiac axis lymph node.
DI NCIt; C5721; Pancreatic adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8149 ! L3.1
SX Female
CA Cancer cell line
//
ID L3.3
AC CVCL_8147
SY L33
DR BTO; BTO:0004571
DR CCLE; L33_PANCREAS
DR GEO; GSM887258
DR GEO; GSM888333
RX PubMed=1544114;
RX PubMed=15235133;
RX PubMed=22460905;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 35 hours (PubMed=25984343).
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Celiac axis lymph node.
DI NCIt; C5721; Pancreatic adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8148 ! L3.2
SX Female
CA Cancer cell line
//
ID L3.4
AC CVCL_8146
RX PubMed=1544114;
RX PubMed=15235133;
CC Derived from metastatic site: Celiac axis lymph node.
DI NCIt; C5721; Pancreatic adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8147 ! L3.3
SX Female
CA Cancer cell line
//
ID L3.5
AC CVCL_8145
RX PubMed=1544114;
RX PubMed=15235133;
CC Derived from metastatic site: Celiac axis lymph node.
DI NCIt; C5721; Pancreatic adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8146 ! L3.4
SX Female
CA Cancer cell line
//
ID L3.6.2
AC CVCL_V108
DR CLO; CLO_0007184
DR CLDB; cl3130
DR IHW; IHW8301
RX PubMed=3517859;
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 4940; HLA-DPB1.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID L3.6pl
AC CVCL_0384
SY L3.6PL; L3_6PL; L3.6 pancreas-liver; Colo357L3.6pl
DR BTO; BTO:0003441
DR MCCL; MCC:0000279
DR Cosmic; 1198211
RX PubMed=10935470;
CC Doubling time: 16 hours (PubMed=10935470).
CC Derived from metastatic site: Celiac axis lymph node.
DI NCIt; C5721; Pancreatic adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8147 ! L3.3
SX Female
CA Cancer cell line
//
ID L3.6sl
AC CVCL_8144
SY L3.6SL; L3.6 spleen-liver
DR Lonza; 915
RX PubMed=10935470;
CC Doubling time: 20 hours (PubMed=10935470).
CC Derived from metastatic site: Celiac axis lymph node.
DI NCIt; C5721; Pancreatic adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8147 ! L3.3
SX Female
CA Cancer cell line
//
ID L3055
AC CVCL_9668
DR EFO; EFO_0001198
RX PubMed=10604993;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID L32
AC CVCL_0C36
DR Cosmic; 2239100
RX PubMed=9559344;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID L3252
AC CVCL_D707
DR Cosmic; 1755116
RX PubMed=22928481;
CC Omics: Array-based CGH.
CC Miscellaneous: STR profile from personal communication of Cleton-Jansen A.-M.
ST Source(s): Direct_author_submission
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10
ST D16S539: 12
ST D21S11: 28,31.2
ST D5S818: 12
ST D7S820: 9,10
ST TH01: 9.3
ST TPOX: 12
ST vWA: 16
DI NCIt; C6476; Dedifferentiated chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID L35
AC CVCL_3831
SY B1 subline L35
DR CLO; CLO_0007185
DR CLDB; cl3131
DR ECACC; 91012319
RX PubMed=2394515;
RX PubMed=7951345;
CC Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC Breed/subspecies: Miniature boar (d/d haplotype).
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_F749 ! B1 [Pig]
SX Male
CA Transformed cell line
//
ID L361
AC CVCL_0C37
DR Cosmic; 2239104
RX PubMed=9559344;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID L368
AC CVCL_E981
DR CLO; CLO_0007187
DR ATCC; HB-149
RX PubMed=6187860;
CC Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID L39-17
AC CVCL_2Z39
SY WC00006
DR CLO; CLO_0013432
DR BioSamples; SAME17769
DR Coriell; WC00006
CC Discontinued: Coriell; WC00006; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID L4.5
AC CVCL_0D72
DR DSMZ; ACC-772
RX PubMed=8675236;
CC Doubling time: ~30-40 hours (DSMZ).
CC Transfected with: MGI; MGI:88337; Cd40lg.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0462 ! NCTC clone 929
SX Male
CA Spontaneously immortalized cell line
//
ID L40
AC CVCL_M973
SY L-40
RX PubMed=12080467;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID L45
AC CVCL_3832
SY B1 subline L45
DR CLO; CLO_0007190
DR CLDB; cl3132
DR ECACC; 91012320
RX PubMed=2394515;
RX PubMed=7951345;
CC Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC Breed/subspecies: Miniature boar (d/d haplotype).
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_F749 ! B1 [Pig]
SX Male
CA Transformed cell line
//
ID L5
AC CVCL_K218
DR CLO; CLO_0007191
DR ATCC; HB-8627
RX Patent=US4737579;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID L5.1
AC CVCL_4534
SY L 5.1
DR CLO; CLO_0007143
DR CLO; CLO_0007192
DR CLDB; cl5216
DR ATCC; HB-84
DR IZSLER; BS Hy 9
RX PubMed=7059675;
CC Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID L5178Y TK+/- (clone 3.7.2C)
AC CVCL_6665
SY L5178Y TK+/-3.7.2c; TK+/- (clone 3.7.2C)
DR CLO; CLO_0007196
DR ATCC; CRL-9518
DR BCRC; 60112
DR BCRJ; 0140
DR CCRID; 3131C0001000800033
DR JCRB; JCRB0709.1
RX DOI=10.1016/j.mrgentox.2016.08.001;
CC Breed/subspecies: DBA/2.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4235 ! L-5178-Y-S
SX Female
CA Cancer cell line
//
ID L5178Y TK+/- (clone 3.7.2C) (IVGT)
AC CVCL_4W65
SY L5178Y tk+/- 3.7.2c (IVGT); L5178Y TK +/-3.7.2c (IVGT)
DR ECACC; 12080201
DR JCRB; JCRB0709.2
RX DOI=10.1016/j.mrgentox.2016.08.001;
CC Part of: In Vitro Genetic Toxicity (IVGT) cell line panel.
CC Breed/subspecies: DBA/2.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6665 ! L5178Y TK+/- (clone 3.7.2C)
SX Female
CA Cancer cell line
//
ID L5178Y ts2
AC CVCL_J373
SY ts2
DR JCRB; JCRB0723
CC Breed/subspecies: DBA/2.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2097 ! L-5178-Y
SX Female
CA Cancer cell line
//
ID L5178Y ts39
AC CVCL_J374
SY ts39
DR JCRB; JCRB0724
CC Breed/subspecies: DBA/2.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2097 ! L-5178-Y
SX Female
CA Cancer cell line
//
ID L5178Y VCRR
AC CVCL_AZ79
SY L5178Y VCR-resistant
RX PubMed=7105380;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Breed/subspecies: DBA/2.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2097 ! L-5178-Y
SX Female
CA Cancer cell line
//
ID L5178Y VDSR
AC CVCL_AZ80
SY L5178Y VDS-resistant
RX PubMed=7105380;
CC Selected for resistance to: ChEBI; CHEBI:36373; Vindesine.
CC Breed/subspecies: DBA/2.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2097 ! L-5178-Y
SX Female
CA Cancer cell line
//
ID L52
AC CVCL_3833
SY B1 subline L52
DR CLO; CLO_0007199
DR CLDB; cl3138
DR ECACC; 91012321
RX PubMed=2394515;
RX PubMed=7951345;
CC Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC Breed/subspecies: Miniature boar (d/d haplotype).
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_F749 ! B1 [Pig]
SX Male
CA Transformed cell line
//
ID L53-10
AC CVCL_3737
DR CLO; CLO_0007405
DR ATCC; CRL-7720
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Misspelling: Occasionally 'LS3-10'.
CC Discontinued: ATCC; CRL-7720; true.
DI NCIt; C2869; Anemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Undefined cell line type
//
ID L54.5
AC CVCL_V109
DR CLO; CLO_0007200
DR CLDB; cl3140
DR IHW; IHW8205
RX PubMed=1429033;
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_V055 ! DAP.3
SX Male
CA Spontaneously immortalized cell line
//
ID L56Br-C1
AC CVCL_DF84
SY L56-BR-C1; L56BrC1
DR BTO; BTO:0004832
DR GEO; GSM155216
RX PubMed=11846806;
RX PubMed=12649339;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C4872; Breast carcinoma
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID L57-3-11
AC CVCL_Z908
DR BTO; BTO:0003935
DR DGRC; 2
RX PubMed=9071589;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z834 ! Kc167
SX Female
CA Spontaneously immortalized cell line
//
ID L57.23
AC CVCL_V110
DR CLO; CLO_0007202
DR CLDB; cl3141
DR IHW; IHW8101
RX PubMed=1429033;
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_V055 ! DAP.3
SX Male
CA Spontaneously immortalized cell line
//
ID L6
AC CVCL_0385
SY L-6; L-6 myoblast
DR BTO; BTO:0002809
DR CLO; CLO_0007203
DR MCCL; MCC:0000280
DR CLDB; cl3142
DR CLDB; cl5220
DR ATCC; CRL-1458
DR BCRJ; 0141
DR CCRID; 3111C0001CCC000192
DR CCRID; 3131C0001000500004
DR ChEMBL-Cells; CHEMBL3308469
DR ChEMBL-Targets; CHEMBL614793
DR IFO; IFO50364
DR IZSLER; BS CL 134
DR JCRB; JCRB9081
DR KCLB; 21458
DR Lonza; 927
DR PRIDE; PXD002557
RX PubMed=5245982;
RX PubMed=5481965;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-130.html
WW https://www.kerafast.com/product/1737/l6-rat-myoblast-cell-line
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID L6-20-4
AC CVCL_CW49
SY L6
DR ATCC; HB-8677
RX Patent=US4906562;
RX Patent=US4975278;
RX PubMed=3731064;
CC Monoclonal antibody target: UniProtKB; P30408; Human TM4SF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID L6-GLUT-4myc
AC CVCL_0P25
SY L6-GLUT4myc
RX PubMed=10484371;
WW https://www.kerafast.com/product/1738/l6-glut4myc-rat-myoblast-cell-line
CC Transfected with: RGD; 2711; Slc2a4.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0385 ! L6
CA Transformed cell line
//
ID L6.C10
AC CVCL_3834
SY L6-C10
DR CLO; CLO_0007204
DR CLDB; cl3143
DR ECACC; 92102118
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Discontinued: ECACC; 92102118; probable.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0385 ! L6
CA Transformed cell line
//
ID L6.C11
AC CVCL_3835
SY L6-C11
DR CLO; CLO_0007205
DR CLDB; cl3144
DR ECACC; 92102119
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0385 ! L6
CA Transformed cell line
//
ID L6.G8
AC CVCL_3836
DR CLO; CLO_0007206
DR CLDB; cl3145
DR ECACC; 92102117
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0385 ! L6
CA Transformed cell line
//
ID L6.G8.C5
AC CVCL_3837
SY L6G8C5
DR CLO; CLO_0007207
DR CLDB; cl3146
DR ECACC; 92121114
DR NCBI_Iran; C601
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0385 ! L6
CA Transformed cell line
//
ID L612
AC CVCL_3733
DR CLO; CLO_0007208
DR ATCC; CRL-10724
RX Patent=US5419904;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-10724; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID L615K
AC CVCL_0J69
RX PubMed=2502521;
CC Breed/subspecies: Kunming.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID L6A4
AC CVCL_C569
SY L6-A4
RX PubMed=8393277;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0385 ! L6
CA Transformed cell line
//
ID L6C5
AC CVCL_3387
SY L6-C5
DR CLO; CLO_0007210
DR CLDB; cl4987
DR ICLC; AL00001
RX PubMed=8393277;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0385 ! L6
CA Transformed cell line
//
ID L6C9
AC CVCL_C570
SY L6-C9
RX PubMed=8393277;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0385 ! L6
CA Transformed cell line
//
ID L6E9
AC CVCL_0386
SY L6-E9
DR BTO; BTO:0003307
DR MCCL; MCC:0000281
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-171.html
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0385 ! L6
CA Transformed cell line
//
ID L6H2
AC CVCL_3388
SY L6-H2
DR CLO; CLO_0007211
DR CLDB; cl4986
DR ICLC; ATL00001
RX PubMed=8393277;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0385 ! L6
CA Transformed cell line
//
ID L6J1
AC CVCL_6F18
DR CLO; CLO_0007212
DR CLDB; cl3147
RX PubMed=374099;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/al6j1.htm
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0385 ! L6
CA Transformed cell line
//
ID L6TG
AC CVCL_C565
DR JCRB; JCRB0209
RX CelloPub=CLPUB00072;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0385 ! L6
CA Transformed cell line
//
ID L6TG Cap
AC CVCL_C566
SY L6TG.CAP; L6TG.CAPr; L6TGcapr; L6TG Cap-r
DR JCRB; JCRB0210
RX CelloPub=CLPUB00072;
CC Selected for resistance to: ChEBI; CHEBI:17698; Chloramphenicol.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_C565 ! L6TG
CA Transformed cell line
//
ID L7212K
AC CVCL_0J70
RX PubMed=2502521;
CC Breed/subspecies: Kunming.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID L749.1
AC CVCL_DR24
RX PubMed=27346203;
DI NCIt; C84814; Leigh disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID L8
AC CVCL_4236
SY L-8
DR BTO; BTO:0002810
DR CLO; CLO_0007213
DR CLDB; cl3148
DR ATCC; CRL-1769
DR ECACC; 95102434
DR IZSLER; BS CL 172
RX PubMed=5481965;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-341.html
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID L804L
AC CVCL_Y197
DR Cosmic; 1513409
RX PubMed=21498706;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID L8057
AC CVCL_E074
SY L-8057
RX PubMed=3457087;
RX PubMed=7678813;
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: C3H/He.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID L835
AC CVCL_D708
DR Cosmic; 1602479
DR Cosmic; 1755114
RX PubMed=22057234;
RX PubMed=22928481;
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
CC Omics: Array-based CGH.
CC Miscellaneous: STR profile from personal communication of Cleton-Jansen A.-M.
ST Source(s): Direct_author_submission
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,13
ST D16S539: 11
ST D21S11: 28,29
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 9.3
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID L84
AC CVCL_C571
RX PubMed=558123;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4236 ! L8
CA Spontaneously immortalized cell line
//
ID L87/4
AC CVCL_6837
DR BTO; BTO:0005051
DR Lonza; 1287
RX PubMed=8142648;
RX PubMed=8536785;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=L87%2F4
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6838 ! L88/5
SX Male
CA Transformed cell line
//
ID L88/5
AC CVCL_6838
DR BTO; BTO:0005052
RX PubMed=8142648;
RX PubMed=8536785;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=L88%2F5
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6837 ! L87/4
SX Male
CA Transformed cell line
//
ID L89.2
AC CVCL_V111
DR CLO; CLO_0007214
DR CLDB; cl3149
DR IHW; IHW8183
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_V055 ! DAP.3
SX Male
CA Spontaneously immortalized cell line
//
ID L91.7
AC CVCL_V112
DR CLO; CLO_0007218
DR CLDB; cl3153
DR IHW; IHW8125
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_V055 ! DAP.3
SX Male
CA Spontaneously immortalized cell line
//
ID L929/A
AC CVCL_AR58
DR ECACC; 14112101
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0462 ! NCTC clone 929
SX Male
CA Spontaneously immortalized cell line
//
ID L929/R
AC CVCL_4237
DR ECACC; 04102001
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0462 ! NCTC clone 929
SX Male
CA Spontaneously immortalized cell line
//
ID L929S
AC CVCL_4238
DR CLO; CLO_0007222
DR CLDB; cl3161
DR ECACC; 86032004
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0462 ! NCTC clone 929
SX Male
CA Spontaneously immortalized cell line
//
ID L96
AC CVCL_0C38
DR Cosmic; 2239103
RX PubMed=9559344;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID L9981
AC CVCL_X188
RX PubMed=20731927;
RX PubMed=21310132;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X186 ! WCQH-9801
CA Cancer cell line
//
ID L9981-BoM
AC CVCL_X190
RX PubMed=24667252;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X189 ! L9981-Luc
CA Cancer cell line
//
ID L9981-BrM
AC CVCL_X191
RX PubMed=24667252;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X189 ! L9981-Luc
CA Cancer cell line
//
ID L9981-LnM
AC CVCL_X192
RX PubMed=24667252;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X189 ! L9981-Luc
CA Cancer cell line
//
ID L9981-Luc
AC CVCL_X189
RX PubMed=20731927;
RX PubMed=24667252;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X188 ! L9981
CA Cancer cell line
//
ID L9981-LuM
AC CVCL_X193
RX PubMed=24667252;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X189 ! L9981-Luc
CA Cancer cell line
//
ID LA 3-5
AC CVCL_4587
SY LA3-5
DR CLO; CLO_0007224
DR ATCC; CRL-10101
RX Patent=WO1987004187A1;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID La Bel
AC CVCL_3734
DR CLO; CLO_0007225
DR ATCC; CRL-1179
DI NCIt; C125700; Ehlers-Danlos syndrome, type VI
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3735 ! La Bel II
SX Female
CA Finite cell line
//
ID La Bel II
AC CVCL_3735
DR CLO; CLO_0007226
DR ATCC; CRL-1195
CC Discontinued: ATCC; CRL-1195; true.
DI NCIt; C125700; Ehlers-Danlos syndrome, type VI
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3734 ! La Bel
SX Female
CA Finite cell line
//
ID La Col
AC CVCL_0F49
DR ATCC; CRL-1119
CC Discontinued: ATCC; CRL-1119; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID La Gay
AC CVCL_0F64
DR ATCC; CRL-1109
CC Discontinued: ATCC; CRL-1109; probable.
DI NCIt; C72070; Systemic scleroderma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID LA-350
AC CVCL_AR50
SY LA350
RX PubMed=1643757;
RX PubMed=2827896;
RX PubMed=3033590;
RX PubMed=3257418;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 9,12
ST D18S51: 17,22
ST D19S433: 13,15
ST D21S11: 29,31
ST D2S1338: 19,25
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 11,13
ST FGA: 21,27
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LA-4 [Mouse hybridoma]
AC CVCL_N290
DR ATCC; HB-8480
RX Patent=US4683196;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID LA-4 [Mouse lung adenoma]
AC CVCL_3535
SY LA 4; LA4
DR CLO; CLO_0007229
DR CLDB; cl3163
DR ATCC; CCL-196
DR BCRC; 60239
DR ECACC; 90040512
DR KCLB; 10196
RX PubMed=167947;
RX PubMed=7065527;
RX PubMed=9347924;
CC Breed/subspecies: A/He.
DI NCIt; C21762; Adenoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID LA-49
AC CVCL_M531
RX PubMed=4858717;
RX PubMed=10936422;
CC Miscellaneous: Cell line has been lost (PubMed=10936422).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LA-5
AC CVCL_N291
DR ATCC; HB-8479
RX Patent=US4683196;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID LA-795
AC CVCL_G363
SY LA795
DR CCRID; 3111C0001CCC000193
DR CCRID; 3111C0001CCC000318
RX PubMed=2249590;
RX PubMed=3250825;
DI NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID LA-9
AC CVCL_4Z39
SY LA9
DR BCRJ; 0142
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0462 ! NCTC clone 929
SX Male
CA Spontaneously immortalized cell line
//
ID LA-N-1
AC CVCL_1827
SY LAN-1; LAN1; Lan1
DR BTO; BTO:0003542
DR CLO; CLO_0007240
DR CLO; CLO_0051542
DR EFO; EFO_0005391
DR BioSample; SAMN03472327
DR BioSample; SAMN03473468
DR Cosmic; 801740
DR Cosmic; 920240
DR Cosmic; 947710
DR Cosmic; 1019927
DR Cosmic; 1037343
DR Cosmic; 1099140
DR Cosmic; 1109118
DR Cosmic; 1153781
DR Cosmic; 1153809
DR Cosmic; 1161991
DR Cosmic; 1167411
DR Cosmic; 1526627
DR Cosmic; 2131578
DR Cosmic; 2239461
DR Cosmic; 2301574
DR Cosmic; 2393635
DR Cosmic; 2485946
DR DSMZ; ACC-655
DR ECACC; 06041201
DR GEO; GSM313802
DR GEO; GSM333797
DR GEO; GSM563355
DR GEO; GSM692872
DR GEO; GSM1366408
DR ICLC; HTL98005
DR RCB; RCB0483
DR TOKU-E; 4118
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=856461;
RX PubMed=2535691;
RX PubMed=7037175;
RX PubMed=7838528;
RX PubMed=18165268;
RX PubMed=18923524;
RX PubMed=22213050;
CC Doubling time: ~100 hours (DSMZ); ~2 days (ECACC).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ICLC; HTL98005; true.
CC Derived from metastatic site: Bone marrow.
ST Source(s): COG; DSMZ; ECACC; RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 14
ST D19S433: 13
ST D21S11: 29,36
ST D2S1338: 16,21
ST D3S1358: 16,16.2
ST D5S818: 12
ST D7S820: 10 (COG)
ST D7S820: 10,11 (DSMZ; ECACC; RCB)
ST D8S1179: 13,14
ST FGA: 19,24
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 16,19
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LA-N-2
AC CVCL_1829
SY LAN-2; LAN2
DR CLO; CLO_0050262
DR BioSample; SAMN03472328
DR BioSample; SAMN03473426
DR Cosmic; 801741
DR Cosmic; 920241
DR Cosmic; 947711
DR Cosmic; 1037344
DR Cosmic; 1099141
DR Cosmic; 1109103
DR Cosmic; 1153782
DR Cosmic; 1526628
DR Cosmic; 2131579
DR Cosmic; 2301575
DR Cosmic; 2485947
DR DSMZ; ACC-671
DR ECACC; 06041202
DR GEO; GSM313803
DR GEO; GSM333798
DR Lonza; 1195
DR RCB; RCB0484
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=856461;
RX PubMed=7037175;
RX PubMed=18923524;
CC Doubling time: ~50-70 hours, but longer after recovery from liquid nitrogen freezing (DSMZ).
CC Omics: SNP array analysis.
ST Source(s): COG; DSMZ; ECACC; RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9,10
ST D18S51: 15,18
ST D19S433: 14
ST D21S11: 29,30
ST D2S1338: 20
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 13,15
ST FGA: 20,22
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LA-N-4
AC CVCL_M158
SY LAN-4
RX PubMed=6172518;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LA-N-5
AC CVCL_0389
SY LAN-5; Lan-5; LAN5; Lan5; NBLAN5T
DR BTO; BTO:0000935
DR CLO; CLO_0007242
DR CLO; CLO_0050264
DR MCCL; MCC:0000284
DR CLDB; cl3170
DR CLDB; cl3171
DR BioSample; SAMN03472329
DR BioSample; SAMN03473428
DR Cosmic; 801742
DR Cosmic; 923828
DR Cosmic; 930066
DR Cosmic; 947705
DR Cosmic; 1037345
DR Cosmic; 1099142
DR Cosmic; 1109122
DR Cosmic; 1153783
DR Cosmic; 1161992
DR Cosmic; 1167989
DR Cosmic; 1212538
DR Cosmic; 1518068
DR Cosmic; 1526629
DR Cosmic; 1890201
DR Cosmic; 2131580
DR Cosmic; 2239462
DR Cosmic; 2301576
DR Cosmic; 2393636
DR DSMZ; ACC-673
DR GEO; GSM313804
DR GEO; GSM333799
DR GEO; GSM692871
DR ICLC; HTL96022
DR Lonza; 1157
DR NCBI_Iran; C613
DR RCB; RCB0485
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=6172518;
RX PubMed=18923524;
RX PubMed=22213050;
RX PubMed=23202128;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/LA-N-5_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-481.html
CC Doubling time: ~100 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ICLC; HTL96022; true.
CC Derived from metastatic site: Bone marrow.
ST Source(s): COG; DSMZ; RCB
ST Amelogenin: X,Y
ST CSF1PO: 10 (COG)
ST CSF1PO: 10,11 (DSMZ; RCB)
ST D13S317: 9,12
ST D16S539: 9,12 (COG; RCB)
ST D16S539: 9 (DSMZ)
ST D18S51: 17,22
ST D19S433: 13,15
ST D21S11: 29,31
ST D2S1338: 19,25
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 11,13
ST FGA: 21,27
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LA-N-6
AC CVCL_1363
SY LAN-6; LAN6
DR BioSample; SAMN03473429
DR ChEMBL-Cells; CHEMBL3308206
DR ChEMBL-Targets; CHEMBL2366123
DR Cosmic; 697283
DR Cosmic; 717430
DR Cosmic; 848929
DR Cosmic; 930067
DR Cosmic; 949170
DR Cosmic; 1109105
DR Cosmic; 1109366
DR Cosmic; 1161993
DR Cosmic; 1167408
DR Cosmic; 1526630
DR Cosmic; 1890102
DR Cosmic; 2301577
DR Cosmic; 2393637
DR Cosmic-CLP; 949170
DR DSMZ; ACC-674
DR GDSC; 949170
DR GEO; GSM1670032
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=8242562;
RX PubMed=15150091;
RX PubMed=23202128;
RX PubMed=24792489;
RX PubMed=27397505;
WW http://www.cogcell.org/dl/NB_Data_Sheets/LA-N-6_Cell_Line_Data_Sheet_COGcell_org.pdf
CC Doubling time: ~1 week (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): COG; Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 10,12
ST D18S51: 16
ST D19S433: 14
ST D21S11: 30,32.2
ST D2S1338: 18,19
ST D3S1358: 15
ST D5S818: 10,12
ST D7S820: 11,12
ST D8S1179: 13,14
ST FGA: 18,21
ST TH01: 6
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LA0001
AC CVCL_8Y08
DR ECACC; 98061805
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C85874; Microcephaly
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LA0002
AC CVCL_8Y09
DR ECACC; 98061806
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C85874; Microcephaly
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID La1
AC CVCL_J832
SY anti-La/SSB
DR CLO; CLO_0007227
DR ATCC; HB-8609
RX Patent=US4784942;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID LA1-55n
AC CVCL_2548
DR BTO; BTO:0005860
DR ECACC; 06041203
CC Doubling time: ~2 days (ECACC).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2549 ! LA1-5s
SX Male
CA Cancer cell line
//
ID LA1-5s
AC CVCL_2549
DR ECACC; 06041204
RX PubMed=2535691;
CC Doubling time: ~2 days (ECACC).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1827 ! LA-N-1
SX Male
CA Cancer cell line
//
ID LA11
AC CVCL_Y951
DR RCB; HPS0103
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T963 ! LA3
OI CVCL_Y949 ! LA5
OI CVCL_Y950 ! LA8
SX Female
CA Induced pluripotent stem cell
//
ID LA3
AC CVCL_T963
DR RCB; HPS0100
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y949 ! LA5
OI CVCL_Y950 ! LA8
OI CVCL_Y951 ! LA11
SX Female
CA Induced pluripotent stem cell
//
ID LA3 beta2mHC2
AC CVCL_V113
DR CLO; CLO_0007228
DR CLDB; cl3165
DR IHW; IHW8004
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LA5
AC CVCL_Y949
DR RCB; HPS0101
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T963 ! LA3
OI CVCL_Y950 ! LA8
OI CVCL_Y951 ! LA11
SX Female
CA Induced pluripotent stem cell
//
ID LA7
AC CVCL_3838
DR CLO; CLO_0007230
DR CLDB; cl3164
DR ATCC; CRL-2283
DR ECACC; 96081411
RX PubMed=375233;
RX PubMed=1717432;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=LA7
CC Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC Discontinued: ECACC; 96081411; probable.
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_Y673 ! Rama 25
SX Female
CA Cancer cell line
//
ID LA8
AC CVCL_Y950
DR RCB; HPS0102
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T963 ! LA3
OI CVCL_Y949 ! LA5
OI CVCL_Y951 ! LA11
SX Female
CA Induced pluripotent stem cell
//
ID LACC-1
AC CVCL_9U23
RX PubMed=25962898;
CC Doubling time: ~37.1 hours (PubMed=25962898).
DI NCIt; C4540; Lacrimal gland adenoid cystic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LACF-NaNaI
AC CVCL_B944
DR CLO; CLO_0051621
DR RCB; RCB2319
OX NCBI_TaxID=9785; ! Loxodonta africana
OI CVCL_B945 ! LACF-NaNaII
SX Female
CA Finite cell line
//
ID LACF-NaNaII
AC CVCL_B945
DR CLO; CLO_0050000
DR RCB; RCB2320
OX NCBI_TaxID=9785; ! Loxodonta africana
OI CVCL_B944 ! LACF-NaNaI
SX Female
CA Finite cell line
//
ID LACO16
AC CVCL_T956
RX PubMed=8494788;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_T954 ! HET16
CA Spontaneously immortalized cell line
//
ID LACO3
AC CVCL_T957
RX PubMed=8494788;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_T953 ! HET15
CA Spontaneously immortalized cell line
//
ID LAD 1
AC CVCL_5220
SY LAD1; Laboratory of Allergic Diseases 1
RX PubMed=12801524;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=LAD1
CC Characteristics: KITLG dependent.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0387 ! LAD 2
SX Male
CA Factor-dependent cell line
//
ID LAD 2
AC CVCL_0387
SY LAD2; LAD-2; Laboratory of Allergic Diseases 2
DR BTO; BTO:0004139
DR MCCL; MCC:0000282
RX PubMed=12801524;
RX PubMed=25195635;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=LAD2
CC Characteristics: KITLG dependent.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5220 ! LAD 1
SX Male
CA Factor-dependent cell line
//
ID LADA
AC CVCL_E748
SY 5193; 18176
DR dbMHC; 48941
DR ECACC; 94071405
DR IHW; IHW9273
DR IMGT/HLA; 10959
WW http://bioinformatics.hsanmartino.it/ecbr/cl273.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LADMAC
AC CVCL_2550
DR CLO; CLO_0007234
DR ATCC; CRL-2420
DR BCRC; 60489
RX PubMed=3877730;
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID LAG
AC CVCL_B950
SY L(AG)
DR CLO; CLO_0050236
DR RCB; RCB2758
DR TKG; TKG 0218
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0462 ! NCTC clone 929
SX Male
CA Spontaneously immortalized cell line
//
ID LAG-MUC1
AC CVCL_B951
DR CLO; CLO_0050237
DR RCB; RCB2846
DR TKG; TKG 0466
CC Transfected with: HGNC; 7508; MUC1.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B950 ! LAG
SX Male
CA Spontaneously immortalized cell line
//
ID LAH1
AC CVCL_6666
DR CLO; CLO_0050155
DR RCB; RCB1733
RX DOI=10.2108/zsj.18.483;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8409; ! Pelophylax nigromaculatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LAH2
AC CVCL_6667
DR CLO; CLO_0050159
DR RCB; RCB1735
RX DOI=10.2108/zsj.18.483;
CC Group: Amphibian cell line.
CC Breed/subspecies: KM stock.
OX NCBI_TaxID=8409; ! Pelophylax nigromaculatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LAH3
AC CVCL_6668
DR CLO; CLO_0050156
DR RCB; RCB1734
RX DOI=10.2108/zsj.18.483;
CC Group: Amphibian cell line.
CC Breed/subspecies: BR stock.
OX NCBI_TaxID=88447; ! Pelophylax porosus brevipodus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LALW-2
AC CVCL_K244
RX PubMed=2720561;
RX PubMed=6609263;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAM
AC CVCL_E749
DR dbMHC; 48942
DR ECACC; 94050345
DR IHW; IHW9271
DR IMGT/HLA; 10960
WW http://bioinformatics.hsanmartino.it/ecbr/cl271.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 94050345; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID LAM1
AC CVCL_W912
SY LAM-1; Lam-1
DR Cosmic; 1054587
RX PubMed=17199440;
CC Miscellaneous: STR profile from personal communication of Marlow L.A.
CC Derived from metastatic site: Left subcarinal lymph node.
ST Source(s): Direct_author_submission
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 10,11
ST D16S539: 8,12
ST D18S51: 15
ST D3S1358: 15,17
ST D5S818: 12,13
ST D7S820: 10,11
ST D8S1179: 12
ST FGA: 19,22
ST TH01: 9.3,10
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAMA-84
AC CVCL_0388
SY Lama-84; LAMA84; Lama84
DR BTO; BTO:0004465
DR CLO; CLO_0007238
DR MCCL; MCC:0000283
DR CLDB; cl3168
DR BioSample; SAMN03473363
DR CCLE; LAMA84_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308267
DR ChEMBL-Targets; CHEMBL2366090
DR CLS; 300261/p2498_Lama-84
DR Cosmic; 787500
DR Cosmic; 907783
DR Cosmic; 1012081
DR Cosmic; 1019834
DR Cosmic; 1026569
DR Cosmic; 1078729
DR Cosmic-CLP; 907783
DR DSMZ; ACC-168
DR GDSC; 907783
DR GEO; GSM887262
DR GEO; GSM888337
DR GEO; GSM1670031
DR Lonza; 961
RX PubMed=3476310;
RX PubMed=8693292;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 36 hours (PubMed=25984343); ~50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12 (Cosmic-CLP)
ST CSF1PO: 8,11,12 (DSMZ)
ST D13S317: 11
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 10
ST vWA: 14,17
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LAMA-87
AC CVCL_1826
SY Lama-87; LAMA87
DR BTO; BTO:0004466
DR CLO; CLO_0007239
DR CLDB; cl55
DR BioSample; SAMN03473337
DR Cosmic; 787501
DR DSMZ; ACC-270
RX PubMed=7996872;
CC Doubling time: ~50-60 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 10
ST vWA: 14,17
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0388 ! LAMA-84
SX Female
CA Cancer cell line
//
ID LAMA-88
AC CVCL_9540
SY Lama-88; LAMA88
RX PubMed=7996872;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0388 ! LAMA-84
SX Female
CA Cancer cell line
//
ID LAMA84-r
AC CVCL_DP57
RX PubMed=10910924;
CC Selected for resistance to: ChEBI; CHEBI:45783; Imatinib (Gleevec; STI571).
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0388 ! LAMA-84
SX Female
CA Cancer cell line
//
ID LAMA84-rn
AC CVCL_DP54
RX PubMed=19047160;
CC Selected for resistance to: ChEBI; CHEBI:52172; Nilotinib (AMN107; Tasigna).
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0388 ! LAMA-84
SX Female
CA Cancer cell line
//
ID LAMA84R
AC CVCL_AE17
SY LAMA84-R
RX PubMed=10688835;
CC Selected for resistance to: ChEBI; CHEBI:45783; Imatinib (Gleevec; STI571).
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0388 ! LAMA-84
SX Female
CA Cancer cell line
//
ID LAN-188
AC CVCL_1828
DR CLO; CLO_0007241
DR CLDB; cl3169
CC From: Galliera Genetic Bank; E.O. Ospedali Galliera; Genova; Italy.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID LAP 4108-6
AC CVCL_V114
DR CLO; CLO_0007244
DR CLDB; cl3174
DR IHW; IHW8306
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LAP-35
AC CVCL_A096
SY LAP35; IOR/LAP-35; IOR-LAP-35
DR Cosmic; 1078388
DR Cosmic; 1082509
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=2177080;
RX PubMed=8617485;
RX PubMed=11891184;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C8776; Peripheral primitive neuroectodermal tumor of bone
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LAPC-3
AC CVCL_4743
SY LAPC3; Los Angeles Prostate Cancer-3
DR ATCC; PTA-1440
RX Patent=US6365797;
RX PubMed=9095173;
RX PubMed=12725112;
WW http://capcelllines.ca/details.asp?id=121
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAPC-4
AC CVCL_4744
SY LAPC4; Los Angeles Prostate Cancer-4
DR BTO; BTO:0002997
DR EFO; EFO_0005392
DR ATCC; CRL-13009
DR ATCC; PTA-1441
DR BioSample; SAMN03471350
DR ChEMBL-Cells; CHEMBL3308023
DR ChEMBL-Targets; CHEMBL613292
DR Cosmic; 1330913
DR Cosmic; 1689711
DR Cosmic; 2537793
DR Cosmic; 2580299
DR GEO; GSM91931
DR GEO; GSM648820
DR GEO; GSM1374616
RX Patent=US6365797;
RX PubMed=9095173;
RX PubMed=12725112;
RX PubMed=14518029;
RX PubMed=15486987;
WW http://capcelllines.ca/details.asp?id=120
CC Characteristics: Has lost chromosome Y.
CC Doubling time: ~72 hours.
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-13009; true.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 9,10,11,12
ST D16S539: 9
ST D5S818: 12
ST D7S820: 10,10.3,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAPC-4*2
AC CVCL_4745
SY LAPC4*2; LAPC-4(2); LAPC-4 squared
RX PubMed=12894499;
WW http://capcelllines.ca/details.asp?id=156
CC Characteristics: Has lost chromosome Y.
CC Derived from metastatic site: Lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4744 ! LAPC-4
SX Male
CA Cancer cell line
//
ID LAPC-9
AC CVCL_4746
SY LAPC9; Los Angeles Prostate Cancer-9
DR EFO; EFO_0005393
DR ATCC; PTA-1442
DR Cosmic; 2580123
RX Patent=US6365797;
RX PubMed=10519419;
WW http://capcelllines.ca/details.asp?id=122
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAQ 8251
AC CVCL_V115
DR CLO; CLO_0007245
DR CLDB; cl3175
DR IHW; IHW8202
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LARB1 1212
AC CVCL_V116
SY LARB1-1212
DR CLO; CLO_0007246
DR CLDB; cl3176
DR IHW; IHW8111
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LAT
AC CVCL_2101
SY Lamb Aortic Tissue
DR CLO; CLO_0007247
DR DSMZ; ACC-349
CC Doubling time: ~30-50 hours (DSMZ).
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Spontaneously immortalized cell line
//
ID LAT 1
AC CVCL_8365
DR CLO; CLO_0007248
DR CLDB; cl3177
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Undefined cell line type
//
ID LAT II
AC CVCL_8366
DR CLO; CLO_0007249
DR CLDB; cl3178
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Undefined cell line type
//
ID LATIF
AC CVCL_E750
DR dbMHC; 48943
DR ECACC; 94022540
DR IHW; IHW9247
DR IMGT/HLA; 10961
WW http://bioinformatics.hsanmartino.it/ecbr/cl247.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID LAU-Me190
AC CVCL_IP27
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Cutaneous.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LAU-Me200
AC CVCL_IP28
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LAU-Me204.A1
AC CVCL_IP29
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Cutaneous.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LAU-Me215
AC CVCL_IP30
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LAU-Me235
AC CVCL_DI17
SY LAU63
DR Cosmic; 1675358
DR GEO; GSM566249
DR GEO; GSM568791
RX PubMed=20862285;
RX PubMed=21494657;
RX PubMed=22197931;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAU-Me242.B1
AC CVCL_IP31
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LAU-Me246.M1
AC CVCL_DI18
SY LAU-Me246M1; LAU108
DR Cosmic; 1675359
DR GEO; GSM566253
DR GEO; GSM568792
RX PubMed=20862285;
RX PubMed=21494657;
RX PubMed=22197931;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Cutaneous.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DI24 ! LAU-Me246.M1-LCL
SX Female
CA Cancer cell line
//
ID LAU-Me246.M1-LCL
AC CVCL_DI24
SY EBV transformed lymphoblastoid cells patient LAU108
DR GEO; GSM568786
RX PubMed=21494657;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DI18 ! LAU-Me246.M1
SX Female
CA Transformed cell line
//
ID LAU-Me243
AC CVCL_IP32
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Cutaneous.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAU-Me248.3
AC CVCL_IP33
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Cutaneous.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAU-Me256
AC CVCL_S595
SY Me 256
RX PubMed=9469433;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LAU-Me260.LN
AC CVCL_S596
SY LAUMe260.LN; Me 260
RX PubMed=9469433;
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DI21 ! LAU-T149D
SX Female
CA Cancer cell line
//
ID LAU-Me261
AC CVCL_IP34
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IP51 ! LAU-T42B
SX Male
CA Cancer cell line
//
ID LAU-Me275
AC CVCL_S597
AS CVCL_DI19
SY LAUMe275; Me275; Me 275; LAU50_1
DR Cosmic; 1675356
DR GEO; GSM566196
DR GEO; GSM566255
DR GEO; GSM566256
DR GEO; GSM566257
DR GEO; GSM566258
DR GEO; GSM568793
RX PubMed=9469433;
RX PubMed=20862285;
RX PubMed=21494657;
RX PubMed=22197931;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DI22 ! LAU-T50B
SX Male
CA Cancer cell line
//
ID LAU-Me276
AC CVCL_IP35
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAU-Me280.R.LN
AC CVCL_DI20
SY LAU165
DR Cosmic; 1675361
DR GEO; GSM566250
DR GEO; GSM568783
RX PubMed=20862285;
RX PubMed=21494657;
RX PubMed=22197931;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DI25 ! LAU-Me280.R.LN-LCL
SX Male
CA Cancer cell line
//
ID LAU-Me280.R.LN-LCL
AC CVCL_DI25
SY EBV transformed lymphoblastoid cells patient LAU165
DR GEO; GSM568782
RX PubMed=21494657;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DI20 ! LAU-Me280.R.LN
SX Male
CA Transformed cell line
//
ID LAU-Me281.M1
AC CVCL_IP36
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Cutaneous.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IP37 ! LAU-Me281.M3
SX Female
CA Cancer cell line
//
ID LAU-Me281.M3
AC CVCL_IP37
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Cutaneous.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IP36 ! LAU-Me281.M1
SX Female
CA Cancer cell line
//
ID LAU-Me290
AC CVCL_S598
SY Me 290; Me290
RX PubMed=9469433;
RX PubMed=20862285;
RX PubMed=24581590;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LAU-Me300
AC CVCL_IP38
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAU-Me305
AC CVCL_IP39
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IP41 ! LAU-Me317
SX Female
CA Cancer cell line
//
ID LAU-Me312
AC CVCL_IP40
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Cutaneous.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LAU-Me317
AC CVCL_IP41
SY LAU-Me317.M2
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Cutaneous.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IP39 ! LAU-Me305
SX Female
CA Cancer cell line
//
ID LAU-Me337
AC CVCL_IP42
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAU-T1255A.b1
AC CVCL_IP43
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IP44 ! LAU-T1255A.g2
SX Male
CA Cancer cell line
//
ID LAU-T1255A.g2
AC CVCL_IP44
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IP43 ! LAU-T1255A.b1
SX Male
CA Cancer cell line
//
ID LAU-T1257A
AC CVCL_IP45
SY LAUT1257A
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
DI NCIt; C114828; Mucosal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IP46 ! LAU-T1257C
SX Male
CA Cancer cell line
//
ID LAU-T1257C
AC CVCL_IP46
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C114828; Mucosal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IP45 ! LAU-T1257A
SX Male
CA Cancer cell line
//
ID LAU-T1262A
AC CVCL_IP47
SY LAU-T1262 A
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IP48 ! LAU-T1262B
SX Female
CA Cancer cell line
//
ID LAU-T1262B
AC CVCL_IP48
SY LAU-T1262 B
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IP47 ! LAU-T1262A
SX Female
CA Cancer cell line
//
ID LAU-T149D
AC CVCL_DI21
SY LAU149
DR Cosmic; 1675360
DR GEO; GSM566251
DR GEO; GSM568790
RX PubMed=20862285;
RX PubMed=21494657;
RX PubMed=22197931;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Visceral.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S596 ! LAU-Me260.LN
SX Female
CA Cancer cell line
//
ID LAU-T331A
AC CVCL_IP49
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAU-T333A
AC CVCL_IP50
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Cutaneous.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAU-T42B
AC CVCL_IP51
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IP34 ! LAU-Me261
SX Male
CA Cancer cell line
//
ID LAU-T441A
AC CVCL_IP52
RX PubMed=20862285;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LAU-T50B
AC CVCL_DI22
SY LAU50_2
DR Cosmic; 1675357
DR GEO; GSM566254
DR GEO; GSM568794
RX PubMed=20862285;
RX PubMed=21494657;
RX PubMed=22197931;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S597 ! LAU-Me275
SX Male
CA Cancer cell line
//
ID LAU-T618A
AC CVCL_DI23
SY LAU618
DR Cosmic; 1675362
DR GEO; GSM566252
DR GEO; GSM568789
RX PubMed=20862285;
RX PubMed=21494657;
RX PubMed=22197931;
CC From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Cutaneous.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LAZ-007
AC CVCL_IQ25
SY LAZ 007; Laz 007; LAZ007
RX PubMed=6346879;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LAZ-149
AC CVCL_BT08
SY LAZ 149; LAZ149; GM10610
DR CLO; CLO_0024280
DR Coriell; GM10610
RX PubMed=947544;
RX PubMed=6196781;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34375; Thalassemia major
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LAZ-156
AC CVCL_IQ24
SY Laz-156; Laz 156; Laz156
RX Patent=US4550086;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LAZ-166
AC CVCL_GY05
SY LAZ 166; LAZ166
RX PubMed=209464;
RX PubMed=3123521;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3822; X-linked agammaglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LAZ-177
AC CVCL_GY94
SY LAZ 177; LAZ177
RX PubMed=6196781;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C129072; Hereditary persistence of fetal hemoglobin
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LAZ-187
AC CVCL_GY06
SY LAZ 187; LAZ187; GM17552
DR CLO; CLO_0013029
DR Coriell; GM17552
RX PubMed=7011617;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C129074; Immunodeficiency with hyper-IgM type 2
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LAZ-221
AC CVCL_1830
SY Laz-221; LAZ 221; Laz 221; LAZ221; Laz221
DR Cosmic; 798667
DR Cosmic; 801716
DR Cosmic; 998709
DR Cosmic; 994181
DR Cosmic; 1037710
DR Cosmic; 2491081
DR DSMZ; ACC-716
DR Lonza; 126
RX Patent=US4550086;
RX PubMed=205365;
RX PubMed=8315353;
RX PubMed=9067587;
RX PubMed=21326318;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Doubling time: >=4 days (PubMed=205365); ~50-80 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D16S539: 11
ST D5S818: 11,14
ST D7S820: 8,11
ST TH01: 8,9
ST TPOX: 11
ST vWA: 17
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GY04 ! LAZ-388
SX Female
CA Cancer cell line
//
ID LAZ-248
AC CVCL_GY07
SY LAZ 248; LAZ248; GM17557
DR CLO; CLO_0013031
DR Coriell; GM17557
RX PubMed=7011617;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C129074; Immunodeficiency with hyper-IgM type 2
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LAZ-256
AC CVCL_IQ26
SY Laz 256
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LAZ-388
AC CVCL_GY04
SY Laz-388; LAZ 388; Laz 388; LAZ388; Laz388
RX PubMed=3884668;
RX PubMed=8315353;
RX PubMed=21326318;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1830 ! LAZ-221
SX Female
CA Transformed cell line
//
ID LAZ-434
AC CVCL_IQ29
SY LAZ 434
RX PubMed=6346879;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LAZ-444
AC CVCL_IQ32
SY LAZ 444; LAZ44
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0475 ! OVCA433
SX Female
CA Transformed cell line
//
ID LAZ-446
AC CVCL_IQ28
SY LAZ 446
RX PubMed=6346879;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3769 ! OVCA432
SX Female
CA Transformed cell line
//
ID LAZ-461
AC CVCL_IQ23
SY Laz-461; LAZ 461; Laz 461; Laz461
RX PubMed=3884668;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LAZ-471
AC CVCL_IQ27
SY LAZ 471; Laz 471
RX Patent=US4550086;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LAZ-509
AC CVCL_IQ22
SY LAZ 509; Laz 509; LAZ509; Laz509
RX Patent=US4550086;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LAZ-67
AC CVCL_GY08
SY LAZ 67; Laz 67; LAZ67
RX PubMed=209464;
RX PubMed=7011617;
CC From: Lazarus H.; Dana-Farber Cancer Institute; Boston; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LB
AC CVCL_E751
SY LB-S; LBS
DR dbMHC; 48944
DR ECACC; 94022541
DR IHW; IHW9289
DR IMGT/HLA; 10964
WW http://bioinformatics.hsanmartino.it/ecbr/cl289.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Lb 224
AC CVCL_J297
DR CLO; CLO_0007250
DR CLDB; cl3179
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Lb 23
AC CVCL_J298
DR CLO; CLO_0007251
DR CLDB; cl3180
RX PubMed=2567642;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Lb 24
AC CVCL_J299
DR CLO; CLO_0007252
DR CLDB; cl3181
RX PubMed=2567642;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LB 27.4
AC CVCL_K219
SY LB 15.13; LB-15.13
DR CLO; CLO_0007253
DR ATCC; HB-99
RX PubMed=6980413;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K166 ! L10.A 2J
CA Hybridoma
//
ID Lb 752
AC CVCL_J300
DR CLO; CLO_0007254
DR CLDB; cl3182
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84898; Mucopolysaccharidosis type IIIB
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LB 84-1
AC CVCL_M514
SY LB84.1
RX PubMed=2492835;
RX PubMed=2537114;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LB 84-2
AC CVCL_W399
SY LB84.2; LB-842; LB842
RX PubMed=2783661;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB 84-3
AC CVCL_W400
SY LB84.3; LB-843; LB843
RX PubMed=2537114;
RX PubMed=2783661;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB 84-4
AC CVCL_W401
SY LB84.4; LB-844; LB844
RX PubMed=2783661;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB 84-5
AC CVCL_W402
SY LB84.5; LB-845; LB845
RX PubMed=2537114;
RX PubMed=2783661;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB 85-1
AC CVCL_W403
SY LB85.1; LB-851
RX PubMed=2537114;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB-831
AC CVCL_E903
SY LB-83-1
DR Cosmic; 742954
RX PubMed=3927997;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E904 ! LB-832
SX Female
CA Cancer cell line
//
ID LB-832
AC CVCL_E904
RX PubMed=3927997;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E903 ! LB-831
SX Female
CA Cancer cell line
//
ID LB-B7
AC CVCL_3390
DR CLDB; cl7170
DR ICLC; HTL05007
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LB-F9
AC CVCL_3391
DR CLDB; cl7169
DR ICLC; HTL05004
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LB10.Bm
AC CVCL_5312
DR CLO; CLO_0007255
DR ATCC; CRL-6060
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6060; true.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5313 ! LB10.K
OI CVCL_5314 ! LB10.Ln
OI CVCL_5315 ! LB10.Sp
OI CVCL_5316 ! LB10.Thy
SX Female
CA Cancer cell line
//
ID LB10.K
AC CVCL_5313
DR CLO; CLO_0007256
DR ATCC; CRL-6061
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5312 ! LB10.Bm
OI CVCL_5314 ! LB10.Ln
OI CVCL_5315 ! LB10.Sp
OI CVCL_5316 ! LB10.Thy
SX Female
CA Finite cell line
//
ID LB10.Ln
AC CVCL_5314
DR CLO; CLO_0007257
DR ATCC; CRL-6062
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6062; true.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5312 ! LB10.Bm
OI CVCL_5313 ! LB10.K
OI CVCL_5315 ! LB10.Sp
OI CVCL_5316 ! LB10.Thy
SX Female
CA Finite cell line
//
ID LB10.Sp
AC CVCL_5315
DR CLO; CLO_0007258
DR ATCC; CRL-6063
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6063; true.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5312 ! LB10.Bm
OI CVCL_5313 ! LB10.K
OI CVCL_5314 ! LB10.Ln
OI CVCL_5316 ! LB10.Thy
SX Female
CA Cancer cell line
//
ID LB10.Thy
AC CVCL_5316
DR CLO; CLO_0007259
DR ATCC; CRL-6064
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6064; true.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5312 ! LB10.Bm
OI CVCL_5313 ! LB10.K
OI CVCL_5314 ! LB10.Ln
OI CVCL_5315 ! LB10.Sp
SX Female
CA Cancer cell line
//
ID LB1017-HNSC
AC CVCL_F234
SY LB1017-ORL; LB1017
RX PubMed=14762065;
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===LB1017-ORL%20cells&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Omics: CNV analysis.
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB1047-EBV
AC CVCL_E908
RX PubMed=14762065;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1364 ! LB1047-RCC
SX Female
CA Transformed cell line
//
ID LB1047-RCC
AC CVCL_1364
DR ChEMBL-Cells; CHEMBL3308329
DR ChEMBL-Targets; CHEMBL2366136
DR Cosmic; 753577
DR Cosmic-CLP; 753577
DR GDSC; 753577
DR GEO; GSM1670033
RX PubMed=27397505;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 12,13
ST D7S820: 9
ST TH01: 7
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E908 ! LB1047-EBV
SX Female
CA Cancer cell line
//
ID LB11.Bm
AC CVCL_N503
DR ATCC; CRL-6065
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6065; true.
CC Breed/subspecies: Hereford.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5317 ! LB11.Ln
OI CVCL_5318 ! LB11.Sp
OI CVCL_5319 ! LB11.Thy
SX Male
CA Finite cell line
//
ID LB11.Ln
AC CVCL_5317
DR CLO; CLO_0007260
DR ATCC; CRL-6066
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6066; true.
CC Breed/subspecies: Hereford.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_N503 ! LB11.Bm
OI CVCL_5318 ! LB11.Sp
OI CVCL_5319 ! LB11.Thy
SX Male
CA Finite cell line
//
ID LB11.Sp
AC CVCL_5318
DR CLO; CLO_0007261
DR ATCC; CRL-6067
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6067; true.
CC Breed/subspecies: Hereford.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_N503 ! LB11.Bm
OI CVCL_5317 ! LB11.Ln
OI CVCL_5319 ! LB11.Thy
SX Male
CA Cancer cell line
//
ID LB11.Thy
AC CVCL_5319
DR CLO; CLO_0007262
DR ATCC; CRL-6068
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6068; true.
CC Breed/subspecies: Hereford.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_N503 ! LB11.Bm
OI CVCL_5317 ! LB11.Ln
OI CVCL_5318 ! LB11.Sp
SX Male
CA Cancer cell line
//
ID LB126-SCLC
AC CVCL_F235
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===lung%20-%20LB126-SCLC%20cells&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB129-SLCL
AC CVCL_DQ75
SY LB-129-SLCL
DR IMGT/HLA; 10966
RX PubMed=9872818;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Derived from metastatic site: Mediastinal lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LB1319-MEL
AC CVCL_F239
RX PubMed=23493799;
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===skin%20-%20LB1319-MEL&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Derived from metastatic site: Inguinal lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB1610-MEL
AC CVCL_E915
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB1622-MEL
AC CVCL_F238
RX PubMed=9894850;
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===skin%20-%20LB1622-MEL&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Derived from metastatic site: In-transit between skin and lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LB173
AC CVCL_2551
DR ECACC; 98062316
RX PubMed=1672363;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8779 ! 144BR
SX Male
CA Transformed cell line
//
ID LB182
AC CVCL_2552
DR ECACC; 98062317
RX PubMed=1672363;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2271 ! 149BR
SX Male
CA Transformed cell line
//
ID LB185
AC CVCL_2553
DR ECACC; 98062318
RX PubMed=1672363;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9
ST D5S818: 10,13
ST D7S820: 11
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2272 ! 153BR
SX Male
CA Transformed cell line
//
ID LB188-SAR
AC CVCL_F232
SY LB188-SARC; LB188
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===LB188-SARC%20cells&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C9118; Sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB198
AC CVCL_2554
DR ECACC; 98062320
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W045 ! TTD HM 1BR
SX Female
CA Transformed cell line
//
ID LB199
AC CVCL_2555
DR ECACC; 98062321
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=11416159
ST Amelogenin: X,Y
ST D18S51: 13,21
ST D21S11: 30,31
ST D8S1179: 11,14
ST FGA: 20,21
ST TH01: 9.3
ST vWA: 17,18
DI NCIt; C4924; Trichothiodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W046 ! TTD1BR
SX Male
CA Transformed cell line
//
ID LB2033-MEL
AC CVCL_DD44
RX PubMed=23493799;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB205
AC CVCL_2556
DR ECACC; 98062329
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W049 ! XP11BR
SX Male
CA Transformed cell line
//
ID LB2241-RCC
AC CVCL_1365
DR ChEMBL-Cells; CHEMBL3308330
DR ChEMBL-Targets; CHEMBL2366330
DR Cosmic; 753578
DR Cosmic-CLP; 753578
DR GDSC; 753578
DR GEO; GSM1670034
RX PubMed=27397505;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 11
ST D16S539: 11
ST D5S818: 12,13
ST D7S820: 10
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LB23-SAR
AC CVCL_E936
SY LB23-SARC
RX PubMed=10919659;
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===LB23-SARC%20cells&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3359; Rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB24-MEL
AC CVCL_E932
SY LB-24-Mel; LB-24-MEL; LB-24; LB24
DR BTO; BTO:0006007
DR Cosmic; 1295339
RX PubMed=8340755;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB242
AC CVCL_2557
DR ECACC; 98062324
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W050 ! CS4BR
SX Female
CA Transformed cell line
//
ID LB2518-EBV
AC CVCL_E914
RX PubMed=14762065;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1366 ! LB2518-MEL
SX Female
CA Transformed cell line
//
ID LB2518-MEL
AC CVCL_1366
DR ChEMBL-Cells; CHEMBL3308331
DR ChEMBL-Targets; CHEMBL2366335
DR Cosmic; 753579
DR Cosmic-CLP; 753579
DR GDSC; 753579
DR GEO; GSM1670035
RX PubMed=14762065;
RX PubMed=27397505;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,11
ST D16S539: 11,13
ST D5S818: 12,13
ST D7S820: 10
ST TH01: 6
ST TPOX: 8,9
ST vWA: 14,15
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E914 ! LB2518-EBV
SX Female
CA Cancer cell line
//
ID LB253
AC CVCL_2558
DR ECACC; 98062330
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9,13
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LB2531-MEL-Z
AC CVCL_V410
DR Cosmic; 753580
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB277
AC CVCL_2559
DR ECACC; 98062331
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LB3.1
AC CVCL_G667
DR CLO; CLO_0007263
DR ATCC; HB-298
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LB30-MEL
AC CVCL_E935
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===skin%20-%20LB30-MEL%20cells&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB316
AC CVCL_2560
DR ECACC; 98062333
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W051 ! XP8BR
SX Male
CA Transformed cell line
//
ID LB33-MEL.A
AC CVCL_E933
RX PubMed=7875194;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Derived from metastatic site: Hypodermis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E934 ! LB33-MEL.B
SX Female
CA Cancer cell line
//
ID LB33-MEL.B
AC CVCL_E934
RX PubMed=7875194;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Derived from metastatic site: Small intestine.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E933 ! LB33-MEL.A
SX Female
CA Cancer cell line
//
ID LB37-NSLCL
AC CVCL_DQ76
SY LB-37-NSLCL
RX PubMed=9872818;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LB373-EBV
AC CVCL_E917
RX PubMed=14762065;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E918 ! LB373-MEL
SX Female
CA Transformed cell line
//
ID LB373-MEL
AC CVCL_E918
SY LB373
RX PubMed=14762065;
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===skin%20-%20LB373-MEL%20cells&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Omics: CNV analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E917 ! LB373-EBV
SX Female
CA Cancer cell line
//
ID LB373-MEL-D
AC CVCL_1367
DR ChEMBL-Cells; CHEMBL3308336
DR ChEMBL-Targets; CHEMBL2366296
DR Cosmic; 753581
DR Cosmic-CLP; 753581
DR GDSC; 753581
DR GEO; GSM1670036
RX PubMed=27397505;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8,10
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8
ST TH01: 6,9
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E918 ! LB373-MEL
SX Female
CA Cancer cell line
//
ID LB39-MEL
AC CVCL_F240
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===skin%20-%20LB39-MEL&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB4
AC CVCL_3389
DR CLDB; cl7168
DR ICLC; HTL05003
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LB4-MEL
AC CVCL_F241
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===skin%20-%20LB4-MEL%20cells&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB42
AC CVCL_2561
DR ECACC; 98062313
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LB443
AC CVCL_2562
DR ECACC; 98062322
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C4924; Trichothiodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W052 ! TTD4BR
SX Male
CA Transformed cell line
//
ID LB45-MEL
AC CVCL_E937
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===skin%20-%20LB45-MEL%20cells&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB541
AC CVCL_2563
DR ECACC; 98062326
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LB58
AC CVCL_2564
DR ECACC; 98062325
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LB583-MEL
AC CVCL_DD45
RX PubMed=23493799;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB59Ly
AC CVCL_E902
RX PubMed=6270254;
DI NCIt; C131469; Bovine leukemia
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Cancer cell line
//
ID LB647-SCLC
AC CVCL_1368
DR ChEMBL-Cells; CHEMBL3308332
DR ChEMBL-Targets; CHEMBL2366140
DR Cosmic; 753582
DR Cosmic; 1995478
DR Cosmic-CLP; 753582
DR GDSC; 753582
DR GEO; GSM1670037
RX PubMed=27397505;
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===lung%20-%20LB647-SCLC%20cells&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,13
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 12
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LB687
AC CVCL_2565
DR ECACC; 98062335
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LB7
AC CVCL_2566
DR ECACC; 98062312
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LB70-MEL
AC CVCL_F237
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===skin%20-%20LB70-MEL&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB707
AC CVCL_2567
DR ECACC; 98062336
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LB708
AC CVCL_2568
DR ECACC; 98062337
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LB750
AC CVCL_2569
DR ECACC; 98062323
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C4924; Trichothiodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LB771-HNC
AC CVCL_1369
SY LB771-HNSCC; LB771-ORL
DR ChEMBL-Cells; CHEMBL3308308
DR ChEMBL-Targets; CHEMBL2366099
DR Cosmic; 753583
DR Cosmic-CLP; 753583
DR GDSC; 753583
DR GEO; GSM1670038
RX PubMed=27397505;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 7,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 19
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LB796-BLC
AC CVCL_E906
SY LB796
RX PubMed=11051255;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB7alpha2mC25
AC CVCL_V117
DR CLO; CLO_0007265
DR CLDB; cl3183
DR IHW; IHW8022
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LB804-ALL
AC CVCL_F236
SY LB804-LEU; LB804
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===LB804-LEU%20cells&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3167; Acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB81
AC CVCL_2570
DR ECACC; 98062327
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3969; Xeroderma pigmentosum, complementation group G
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LB823
AC CVCL_2571
DR ECACC; 98062338
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3968; Xeroderma pigmentosum, complementation group F
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LB83
AC CVCL_2572
SY XPG83; XPG 83
DR ECACC; 98062328
RX PubMed=8327515;
RX PubMed=8483504;
RX PubMed=8483505;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3969; Xeroderma pigmentosum, complementation group G
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W053 ! XP125LO
SX Female
CA Transformed cell line
//
ID LB831-BLC
AC CVCL_1370
SY LB831
DR ChEMBL-Cells; CHEMBL3308853
DR ChEMBL-Targets; CHEMBL2366222
DR Cosmic; 753584
DR Cosmic-CLP; 753584
DR GDSC; 753584
DR GEO; GSM1670039
DR TOKU-E; 3997
RX PubMed=9637538;
RX PubMed=11051255;
RX PubMed=27397505;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 12
ST D5S818: 12,13
ST D7S820: 10,12
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E913 ! LB831-EBV
SX Male
CA Cancer cell line
//
ID LB831-EBV
AC CVCL_E913
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1370 ! LB831-BLC
SX Male
CA Transformed cell line
//
ID LB9.Bm
AC CVCL_5320
DR CLO; CLO_0007266
DR ATCC; CRL-6053
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5321 ! LB9.D
OI CVCL_S344 ! LB9.K
OI CVCL_S343 ! LB9.Li
OI CVCL_5322 ! LB9.Ln
OI CVCL_5323 ! LB9.Sp
OI CVCL_5324 ! LB9.Sp/Thy/Bm
OI CVCL_5325 ! LB9.Thy
SX Female
CA Cancer cell line
//
ID LB9.D
AC CVCL_5321
SY LB9.Sk
DR CLO; CLO_0007267
DR ATCC; CRL-6054
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5320 ! LB9.Bm
OI CVCL_S344 ! LB9.K
OI CVCL_S343 ! LB9.Li
OI CVCL_5322 ! LB9.Ln
OI CVCL_5323 ! LB9.Sp
OI CVCL_5324 ! LB9.Sp/Thy/Bm
OI CVCL_5325 ! LB9.Thy
SX Female
CA Finite cell line
//
ID LB9.K
AC CVCL_S344
DR ATCC; CRL-6055
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6055; true.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5320 ! LB9.Bm
OI CVCL_5321 ! LB9.D
OI CVCL_S343 ! LB9.Li
OI CVCL_5322 ! LB9.Ln
OI CVCL_5323 ! LB9.Sp
OI CVCL_5324 ! LB9.Sp/Thy/Bm
OI CVCL_5325 ! LB9.Thy
SX Female
CA Finite cell line
//
ID LB9.Li
AC CVCL_S343
DR ATCC; CRL-6056
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6056; true.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5320 ! LB9.Bm
OI CVCL_5321 ! LB9.D
OI CVCL_S344 ! LB9.K
OI CVCL_5322 ! LB9.Ln
OI CVCL_5323 ! LB9.Sp
OI CVCL_5324 ! LB9.Sp/Thy/Bm
OI CVCL_5325 ! LB9.Thy
SX Female
CA Finite cell line
//
ID LB9.Ln
AC CVCL_5322
DR CLO; CLO_0007268
DR ATCC; CRL-6057
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6057; true.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5320 ! LB9.Bm
OI CVCL_5321 ! LB9.D
OI CVCL_S344 ! LB9.K
OI CVCL_S343 ! LB9.Li
OI CVCL_5323 ! LB9.Sp
OI CVCL_5324 ! LB9.Sp/Thy/Bm
OI CVCL_5325 ! LB9.Thy
SX Female
CA Finite cell line
//
ID LB9.Sp
AC CVCL_5323
DR CLO; CLO_0007269
DR ATCC; CRL-6058
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6058; true.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5320 ! LB9.Bm
OI CVCL_5321 ! LB9.D
OI CVCL_S344 ! LB9.K
OI CVCL_S343 ! LB9.Li
OI CVCL_5322 ! LB9.Ln
OI CVCL_5324 ! LB9.Sp/Thy/Bm
OI CVCL_5325 ! LB9.Thy
SX Female
CA Cancer cell line
//
ID LB9.Sp/Thy/Bm
AC CVCL_5324
SY LB9.Sp/Thy
DR CLO; CLO_0007270
DR ATCC; CRL-6052
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6052; true.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5320 ! LB9.Bm
OI CVCL_5321 ! LB9.D
OI CVCL_S344 ! LB9.K
OI CVCL_S343 ! LB9.Li
OI CVCL_5322 ! LB9.Ln
OI CVCL_5323 ! LB9.Sp
OI CVCL_5325 ! LB9.Thy
SX Female
CA Cancer cell line
//
ID LB9.Thy
AC CVCL_5325
DR CLO; CLO_0007271
DR ATCC; CRL-6059
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6059; true.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5320 ! LB9.Bm
OI CVCL_5321 ! LB9.D
OI CVCL_S344 ! LB9.K
OI CVCL_S343 ! LB9.Li
OI CVCL_5322 ! LB9.Ln
OI CVCL_5323 ! LB9.Sp
OI CVCL_5324 ! LB9.Sp/Thy/Bm
SX Female
CA Finite cell line
//
ID LB905-BLC
AC CVCL_E905
SY LB905
RX PubMed=11051255;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB929-MEL
AC CVCL_F233
SY LB929
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===skin%20-%20LB929-MEL&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB951-MEL
AC CVCL_E916
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LB96-SAR
AC CVCL_F721
DR IMGT/HLA; 10968
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LB996-EBV
AC CVCL_E912
RX PubMed=14762065;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1371 ! LB996-RCC
SX Male
CA Transformed cell line
//
ID LB996-RCC
AC CVCL_1371
DR ChEMBL-Cells; CHEMBL3308309
DR ChEMBL-Targets; CHEMBL2366110
DR Cosmic; 753585
DR Cosmic-CLP; 753585
DR GDSC; 753585
DR GEO; GSM1670040
RX PubMed=14762065;
RX PubMed=27397505;
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===kidney%20-%20LB996-RCC%20cells&-Find
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 9,10
ST TPOX: 9,11
ST vWA: 14,17
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E912 ! LB996-EBV
SX Male
CA Cancer cell line
//
ID LbetaT2
AC CVCL_0398
SY L-beta-T2; Lbetat2
DR BTO; BTO:0004467
DR EFO; EFO_0002070
DR MCCL; MCC:0000292
DR Lonza; 1263
DR TOKU-E; 4079
RX PubMed=8770922;
RX PubMed=8898243;
RX PubMed=15541569;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID LbetaT4
AC CVCL_U354
SY L-beta-T4
RX PubMed=8898243;
RX PubMed=15541569;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID LBF
AC CVCL_E752
SY LBUF; GM03163
DR CLO; CLO_0013548
DR Coriell; GM03163
DR dbMHC; 48945
DR dbMHC; 48946
DR ECACC; 88052096
DR IHW; IHW9096
DR IHW; IHW9048
DR IMGT/HLA; 10969
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl96.html
WW http://bioinformatics.hsanmartino.it/ecbr/cl48.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 88052096; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LBF-2
AC CVCL_R977
CC Group: Fish cell line.
OX NCBI_TaxID=27706; ! Micropterus salmoides
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LBLN
AC CVCL_5326
DR CLO; CLO_0007273
DR ATCC; CRL-6046
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6046; true.
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Finite cell line
//
ID LBRM-33
AC CVCL_K174
RX PubMed=6968790;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=LBRM-33
CC Breed/subspecies: B10.BR.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID LBRM-33 clone 1A5
AC CVCL_3839
SY LBRM-33-1A5; LBRM-33 1A5; LBRM-33 1 A-5; 1A5
DR CLO; CLO_0007276
DR CLDB; cl3185
DR ATCC; CRL-8079
DR ECACC; 86060302
DR KCLB; 28079
RX Patent=US4404280;
RX PubMed=6968790;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=LBRM-33
CC Discontinued: KCLB; 28079; probable.
CC Breed/subspecies: B10.BR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K174 ! LBRM-33
CA Cancer cell line
//
ID LBRM-33 clone 4A2
AC CVCL_6490
SY LBRM-33-4A2; LBRM-33 4A2; 4A2
DR CLO; CLO_0007275
DR ATCC; TIB-155
RX PubMed=6968790;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=LBRM-33
CC Breed/subspecies: B10.BR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K174 ! LBRM-33
CA Cancer cell line
//
ID LBRM-33 clone 5A4
AC CVCL_K175
SY LBRM-33-5A4; LBRM-33 5A4; 5A4
DR ATCC; CRL-8080
RX Patent=US4404280;
RX PubMed=6968790;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=LBRM-33
CC Discontinued: ATCC; CRL-8080; probable.
CC Breed/subspecies: B10.BR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K174 ! LBRM-33
CA Cancer cell line
//
ID LBRM-TG6
AC CVCL_4239
SY LBRM TG6
DR CLO; CLO_0007274
DR ATCC; CRL-1778
DR ECACC; 96020937
RX PubMed=3873500;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=LBRM-TG6
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: B10.BR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6490 ! LBRM-33 clone 4A2
CA Cancer cell line
//
ID LC-06-JCK
AC CVCL_D550
SY LC06JCK
RX PubMed=19265263;
DI NCIt; C45516; Lung clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC-1/sq
AC CVCL_3008
SY LC-1 sq; LC-1-sq; LC-1Sq; LC1/Sq; LC1-Sq; LC1-sq; LC1sq; Lc1sq; LC1SQ; Lung cancer-1/squamous; LC-1
DR CLO; CLO_0050045
DR BioSample; SAMN03471667
DR CGH-DB; 188-1
DR CGH-DB; 9178-4
DR Cosmic; 713858
DR Cosmic; 801579
DR Cosmic; 844843
DR Cosmic; 876169
DR Cosmic; 889102
DR Cosmic; 917979
DR Cosmic; 929146
DR Cosmic; 932926
DR Cosmic; 1219072
DR Cosmic; 1239906
DR Cosmic-CLP; 1298223
DR GDSC; 1298223
DR GEO; GSM784280
DR GEO; GSM827201
DR GEO; GSM1374618
DR GEO; GSM1670042
DR JCRB; JCRB0258
DR RCB; RCB0455
RX PubMed=1917142;
RX PubMed=11005564;
RX PubMed=14581340;
RX PubMed=15185009;
RX PubMed=15746151;
RX PubMed=19472407;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,13
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 12
ST TH01: 7,9
ST TPOX: 8,12
ST vWA: 17,18
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1372 ! LC-1F
SX Male
CA Cancer cell line
//
ID LC-1/sq-SF
AC CVCL_5480
SY LC1_sq-SF
DR CLO; CLO_0050066
DR CCLE; LC1SQSF_LUNG
DR Cosmic; 2125266
DR GEO; GSM887263
DR GEO; GSM888338
DR RCB; RCB0438
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,13
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 12
ST TH01: 7,9
ST TPOX: 8,12
ST vWA: 17,18
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3008 ! LC-1/sq
SX Male
CA Cancer cell line
//
ID LC-1F
AC CVCL_1372
SY Lung cancer-1/squamous, floating variant
DR CLO; CLO_0050026
DR EFO; EFO_0002827
DR BioSample; SAMN03472313
DR CCLE; LC1F_LUNG
DR ChEMBL-Cells; CHEMBL3308207
DR ChEMBL-Targets; CHEMBL2366216
DR Cosmic; 907785
DR Cosmic; 1995479
DR GDSC; 907785
DR GEO; GSM1670041
DR RCB; RCB0439
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: DNA methylation analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 12
ST TH01: 7,9
ST TPOX: 8,12
ST vWA: 17,18
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3008 ! LC-1/sq
SX Male
CA Cancer cell line
//
ID LC-2/ad
AC CVCL_1373
SY LC-2-Ad; LC-2-ad; LC-2 ad; LC2/Ad; LC2/AD
DR CLO; CLO_0050073
DR EFO; EFO_0003140
DR BioSample; SAMN03472314
DR ChEMBL-Cells; CHEMBL3308545
DR ChEMBL-Targets; CHEMBL2366260
DR Cosmic; 907786
DR Cosmic; 946052
DR Cosmic; 1154602
DR Cosmic; 1571726
DR Cosmic; 1656903
DR Cosmic; 1995480
DR Cosmic-CLP; 907786
DR ECACC; 94072247
DR GDSC; 907786
DR GEO; GSM1670043
DR RCB; RCB0440
RX PubMed=8291444;
RX PubMed=22313637;
RX PubMed=23578175;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; ECACC; RCB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,12
ST D16S539: 9
ST D5S818: 10
ST D7S820: 11
ST TH01: 7
ST TPOX: 11
ST vWA: 16,19
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LC-540
AC CVCL_3536
SY LC540; LC 540
DR CLO; CLO_0007277
DR CLO; CLO_0007278
DR CLO; CLO_0007279
DR CLDB; cl3188
DR CLDB; cl3189
DR ATCC; CCL-43
DR BCRC; 60509
DR CLS; 500262/p2503_LC-540
DR ECACC; 89031604
DR IZSLER; BS TCL 35
DR JCRB; JCRB9064
DR KCLB; 10043
CC Breed/subspecies: Fischer.
DI NCIt; C60429; Rat Leydig cell adenoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID LC-T
AC CVCL_0B64
RX PubMed=1311980;
RX PubMed=7736387;
RX PubMed=10100721;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LC01
AC CVCL_Y146
DR CGH-DB; 424-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC02
AC CVCL_Y147
DR CGH-DB; 400-3
DR CGH-DB; 414-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC02-No.2
AC CVCL_Y148
DR CGH-DB; 404-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC03
AC CVCL_Y149
DR CGH-DB; 436-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC04
AC CVCL_Y150
DR CGH-DB; 437-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC05
AC CVCL_Y151
DR CGH-DB; 438-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC06
AC CVCL_Y152
DR CGH-DB; 399-3
DR CGH-DB; 415-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC07
AC CVCL_Y153
DR CGH-DB; 402-3
DR CGH-DB; 421-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC08
AC CVCL_Y154
DR CGH-DB; 401-3
DR CGH-DB; 417-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC09
AC CVCL_Y155
DR CGH-DB; 425-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC10
AC CVCL_Y156
DR CGH-DB; 426-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC11
AC CVCL_Y157
DR CGH-DB; 427-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC114
AC CVCL_W458
RX PubMed=20724021;
DI NCIt; C3732; Pulmonary blastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LC15
AC CVCL_Y158
DR CGH-DB; 418-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC16
AC CVCL_Y159
DR CGH-DB; 419-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC17
AC CVCL_Y160
DR CGH-DB; 420-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC18
AC CVCL_Y161
DR CGH-DB; 428-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC20
AC CVCL_Y162
DR CGH-DB; 429-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC21
AC CVCL_Y163
DR CGH-DB; 439-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC23
AC CVCL_Y164
DR CGH-DB; 430-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC25
AC CVCL_Y165
DR CGH-DB; 449-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC26
AC CVCL_Y166
DR CGH-DB; 450-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC27
AC CVCL_Y167
DR CGH-DB; 451-3
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LC4-1
AC CVCL_1374
DR BTO; BTO:0004945
DR BioSample; SAMN03470796
DR ChEMBL-Cells; CHEMBL3308835
DR ChEMBL-Targets; CHEMBL2366091
DR Cosmic; 907787
DR Cosmic; 996283
DR Cosmic; 998692
DR Cosmic; 1037719
DR Cosmic-CLP; 907787
DR GDSC; 907787
DR GEO; GSM827293
DR GEO; GSM1670044
DR JCRB; JCRB0114
RX PubMed=3115091;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 8,12
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 17,19
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LC5
AC CVCL_5G52
RX Patent=US5582967;
RX PubMed=2201317;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (L-132) has been shown to be a HeLa derivative.
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-842.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1908 ! L-132
SX Female
CA Cancer cell line
//
ID LC5-HIV
AC CVCL_5G53
RX Patent=US5582967;
RX PubMed=2201317;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Grand-parent cell line (L-132) has been shown to be a HeLa derivative.
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-843.
CC Characteristics: HIV-1 producing cell line.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5G52 ! LC5
SX Female
CA Cancer cell line
//
ID Lc817
AC CVCL_D230
SY LC817
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LCA1-hiPSC1
AC CVCL_C814
SY LCA.1.H.iPSC.1; RIi010-A
DR hPSCreg; RIi010-A
DR RSCB; RSCB0096
CC From: Royan Institute; Theran; Iran.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C815 ! LCA1-hiPSC2
OI CVCL_C816 ! LCA1-hiPSC3
OI CVCL_C817 ! LCA1-hiPSC4
SX Male
CA Induced pluripotent stem cell
//
ID LCA1-hiPSC2
AC CVCL_C815
SY LCA.1.H.iPSC.2
DR RSCB; RSCB0097
CC From: Royan Institute; Theran; Iran.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C814 ! LCA1-hiPSC1
OI CVCL_C816 ! LCA1-hiPSC3
OI CVCL_C817 ! LCA1-hiPSC4
SX Male
CA Induced pluripotent stem cell
//
ID LCA1-hiPSC3
AC CVCL_C816
SY LCA.1.H.iPSC.3
DR RSCB; RSCB0098
CC From: Royan Institute; Theran; Iran.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C814 ! LCA1-hiPSC1
OI CVCL_C815 ! LCA1-hiPSC2
OI CVCL_C817 ! LCA1-hiPSC4
SX Male
CA Induced pluripotent stem cell
//
ID LCA1-hiPSC4
AC CVCL_C817
SY LCA.1.H.iPSC.4
DR RSCB; RSCB0099
CC From: Royan Institute; Theran; Iran.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C814 ! LCA1-hiPSC1
OI CVCL_C815 ! LCA1-hiPSC2
OI CVCL_C816 ! LCA1-hiPSC3
SX Male
CA Induced pluripotent stem cell
//
ID LCAM1
AC CVCL_E062
SY LCAM
DR CLO; CLO_0050034
DR BioSample; SAMN03472135
DR RCB; RCB1425
RX PubMed=9142195;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 11,13
ST D5S818: 10,13
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,12
ST vWA: 15,19
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LCC-18
AC CVCL_W648
SY LCC18
DR TOKU-E; 4056
RX PubMed=1782079;
DI NCIt; C96156; Colorectal neuroendocrine carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LCE
AC CVCL_S937
SY Lates Calcarifer Epitheloid cells
RX DOI=10.1111/j.1365-2109.2005.01387.x;
CC Group: Fish cell line.
OX NCBI_TaxID=8187; ! Lates calcarifer
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LCF
AC CVCL_S938
SY Lates Calcarifer Fibroblastic cells
RX DOI=10.1111/j.1365-2109.2005.01387.x;
CC Group: Fish cell line.
OX NCBI_TaxID=8187; ! Lates calcarifer
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LCG-F
AC CVCL_IJ27
SY Liaoning Cashmere Goat Fibroblast
RX PubMed=23065271;
CC Doubling time: 65.5 hours (PubMed=23065271).
CC Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the cell description.
CC Breed/subspecies: Liaoning cashmere.
OX NCBI_TaxID=9925; ! Capra hircus
SX Female
CA Finite cell line
//
ID LCK
AC CVCL_E753
DR dbMHC; 48947
DR IHW; IHW9367
DR IMGT/HLA; 25978
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL 721
AC CVCL_2102
SY 721; 721 LCL; B-LCL 721; LCL721
DR dbMHC; 48948
DR ECACC; 09071301
DR IHW; IHW9249
DR IMGT/HLA; 10972
RX PubMed=6933474;
WW http://bioinformatics.hsanmartino.it/ecbr/cl249.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL 721.114
AC CVCL_D326
SY 721.114; .114
RX PubMed=2785140;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2102 ! LCL 721
SX Female
CA Transformed cell line
//
ID LCL 721.127
AC CVCL_D329
SY 721.127; .127
RX PubMed=2785140;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2102 ! LCL 721
SX Female
CA Transformed cell line
//
ID LCL 721.144
AC CVCL_D328
SY 721.144; .144
RX PubMed=2785140;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2102 ! LCL 721
SX Female
CA Transformed cell line
//
ID LCL 721.174
AC CVCL_6260
SY 721.174
DR Lonza; 174
RX PubMed=6092300;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2102 ! LCL 721
SX Female
CA Transformed cell line
//
ID LCL 721.180
AC CVCL_6261
SY 721.180; .180
RX PubMed=6092300;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2102 ! LCL 721
SX Female
CA Transformed cell line
//
ID LCL 721.184
AC CVCL_D327
SY 721.184; .184
RX PubMed=2785140;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2102 ! LCL 721
SX Female
CA Transformed cell line
//
ID LCL 721.22
AC CVCL_6262
SY 721.22; .22
DR Lonza; 787
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2102 ! LCL 721
SX Female
CA Transformed cell line
//
ID LCL 721.220
AC CVCL_D325
SY 721.220; .220
RX PubMed=2785140;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2102 ! LCL 721
SX Female
CA Transformed cell line
//
ID LCL 721.221
AC CVCL_6263
SY 721.221; .221
DR ATCC; CRL-1855
DR BioSample; SAMN03471255
DR Lonza; 176
DR TOKU-E; 4103
RX PubMed=2785140;
RX PubMed=3257565;
WW http://www.atcc.org/support/faqs/11472/LCL%20721221%20ATCC%20CRL1855-1077.aspx
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-1855; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 9.3
ST TPOX: 8,12
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2102 ! LCL 721
SX Female
CA Transformed cell line
//
ID LCL 721.45
AC CVCL_E420
SY LCL721.45; 721.45; .45
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2102 ! LCL 721
SX Female
CA Transformed cell line
//
ID LCL 8664
AC CVCL_3464
SY LCL/8664; LCL8664
DR CLO; CLO_0007281
DR ATCC; CRL-1805
RX PubMed=3017870;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 45455; Rhesus lymphocryptovirus (Macacine herpesvirus 4).
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Cancer cell line
//
ID LCL CL-PI 50
AC CVCL_9V46
DR NCBI_Iran; C488
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84663; Cutis laxa
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9V72 ! HCL BMF-PI 51
SX Female
CA Transformed cell line
//
ID LCL-CB-PI 49
AC CVCL_CW03
DR NCBI_Iran; C487
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: NCBI_Iran; C487; probable.
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 9,13
ST D18S51: 15,21
ST D21S11: 27,31
ST D3S1358: 15,17
ST D5S818: 9,11
ST D7S820: 8,11
ST D8S1179: 14,15
ST FGA: 19,20
ST TH01: 6,10
ST TPOX: 8
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LCL-Ho
AC CVCL_1868
SY LCL-HO; LCL Ho
DR CLO; CLO_0007285
DR CLDB; cl3192
DR BioSample; SAMN03473367
DR DSMZ; ACC-185
RX PubMed=10508494;
CC Doubling time: ~30 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Caution: This cell line was reported to be isogenic with MEL-Ho (CVCL_1402) but it does not have the same STR profile (PubMed=10508494).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 13
ST D16S539: 13
ST D5S818: 11
ST D7S820: 8,12
ST TH01: 7,9.3
ST TPOX: 9,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-OHN
AC CVCL_W859
RX PubMed=3034807;
RX PubMed=12967475;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LCL-partial trisomy 12p13
AC CVCL_GR58
RX PubMed=223966;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the cell description.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 1
AC CVCL_9V47
DR NCBI_Iran; C159
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 9,11
ST D18S51: 16,17
ST D21S11: 32,33
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 13,14
ST FGA: 22,24
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 100
AC CVCL_CV96
DR NCBI_Iran; C311
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 101
AC CVCL_9V60
DR NCBI_Iran; C312
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 8,11
ST D18S51: 15,16
ST D21S11: 29,33
ST D3S1358: 16,18
ST D5S818: 13
ST D7S820: 8,11
ST D8S1179: 11,15
ST FGA: 22,24
ST TH01: 6,9
ST TPOX: 11
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 103
AC CVCL_CV98
DR NCBI_Iran; C314
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 104
AC CVCL_9V61
DR NCBI_Iran; C315
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 12
ST D18S51: 15,19
ST D21S11: 28,31
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 12,13
ST D8S1179: 13,15
ST FGA: 19,24
ST TH01: 9,10
ST TPOX: 8
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 105
AC CVCL_CW00
DR NCBI_Iran; C316
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 106
AC CVCL_CW01
DR NCBI_Iran; C317
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 11
AC CVCL_9V53
DR NCBI_Iran; C177
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LCL-PI 116
AC CVCL_CW02
DR NCBI_Iran; C327
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 117
AC CVCL_9V62
DR NCBI_Iran; C328
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 13,15
ST D21S11: 27,31
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 11,12
ST D8S1179: 13,15
ST FGA: 26
ST TH01: 6,10
ST TPOX: 11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 118
AC CVCL_CW04
DR NCBI_Iran; C329
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 12
AC CVCL_9V54
DR NCBI_Iran; C178
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12,13
ST D16S539: 10,11
ST D18S51: 15,18
ST D21S11: 27,28
ST D3S1358: 15,17
ST D5S818: 10,12
ST D7S820: 11,12
ST D8S1179: 15,16
ST FGA: 19
ST TH01: 6
ST TPOX: 7,8
ST vWA: 15,18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LCL-PI 120
AC CVCL_CW05
DR NCBI_Iran; C331
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 122
AC CVCL_CW06
DR NCBI_Iran; C333
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 129
AC CVCL_9V63
DR NCBI_Iran; C340
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,11
ST D16S539: 8,10
ST D18S51: 15,16
ST D21S11: 30,31
ST D3S1358: 15,18
ST D5S818: 10
ST D7S820: 12,13
ST D8S1179: 13,14
ST FGA: 21,22
ST TH01: 6
ST TPOX: 8
ST vWA: 13,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 133
AC CVCL_9V64
DR NCBI_Iran; C344
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 9,10
ST D16S539: 9,11
ST D18S51: 12
ST D21S11: 28,32
ST D3S1358: 15,18
ST D5S818: 11,13
ST D7S820: 8,10
ST D8S1179: 11,13
ST FGA: 21,25
ST TH01: 6,10
ST TPOX: 8,12
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 135
AC CVCL_CW09
DR NCBI_Iran; C346
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 14
AC CVCL_CV53
DR NCBI_Iran; C225
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 140
AC CVCL_CW10
DR NCBI_Iran; C351
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 141
AC CVCL_CW11
SY LCL-PI141
DR NCBI_Iran; C423
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 145
AC CVCL_CW12
DR NCBI_Iran; C356
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 146
AC CVCL_9V65
DR NCBI_Iran; C357
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8,10
ST D16S539: 8,12
ST D18S51: 14,16
ST D21S11: 30,31
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 15
ST FGA: 20
ST TH01: 9,10
ST TPOX: 8,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 147
AC CVCL_CW13
DR NCBI_Iran; C358
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 158
AC CVCL_CW14
DR NCBI_Iran; C369
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 162
AC CVCL_9V66
DR NCBI_Iran; C373
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 14,16
ST D21S11: 27,32
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10,13
ST D8S1179: 11,15
ST FGA: 22,25
ST TH01: 9,10
ST TPOX: 8
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 170
AC CVCL_9V67
DR NCBI_Iran; C381
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 11,13
ST D21S11: 28,29
ST D3S1358: 16,19
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 10
ST FGA: 21
ST TH01: 6,7
ST TPOX: 10,12
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 171
AC CVCL_9V68
DR NCBI_Iran; C382
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 11,13
ST D16S539: 11,12
ST D18S51: 15,21
ST D21S11: 29,31
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 10
ST FGA: 22
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 172
AC CVCL_CW17
DR NCBI_Iran; C383
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 173
AC CVCL_CW18
DR NCBI_Iran; C384
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 178
AC CVCL_CW19
DR NCBI_Iran; C389
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 179
AC CVCL_9V69
DR NCBI_Iran; C390
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9,11
ST D18S51: 13,18
ST D21S11: 31
ST D3S1358: 15,17
ST D5S818: 11,13
ST D7S820: 11,13
ST D8S1179: 12,14
ST FGA: 18,24
ST TH01: 7,8
ST TPOX: 8
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 18
AC CVCL_CV54
DR NCBI_Iran; C229
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 184
AC CVCL_9V70
DR NCBI_Iran; C395
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 10,12
ST D18S51: 12,15
ST D21S11: 26,27
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 8
ST D8S1179: 13,14
ST FGA: 21,24
ST TH01: 6
ST TPOX: 8
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 185
AC CVCL_CW22
DR NCBI_Iran; C396
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 187
AC CVCL_CW23
DR NCBI_Iran; C398
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 188
AC CVCL_CW24
DR NCBI_Iran; C399
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 199
AC CVCL_CW25
DR NCBI_Iran; C410
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 20
AC CVCL_CV55
DR NCBI_Iran; C231
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 200
AC CVCL_CW26
DR NCBI_Iran; C411
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 203
AC CVCL_CW29
SY LCL-PI203
DR NCBI_Iran; C424
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 207
AC CVCL_CW27
DR NCBI_Iran; C418
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 21
AC CVCL_CV56
DR NCBI_Iran; C232
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 210
AC CVCL_CW28
DR NCBI_Iran; C421
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 211
AC CVCL_CV66
DR NCBI_Iran; C422
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Caution: There seems to be 3 distinct cell lines which were assigned NCBI_Iran catalog number C422.
CC Discontinued: NCBI_Iran; C422; probable.
ST Source(s): PubMed=17254797
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 10,11
ST D18S51: 14
ST D21S11: 29
ST D3S1358: 15,17
ST D5S818: 9,13
ST D7S820: 8,11
ST D8S1179: 10,15
ST FGA: 19,20
ST TH01: 6
ST TPOX: 8
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 25
AC CVCL_CV57
SY LCL-PI25
DR NCBI_Iran; C426
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Caution: There seems to be two distinct cell lines which were assigned NCBI_Iran catalog number C426.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 28
AC CVCL_CV58
DR NCBI_Iran; C239
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 29
AC CVCL_CV59
DR NCBI_Iran; C240
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 30
AC CVCL_CV60
DR NCBI_Iran; C241
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 31
AC CVCL_CV61
DR NCBI_Iran; C242
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 311
AC CVCL_CV97
DR NCBI_Iran; C522
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Caution: There seems to be two distinct cell lines which were assigned NCBI_Iran catalog number C522.
CC Discontinued: NCBI_Iran; C522; probable.
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,14
ST D16S539: 12,13
ST D18S51: 11,19
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 11,13
ST FGA: 19,25
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LCL-PI 316
AC CVCL_CV99
DR NCBI_Iran; C527
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Caution: There seems to be two distinct cell lines which were assigned NCBI_Iran catalog number C527.
CC Discontinued: NCBI_Iran; C527; probable.
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,9
ST D16S539: 9,12
ST D18S51: 15,17
ST D21S11: 30,32
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 8,9
ST D8S1179: 10,14
ST FGA: 19,22
ST TH01: 7,8
ST TPOX: 8,10
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LCL-PI 33
AC CVCL_9V55
DR NCBI_Iran; C244
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 13,16
ST D21S11: 29,31
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 14,15
ST FGA: 23,24
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 34
AC CVCL_CV62
DR NCBI_Iran; C245
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 35
AC CVCL_9V56
DR NCBI_Iran; C246
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LCL-PI 36
AC CVCL_CV63
DR NCBI_Iran; C247
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 37
AC CVCL_CV64
DR NCBI_Iran; C248
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 4
AC CVCL_9V48
SY LCL PI 4
DR NCBI_Iran; C173
RX CelloPub=CLPUB00310;
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 10,12
ST D18S51: 12
ST D21S11: 29,31
ST D3S1358: 16,18
ST D5S818: 12,14
ST D7S820: 11
ST D8S1179: 13,15
ST FGA: 23,26
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 49
AC CVCL_CV65
DR NCBI_Iran; C260
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 5
AC CVCL_9V49
DR NCBI_Iran; C174
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 51
AC CVCL_CV67
DR NCBI_Iran; C262
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 52
AC CVCL_CV68
DR NCBI_Iran; C263
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 54
AC CVCL_CV51
DR NCBI_Iran; C265
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,9
ST D16S539: 8
ST D18S51: 11,13
ST D21S11: 27
ST D3S1358: 15,18
ST D5S818: 9,12
ST D7S820: 8,9
ST D8S1179: 10,14
ST FGA: 22
ST TH01: 6
ST TPOX: 7,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 55
AC CVCL_CV69
DR NCBI_Iran; C266
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 56
AC CVCL_CV70
DR NCBI_Iran; C267
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 57
AC CVCL_CV71
DR NCBI_Iran; C268
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 58
AC CVCL_9V57
DR NCBI_Iran; C269
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,12
ST D16S539: 12
ST D18S51: 13
ST D21S11: 31
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 9
ST D8S1179: 13,15
ST FGA: 22,24
ST TH01: 6,9
ST TPOX: 11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 6
AC CVCL_9V50
DR NCBI_Iran; C219
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3822; X-linked agammaglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 61
AC CVCL_CV72
SY LCL-PI61
DR NCBI_Iran; C427
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Caution: There seems to be two distinct cell lines which were assigned NCBI_Iran catalog number C427.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 62
AC CVCL_CV73
DR NCBI_Iran; C273
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 63
AC CVCL_CV74
DR NCBI_Iran; C274
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 65
AC CVCL_9V58
DR NCBI_Iran; C249
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,13
ST D16S539: 11,12
ST D18S51: 12,17
ST D21S11: 30,33
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 12,14
ST FGA: 20,23
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 66
AC CVCL_CV75
DR NCBI_Iran; C277
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 67
AC CVCL_CV76
DR NCBI_Iran; C278
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 68
AC CVCL_CV77
DR NCBI_Iran; C279
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 7
AC CVCL_9V51
DR NCBI_Iran; C175
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 70
AC CVCL_CV78
DR NCBI_Iran; C281
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 71
AC CVCL_CV79
DR NCBI_Iran; C282
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 73
AC CVCL_CV80
DR NCBI_Iran; C284
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 74
AC CVCL_CV81
DR NCBI_Iran; C285
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 76
AC CVCL_CV82
DR NCBI_Iran; C287
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 78
AC CVCL_9V59
DR NCBI_Iran; C289
RX PubMed=17254797;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Caution: Indicated as originating from a healthy female in NCBI_Iran catalog, but the STR profile is that of a male.
ST Source(s): PubMed=17254797
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 10,11
ST D18S51: 14
ST D21S11: 27,30
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 8,12
ST D8S1179: 10,14
ST FGA: 20,25
ST TH01: 6
ST TPOX: 8
ST vWA: 15,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 79
AC CVCL_CV83
DR NCBI_Iran; C290
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 8
AC CVCL_9V52
DR NCBI_Iran; C176
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 81
AC CVCL_CV84
DR NCBI_Iran; C292
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 82
AC CVCL_CV85
DR NCBI_Iran; C293
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 83
AC CVCL_CV86
DR NCBI_Iran; C294
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 84
AC CVCL_CV87
DR NCBI_Iran; C422
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Caution: There seems to be 3 distinct cell lines which were assigned NCBI_Iran catalog number C422.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 85
AC CVCL_CV88
DR NCBI_Iran; C296
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 87
AC CVCL_CV89
DR NCBI_Iran; C298
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 9
AC CVCL_CV52
DR NCBI_Iran; C220
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 92
AC CVCL_CV90
DR NCBI_Iran; C303
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LCL-PI 94
AC CVCL_CV91
DR NCBI_Iran; C305
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 95
AC CVCL_CV92
DR NCBI_Iran; C306
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 97
AC CVCL_CV93
DR NCBI_Iran; C308
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 98
AC CVCL_CV94
DR NCBI_Iran; C309
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-PI 99
AC CVCL_CV95
DR NCBI_Iran; C310
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL-Wei
AC CVCL_1869
SY LCL-WEI; LCL Wei
DR CLO; CLO_0007287
DR CLDB; cl3194
DR BioSample; SAMN03473378
DR DSMZ; ACC-218
RX PubMed=10508494;
CC Doubling time: ~30-40 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Caution: This cell line was reported to be isogenic with MEL-Wei (CVCL_3981) but it does not have the same STR profile (PubMed=10508494).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 13
ST D5S818: 11,13
ST D7S820: 12
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LCL10538
AC CVCL_C690
RX PubMed=8459226;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A648 ! Me10538
SX Female
CA Transformed cell line
//
ID LCL15392
AC CVCL_HE34
SY LCL 15392
RX PubMed=9973437;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C604 ! Me15392
CA Transformed cell line
//
ID LCL1811
AC CVCL_C689
RX PubMed=8459226;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C675 ! Me1811
CA Transformed cell line
//
ID LCL41
AC CVCL_5995
RX PubMed=8189054;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=LCL41
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LCL4405
AC CVCL_C688
RX PubMed=8459226;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C680 ! Me4405
SX Female
CA Transformed cell line
//
ID LCL48
AC CVCL_5996
RX PubMed=8189054;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LCL5810
AC CVCL_C687
RX PubMed=8459226;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C682 ! Me5810
SX Female
CA Transformed cell line
//
ID LCL9742
AC CVCL_C686
RX PubMed=8459226;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C685 ! Me9742
CA Transformed cell line
//
ID LCLC-103H
AC CVCL_1375
SY LCLC103H
DR CLO; CLO_0007282
DR EFO; EFO_0006634
DR BioSample; SAMN03473087
DR BioSample; SAMN03473330
DR CCLE; LCLC103H_LUNG
DR ChEMBL-Cells; CHEMBL3307853
DR ChEMBL-Targets; CHEMBL614066
DR Cosmic; 753586
DR Cosmic; 1146947
DR Cosmic; 1995481
DR Cosmic-CLP; 753586
DR DSMZ; ACC-384
DR GDSC; 753586
DR GEO; GSM434287
DR GEO; GSM784240
DR GEO; GSM827374
DR GEO; GSM887264
DR GEO; GSM888339
DR GEO; GSM1670045
DR IGRhCellID; LCLC103HGEO
RX PubMed=2840315;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 13
ST D18S51: 19
ST D21S11: 29,31.2
ST D3S1358: 16,17
ST D5S818: 11,12 (Cosmic-CLP; DSMZ)
ST D5S818: 12 (PubMed=25877200)
ST D7S820: 8,11
ST D8S1179: 12,14
ST FGA: 22
ST Penta D: 9
ST Penta E: 16
ST TH01: 6
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LCLC-97TM1
AC CVCL_1376
SY LCLC97TM1
DR CLO; CLO_0007283
DR EFO; EFO_0006635
DR BioSample; SAMN03473042
DR BioSample; SAMN03473572
DR CCLE; LCLC97TM1_LUNG
DR ChEMBL-Cells; CHEMBL3308112
DR ChEMBL-Targets; CHEMBL1075489
DR CLS; 300409/p504_LCLC-97TM1
DR Cosmic; 946361
DR Cosmic; 1146948
DR Cosmic; 1995482
DR Cosmic-CLP; 946361
DR DSMZ; ACC-388
DR GDSC; 946361
DR GEO; GSM434288
DR GEO; GSM784234
DR GEO; GSM887265
DR GEO; GSM888340
DR GEO; GSM1670046
DR IGRhCellID; LCLC97TM1GEO
DR PRIDE; PXD002556
RX PubMed=2840315;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=26361996;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: >50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'LCL97TM' in PubMed=26361996.
ST Source(s): CLS; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 12,13
ST D18S51: 16
ST D21S11: 27,30
ST D3S1358: 15
ST D5S818: 11,12 (CLS)
ST D5S818: 10,12 (Cosmic-CLP; DSMZ; PubMed=25877200)
ST D7S820: 10,11 (CLS; Cosmic-CLP; DSMZ)
ST D7S820: 10,10.2,11 (PubMed=25877200)
ST D8S1179: 14
ST FGA: 23
ST Penta D: 12,15
ST Penta E: 15
ST TH01: 8
ST TPOX: 8,11
ST vWA: 19,20
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LCM-Mel
AC CVCL_M742
DR Cosmic; 1295335
CC From: Guadagni F.; Istituto Regina Elena; Roma; Italy.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LCP-Mel
AC CVCL_7053
DR Cosmic; 1109807
DR Cosmic; 1295328
DR Cosmic; 1949556
RX PubMed=18384130;
CC From: Guadagni F.; Istituto Regina Elena; Roma; Italy.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LCSC-1
AC CVCL_5U55
RX CelloPub=CLPUB00282;
RX PubMed=19446912;
CC Doubling time: 18 hours (CelloPub=CLPUB00282).
CC Transformant: ChEBI; CHEBI:17356; 2-acetamidofluorene (2AAF).
CC Transformant: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60372; Rat cholangiocarcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID LCSC-2
AC CVCL_5U56
RX PubMed=19446912;
CC Transformant: ChEBI; CHEBI:17356; 2-acetamidofluorene (2AAF).
CC Transformant: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60372; Rat cholangiocarcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID LCSC-3
AC CVCL_5U57
RX PubMed=19446912;
CC Transformant: ChEBI; CHEBI:17356; 2-acetamidofluorene (2AAF).
CC Transformant: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60372; Rat cholangiocarcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID LCSC-4
AC CVCL_5U58
RX PubMed=19446912;
CC Transformant: ChEBI; CHEBI:17356; 2-acetamidofluorene (2AAF).
CC Transformant: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60372; Rat cholangiocarcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID LCSC-5
AC CVCL_5U59
RX PubMed=19446912;
CC Transformant: ChEBI; CHEBI:17356; 2-acetamidofluorene (2AAF).
CC Transformant: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60372; Rat cholangiocarcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID LCSC-6
AC CVCL_5U60
RX PubMed=19446912;
CC Transformant: ChEBI; CHEBI:17356; 2-acetamidofluorene (2AAF).
CC Transformant: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60372; Rat cholangiocarcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID LCSC#1
AC CVCL_A643
SY LCSC-1
DR Cosmic; 946053
DR Cosmic; 1066160
DR Cosmic; 1571724
DR Cosmic; 1656899
RX PubMed=22313637;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LCSC#2
AC CVCL_A644
SY LCSC-2
DR Cosmic; 946054
DR Cosmic; 1066161
DR Cosmic; 1571725
DR Cosmic; 1656900
RX PubMed=22313637;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LD
AC CVCL_Y435
RX PubMed=17760811;
CC Doubling time: ~10 days (PubMed=17760811).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LD-T
AC CVCL_0C18
DR Cosmic; 2239088
RX PubMed=7736387;
RX PubMed=9559344;
RX PubMed=9815546;
RX PubMed=10100721;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LD137
AC CVCL_EJ12
DR Cosmic; 943736
RX PubMed=9850064;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LD2B
AC CVCL_E754
DR dbMHC; 48949
DR ECACC; 94122026
DR IHW; IHW9083
DR IMGT/HLA; 11638
WW http://bioinformatics.hsanmartino.it/ecbr/cl83.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LD583
AC CVCL_EJ13
DR Cosmic; 943747
RX PubMed=9850064;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ16 ! LD611
CA Cancer cell line
//
ID LD600
AC CVCL_EJ14
DR Cosmic; 943740
RX PubMed=9850064;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LD605
AC CVCL_EJ15
DR Cosmic; 943745
RX PubMed=9850064;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LD611
AC CVCL_EJ16
DR Cosmic; 943748
RX PubMed=9850064;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ13 ! LD583
CA Cancer cell line
//
ID LD627
AC CVCL_EJ17
DR Cosmic; 943737
RX PubMed=9850064;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LD630
AC CVCL_EJ18
DR Cosmic; 943741
RX PubMed=9850064;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LD660
AC CVCL_EJ19
DR Cosmic; 943738
RX PubMed=9850064;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ20 ! LD692
CA Cancer cell line
//
ID LD692
AC CVCL_EJ20
DR Cosmic; 943739
RX PubMed=9850064;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ19 ! LD660
CA Cancer cell line
//
ID LD7/4
AC CVCL_T961
SY LD7.4; IO/LD7/4
RX Patent=US6878544;
RX PubMed=8982103;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: PVG.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID LD700
AC CVCL_EJ21
DR Cosmic; 943735
RX PubMed=9850064;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LD71
AC CVCL_EJ22
DR Cosmic; 943746
RX PubMed=9850064;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LD8
AC CVCL_K251
SY LD-8
DR BCRJ; 0144
RX PubMed=2258612;
CC Characteristics: IL4 dependent.
CC Discontinued: BCRJ; 0144; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K250 ! C30.1
CA Factor-dependent cell line
//
ID LDA1
AC CVCL_Z248
RX PubMed=11928998;
CC Group: Insect cell line.
CC Doubling time: 81.1 hours (at 28th passage), 78.1 hours (at 67th passage) (PubMed=11928998).
OX NCBI_TaxID=7539; ! Leptinotarsa decemlineata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LDA2
AC CVCL_Z249
RX PubMed=11928998;
CC Group: Insect cell line.
CC Doubling time: 64 hours (at 42th passage), 47 hours (at 45th passage) (PubMed=11928998).
OX NCBI_TaxID=7539; ! Leptinotarsa decemlineata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LDE1
AC CVCL_Z250
RX PubMed=11928998;
CC Group: Insect cell line.
CC Doubling time: 113.6 hours, at 112th passage (PubMed=11928998).
OX NCBI_TaxID=7539; ! Leptinotarsa decemlineata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LDL1
AC CVCL_Z251
RX PubMed=11928998;
CC Group: Insect cell line.
CC Doubling time: 31 hours (at 29th passage), 40.2 hours (at 31th passage) (PubMed=11928998).
OX NCBI_TaxID=7539; ! Leptinotarsa decemlineata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LdlD
AC CVCL_1V03
SY CHO ldlD; LDLD
RX PubMed=3948246;
RX PubMed=6089204;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID LDR+25
AC CVCL_V118
DR CLO; CLO_0007290
DR CLDB; cl3195
DR IHW; IHW8121
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LDR2a
AC CVCL_V119
SY LDR2A
DR CLO; CLO_0007291
DR CLDB; cl3196
DR IHW; IHW8105
RX PubMed=3128633;
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 4947; HLA-DRA.
CC Transfected with: HGNC; 4953; HLA-DRB5.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LDR2b
AC CVCL_V120
SY LDR2B
DR CLO; CLO_0007292
DR CLDB; cl3197
DR IHW; IHW8108
RX PubMed=3128633;
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 4947; HLA-DRA.
CC Transfected with: HGNC; 4948; HLA-DRB1 (allele DR15).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LDR7
AC CVCL_V121
DR CLO; CLO_0007295
DR CLDB; cl3198
DR IHW; IHW8129
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LDR8
AC CVCL_V122
DR CLO; CLO_0007296
DR CLDB; cl3199
DR IHW; IHW8130
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LDS 73/LW1
AC CVCL_L704
SY LW1
DR ECACC; 96050401
CC Monoclonal antibody target: UniProtKB; P46418; Rat Gsta5.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID LDS-Falck 01
AC CVCL_T756
SY LDS-Falck01
DR Cosmic; 1092551
RX PubMed=17970070;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LDS-iPSC8
AC CVCL_DQ94
RX PubMed=27346194;
DI NCIt; C128191; Lymphedema-distichiasis syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID LDV/7
AC CVCL_D268
SY LDV-7
DR ChEMBL-Cells; CHEMBL3307854
DR ChEMBL-Targets; CHEMBL614079
RX Patent=US4316962;
RX PubMed=6983077;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Spontaneously immortalized cell line
//
ID Le Ana
AC CVCL_3438
DR CLO; CLO_0007300
DR ATCC; CRL-1192
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Le Fin
AC CVCL_0F65
DR ATCC; CRL-1115
CC Discontinued: ATCC; CRL-1115; probable.
DI NCIt; C72070; Systemic scleroderma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID Le Mor
AC CVCL_X714
DR ATCC; CRL-1224
RX PubMed=3860870;
CC Discontinued: ATCC; CRL-1224; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Le Pat
AC CVCL_U782
DR ATCC; CRL-1136
CC Discontinued: ATCC; CRL-1136; true.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Le San
AC CVCL_X715
DR ATCC; CRL-1229
CC Discontinued: ATCC; CRL-1229; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Le-H-HNU7
AC CVCL_Z572
SY Le H HNU7
RX DOI=10.3923/jas.2007.4040.4043;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LE-II
AC CVCL_U334
SY LE II; LEII
DR CLO; CLO_0007305
DR CLDB; cl3201
RX PubMed=1696271;
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID LE023
AC CVCL_E755
SY LEO23; TER90; TER179; TER237
DR dbMHC; 48950
DR IHW; IHW9267
DR IMGT/HLA; 10979
WW http://bioinformatics.hsanmartino.it/ecbr/cl267.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LE9211-EBV
AC CVCL_E910
RX PubMed=8781117;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E911 ! LE9211-RCC
CA Transformed cell line
//
ID LE9211-RCC
AC CVCL_E911
RX PubMed=8781117;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E910 ! LE9211-EBV
CA Cancer cell line
//
ID Lec1
AC CVCL_3440
SY CHO-Lec1; CHO Lec1; Pro-Lec1.3C; Pro-5 Lec1.3c; Pro-5WgaRI3C
DR CLO; CLO_0007301
DR ATCC; CRL-1735
DR CCRID; 3131C0001000100008
RX PubMed=1182798;
RX PubMed=3785164;
RX PubMed=8910379;
RX PubMed=24078077;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-202.html
CC Characteristics: Has the mutations MGAT1 p.Cys123Arg, p.Gln339Arg and pLys401Arg. The MGAT1 pCys123Arg mutation abolishes the activity of the enzyme.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4382 ! CHO Pro-5
SX Female
CA Spontaneously immortalized cell line
//
ID Lec15.1
AC CVCL_7054
AS CVCL_DD08
SY CHO Lec15.1; Lec15.1 CHO; B4-2-1; B421
DR BTO; BTO:0002430
RX PubMed=1986234;
RX PubMed=2105319;
RX PubMed=2267628;
RX PubMed=6270122;
RX PubMed=9753618;
RX PubMed=14680801;
RX PubMed=20331963;
CC Characteristics: Has a DPM2 p.Gly10Glu mutation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_DD06 ! N211-1-8
SX Female
CA Spontaneously immortalized cell line
//
ID Lec2
AC CVCL_3442
SY CHO-Lec2; CHO Lec2; Pro-Lec2.6A; Pro-5WgaRII6A
DR CLO; CLO_0007302
DR ATCC; CRL-1736
DR TOKU-E; 2189
RX PubMed=3785164;
RX PubMed=9279382;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-191.html
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4382 ! CHO Pro-5
SX Female
CA Spontaneously immortalized cell line
//
ID Lec3.2.8.1
AC CVCL_K173
SY CHO-Lec3.2.8.1; CHO Lec3.2.8.1
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4382 ! CHO Pro-5
SX Female
CA Spontaneously immortalized cell line
//
ID Lec4
AC CVCL_IP61
SY CHO-Lec4; CHO Lec4; Gat~Lec4.2D; Pro~5.Lec4.7B
DR BTO; BTO:0005988
RX PubMed=2530238;
RX PubMed=6295280;
RX PubMed=8910328;
RX PubMed=24078077;
CC Characteristics: Has two MGAT5 insertion mutations that produce a truncated protein lacking enzymatic activity.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4382 ! CHO Pro-5
SX Female
CA Spontaneously immortalized cell line
//
ID Lec4A
AC CVCL_IP62
SY CHO-Lec4A; CHO Lec4A; Pro~Lec4.12-2; Pro~Lec4A.12-2; ProLec4A.12.2
DR BTO; BTO:0005989
RX PubMed=2530238;
RX PubMed=6295280;
RX PubMed=8910328;
RX PubMed=24078077;
CC Characteristics: Has a MGAT5 p.Leu188Arg mutation that leads to mistargeting of the protein to the ER.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4382 ! CHO Pro-5
SX Female
CA Spontaneously immortalized cell line
//
ID Lec8
AC CVCL_3443
SY CHO-Lec8; CHO Lec8; Pro-Lec8.D3; Pro-5WgaRVIII3D
DR CLO; CLO_0007303
DR ATCC; CRL-1737
RX PubMed=3785164;
RX PubMed=9279382;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4382 ! CHO Pro-5
SX Female
CA Spontaneously immortalized cell line
//
ID Lec9
AC CVCL_DD12
SY Lec9.12A; Pro-Lec9.12A
RX PubMed=2267628;
RX PubMed=3785164;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4382 ! CHO Pro-5
SX Female
CA Spontaneously immortalized cell line
//
ID LeCa 19.4
AC CVCL_1E34
SY LeCa 19-4; 19.4; LeCa Str 19-4; M-7
RX CelloPub=CLPUB00255;
RX PubMed=1127734;
RX PubMed=5487065;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1E35 ! LeCa 26.5
CA Cancer cell line
//
ID LeCa 26.5
AC CVCL_1E35
SY LeCa 26-5
RX CelloPub=CLPUB00255;
RX PubMed=327080;
RX PubMed=833871;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1E34 ! LeCa 19.4
CA Cancer cell line
//
ID Led-130
AC CVCL_1E38
SY Led 130; Lederle 130
RX PubMed=4203458;
RX PubMed=14207842;
RX PubMed=14328924;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID Led-T1
AC CVCL_8438
SY LED-T1; LED-Ti
DR BioSample; SAMN03151737
RX PubMed=4203458;
RX PubMed=6451928;
RX PubMed=14328924;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928, PubMed=20143388). Originally thought to be a transformed Led-30 (CVCL_1E38) cell line.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID LEE-1
AC CVCL_6F84
SY Leucoraja Erinacea Embryo-1
RX PubMed=18407792;
CC Group: Fish cell line.
OX NCBI_TaxID=7782; ! Leucoraja erinacea
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LEE743
AC CVCL_F722
DR IMGT/HLA; 10980
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Lei Cap
AC CVCL_3444
DR CLO; CLO_0007304
DR ATCC; CRL-1098
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID LEIO-2
AC CVCL_W486
RX PubMed=12237927;
CC Derived from metastatic site: Stomach.
DI NCIt; C27200; Gastric leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LEK
AC CVCL_F742
DR CLO; CLO_0007306
DR CLDB; cl3202
RX PubMed=24000610;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/alek.htm
OX NCBI_TaxID=9913; ! Bos taurus
SX Sex undetermined
CA Finite cell line
//
ID LEM-CQ-01
AC CVCL_Z240
RX PubMed=22310541;
CC Group: Insect cell line.
CC Miscellaneous: Provisional name until main author of paper respond to request to assign a name to the cell line.
OX NCBI_TaxID=7176; ! Culex quinquefasciatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Lena
AC CVCL_0E93
SY LENA
DR ATCC; CRL-1868
RX PubMed=1690682;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-1868; true.
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Female
CA Transformed cell line
//
ID Leo
AC CVCL_A016
RX PubMed=21321976;
CC Breed/subspecies: Mixed breed.
DI NCIt; C128122; Canine prostate carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID LES
AC CVCL_D524
RX PubMed=7949178;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LEW311
AC CVCL_E756
DR dbMHC; 48951
DR IHW; IHW9396
DR IMGT/HLA; 26000
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID Lex-1
AC CVCL_C696
SY Lex1; LEX1
WW http://mmrrc.ucdavis.edu/files/protocols/lex1_protocol.pdf
CC Breed/subspecies: 129S5/SvEvBrd.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID Lex-2
AC CVCL_0J18
SY Lex2
CC Breed/subspecies: 129S5/SvEvBrd.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID LF-CL2A
AC CVCL_2103
SY LF Cl.2A; LFCl2A; LF clone 2A
DR CLO; CLO_0007309
DR CLDB; cl3204
DR ChEMBL-Cells; CHEMBL3308563
DR ChEMBL-Targets; CHEMBL614690
DR DSMZ; ACC-195
RX PubMed=1309725;
CC Doubling time: ~20-25 hours (DSMZ).
CC Transformant: ChEBI; CHEBI:76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC Breed/subspecies: Wistar Commentry.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID LF1
AC CVCL_C120
RX PubMed=9242615;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID LF2
AC CVCL_AS05
DR GEO; GSM397408
DR GEO; GSM397409
DR GEO; GSM413114
DR GEO; GSM413115
DR GEO; GSM413116
DR GEO; GSM413120
DR GEO; GSM413121
DR GEO; GSM413122
DR GEO; GSM413126
DR GEO; GSM413127
DR GEO; GSM413128
DR GEO; GSM413132
DR GEO; GSM413133
DR GEO; GSM413134
DR GEO; GSM413138
DR GEO; GSM413139
DR GEO; GSM413140
DR GEO; GSM413144
DR GEO; GSM413145
DR GEO; GSM413146
DR GEO; GSM413150
DR GEO; GSM413151
DR GEO; GSM413152
DR GEO; GSM413156
DR GEO; GSM413157
DR GEO; GSM413158
DR Ximbio; 152568
RX PubMed=2129226;
RX PubMed=16244654;
RX PubMed=19581487;
RX PubMed=23850244;
CC Omics: DNA methylation analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9me2 ChIP-seq epigenome analysis.
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID LFC12.Sp
AC CVCL_S342
SY FCZsp
DR ATCC; CRL-6172
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6172; true.
OX NCBI_TaxID=9685; ! Felis catus
SX Male
CA Undefined cell line type
//
ID LFC16.Ln
AC CVCL_6415
SY FC16.Ln
DR CLO; CLO_0007308
DR ATCC; CRL-6173
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6173; true.
OX NCBI_TaxID=9685; ! Felis catus
OI CVCL_4944 ! FC16.Sp
SX Female
CA Finite cell line
//
ID LG-T
AC CVCL_0C19
RX PubMed=1311980;
RX PubMed=7736387;
RX PubMed=9815546;
CC Derived from metastatic site: Supraclavicular lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LGMD2Cl11
AC CVCL_6B28
RX PubMed=22040608;
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 11730; TERT.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID LGW01
AC CVCL_W910
DR Cosmic; 1016882
RX PubMed=16885334;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LGW01-G600
AC CVCL_0C33
SY LGWO1 G600; LGWO 1 G600; LGWO1G600
DR Cosmic; 2037950
DR GEO; GSM1574572
RX PubMed=24018021;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W910 ! LGW01
CA Cancer cell line
//
ID LH6215
AC CVCL_0B86
WW https://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-str-profiles
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11
ST D18S51: 12,17
ST D19S433: 14
ST D21S11: 30,31.2
ST D2S1338: 20
ST D3S1358: 16,17
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 11,14
ST FGA: 22,23
ST TH01: 6,9.3
ST TPOX: 10,11
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LH86
AC CVCL_8889
SY LH-86
DR BTO; BTO:0004142
RX PubMed=17983809;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LHCN-M2
AC CVCL_8890
SY LHCN-Myogenic clone no.2
DR BTO; BTO:0005046
DR EFO; EFO_0005714
DR ENCODE; ENCBS231AAA
DR ENCODE; ENCBS232AAA
DR ENCODE; ENCBS233AAA
DR ENCODE; ENCBS810TWL
DR ENCODE; ENCBS836YFM
RX PubMed=17559502;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/LHCNM2_Wold_protocol.pdf
WW http://www.evercyte.com/lhcn-m2-97.html
CC Part of: ENCODE project common cell types; tier 2.
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID LHK2
AC CVCL_D228
SY LHK-2
RX PubMed=12060610;
RX PubMed=19818766;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LHON1-hiPSC1
AC CVCL_C880
SY LHON.1.H.iPSC.1
DR RSCB; RSCB0127
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84808; Leber hereditary optic atrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C881 ! LHON1-hiPSC2
OI CVCL_C882 ! LHON1-hiPSC4
OI CVCL_C883 ! LHON1-hiPSC5
SX Male
CA Induced pluripotent stem cell
//
ID LHON1-hiPSC2
AC CVCL_C881
SY LHON.1.H.iPSC.2
DR RSCB; RSCB0128
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84808; Leber hereditary optic atrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C880 ! LHON1-hiPSC1
OI CVCL_C882 ! LHON1-hiPSC4
OI CVCL_C883 ! LHON1-hiPSC5
SX Male
CA Induced pluripotent stem cell
//
ID LHON1-hiPSC4
AC CVCL_C882
SY LHON.1.H.iPSC.4
DR RSCB; RSCB0129
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84808; Leber hereditary optic atrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C880 ! LHON1-hiPSC1
OI CVCL_C881 ! LHON1-hiPSC2
OI CVCL_C883 ! LHON1-hiPSC5
SX Male
CA Induced pluripotent stem cell
//
ID LHON1-hiPSC5
AC CVCL_C883
SY LHON.1.H.iPSC.5; RIi014-A
DR hPSCreg; RIi014-A
DR RSCB; RSCB0130
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84808; Leber hereditary optic atrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C880 ! LHON1-hiPSC1
OI CVCL_C881 ! LHON1-hiPSC2
OI CVCL_C882 ! LHON1-hiPSC4
SX Male
CA Induced pluripotent stem cell
//
ID LHR-1055
AC CVCL_G205
DR CLO; CLO_0007310
DR ATCC; CRL-2687
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LHR-29
AC CVCL_G206
DR CLO; CLO_0007311
DR ATCC; CRL-2685
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LHR-74
AC CVCL_G207
DR CLO; CLO_0007312
DR ATCC; CRL-2686
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LHY-821
AC CVCL_D698
RX PubMed=22806968;
CC Doubling time: 44.6-47.7 hours(PubMed=22806968).
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LI
AC CVCL_L881
DR CLO; CLO_0007314
DR CLDB; cl3206
RX PubMed=3225639;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LI 27
AC CVCL_J159
SY L127; L 127; M-1
DR CLO; CLO_0007315
DR ATCC; HB-8437
RX Patent=US4806628;
RX Patent=US4808704;
CC Discontinued: ATCC; HB-8437; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID LI 66
AC CVCL_J160
SY L166; L 166; M-12
DR CLO; CLO_0007316
DR ATCC; HB-8442
RX Patent=US4806628;
RX Patent=US4808704;
CC Discontinued: ATCC; HB-8442; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Li-10
AC CVCL_E898
SY Liver-10; LI 10
RX PubMed=436973;
RX PubMed=7067703;
CC Misspelling: 'LI-IO' in PubMed=20144999.
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Finite cell line
//
ID Li-136/SV40
AC CVCL_V295
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3192; Lipoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Li-14/SV40
AC CVCL_V296
SY Li-14-SV40
DR Cosmic; 1430274
RX PubMed=1326410;
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3192; Lipoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LI-3H2-G6
AC CVCL_U036
SY D-13
DR ECACC; 08041714
RX PubMed=6373932;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Li-501/SV40
AC CVCL_V297
SY Li-501-SV40
DR Cosmic; 1430275
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3192; Lipoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Li-502/SV40
AC CVCL_V298
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3192; Lipoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Li-506/SV40
AC CVCL_V299
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3192; Lipoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Li-538/SV40
AC CVCL_V300
SY Li-538-SV40
DR Cosmic; 1430276
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3192; Lipoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Li-7
AC CVCL_3840
SY LI7; Li7
DR CLO; CLO_0050854
DR BioSample; SAMN03470992
DR CCLE; LI7_LIVER
DR CGH-DB; 9074-4
DR Cosmic; 2023862
DR Cosmic; 2162529
DR GEO; GSM565882
DR GEO; GSM887266
DR GEO; GSM888341
DR PRIDE; PXD002486
DR RCB; RCB1941
DR TKG; TKG 0368
RX PubMed=85491;
RX PubMed=12029633;
RX PubMed=15767549;
RX PubMed=22460905;
RX PubMed=23887712;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR45 cancer cell line panel.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9
ST D18S51: 16
ST D19S433: 12,14
ST D21S11: 30
ST D2S1338: 17,19
ST D3S1358: 15,16
ST D5S818: 9,11
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 20
ST Penta D: 10
ST Penta E: 5
ST TH01: 7
ST TPOX: 8,11 (PubMed=25877200; RCB)
ST TPOX: 8 (TKG)
ST vWA: 16,19
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LI90
AC CVCL_0390
SY LI 90; LI-90
DR BTO; BTO:0003519
DR MCCL; MCC:0000285
DR BioSample; SAMN03470815
DR GEO; GSM827257
DR JCRB; JCRB0160
DR JCRB; NIHS0234
DR TKG; TKG 0507
RX PubMed=7540235;
CC Discontinued: JCRB; NIHS0234; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 11,12
ST D16S539: 9,10
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3800; Epithelioid hemangioendothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LIB
AC CVCL_H209
CC From: Al Saati T.; Purpan Hospital; Toulouse; France.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LiCo 16-86
AC CVCL_0U49
SY LICO 16-86
DR ATCC; HB-8496
RX Patent=US4997762;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 12
ST D16S539: 12
ST D5S818: 12,13
ST D7S820: 8,12
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0U50 ! LiCo 16-88
CA Spontaneously immortalized cell line
//
ID LiCo 16-88
AC CVCL_0U50
SY LICO 16-88
DR ATCC; HB-8495
DR BioSample; SAMN03471082
RX Patent=US4997762;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 12
ST D16S539: 12
ST D5S818: 12,13
ST D7S820: 8,12
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0U49 ! LiCo 16-86
CA Spontaneously immortalized cell line
//
ID LiCo 6a3-1
AC CVCL_0U47
SY LiCo6a3-1; LICO 6A3-1
DR ATCC; HB-8493
RX Patent=US4997762;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Lico 7a4
AC CVCL_0U48
SY LICO 7A4
DR ATCC; HB-8494
RX Patent=US4997762;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID LICR LON TR2CL
AC CVCL_Y901
SY TR2CL
RX PubMed=7073949;
CC Breed/subspecies: Fischer 344.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID LIE
AC CVCL_F729
DR IMGT/HLA; 10987
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LiLa-1
AC CVCL_7987
SY LILA-1
DR Cosmic; 1130239
DR Cosmic; 2491069
RX PubMed=1378917;
RX PubMed=9067587;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LIM1215
AC CVCL_2574
SY Lim1215; LIM 1215; LIM-1215
DR BTO; BTO:0001916
DR CBA; CBA-0161
DR Cosmic; 869795
DR Cosmic; 1184335
DR Cosmic; 1238050
DR Cosmic; 1479632
DR Cosmic; 1482515
DR Cosmic; 1486135
DR Cosmic; 1524335
DR Cosmic; 1676746
DR Cosmic; 1805257
DR Cosmic; 2301991
DR Cosmic-CLP; 2162949
DR ECACC; 10092301
DR GDSC; 869795
DR GEO; GSM741246
DR GEO; GSM1346878
DR GEO; GSM1448118
DR PRIDE; PXD000120
RX PubMed=1427983;
RX PubMed=3857372;
RX PubMed=9515795;
RX PubMed=19378335;
RX PubMed=23458625;
RX PubMed=24295106;
RX PubMed=24755471;
RX PubMed=25926053;
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
CC Doubling time: 32 hours, at 8th passage (PubMed=3857372); 28 hours (PubMed=142798).
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Omentum.
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D21S11: 29,31
ST D8S1179: 11,13
ST TH01: 9.3,10
ST vWA: 16
DI NCIt; C4349; Colon adenocarcinoma
DI NCIt; C8494; Lynch syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LIM1839
AC CVCL_4433
SY LIM 1839; LIM-1839
DR Cosmic; 1482527
DR Cosmic; 1524336
RX PubMed=2606577;
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LIM1863
AC CVCL_4434
SY Lim1863; LIM 1863; LIM-1863
DR BTO; BTO:0001918
DR CBA; CBA-0162
DR Cosmic; 948846
DR Cosmic; 1043818
DR Cosmic; 1184327
DR Cosmic; 1238051
DR Cosmic; 1482516
DR Cosmic; 1524337
DR Cosmic; 1805258
RX PubMed=1427983;
RX PubMed=3567898;
RX PubMed=11226274;
RX PubMed=19378335;
RX PubMed=20606684;
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/LIM1863.html
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
CC Doubling time: 53 hours (PubMed=142798); 2-3 days (CBA).
CC Misspelling: 'LIM21-1863' in Cosmic 948846.
CC Misspelling: 'LM1863' in Cosmic 1043818.
DI NCIt; C5105; Colorectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LIM1899
AC CVCL_4435
SY LIM 1899; LIM-1899
DR CBA; CBA-0163
DR Cosmic; 1238052
DR Cosmic; 1482517
DR Cosmic; 1486136
DR Cosmic; 1805259
DR Cosmic; 2301992
DR ECACC; 12062001
DR GEO; GSM1346879
DR GEO; GSM1448136
DR PRIDE; PXD000120
RX PubMed=1427983;
RX PubMed=2386931;
RX PubMed=19378335;
RX PubMed=23458625;
RX PubMed=24295106;
RX PubMed=24755471;
RX PubMed=25926053;
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
CC Doubling time: 48 hours (PubMed=142798).
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Deep glycome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LIM2045
AC CVCL_DG01
SY Lim2045
DR GEO; GSM784015
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
DI NCIt; C5105; Colorectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LIM2099
AC CVCL_4436
SY LIM 2099; LIM-2099
DR CBA; CBA-0164
DR Cosmic; 1238053
DR Cosmic; 1524326
DR Cosmic; 1805260
DR Cosmic; 2301993
DR ECACC; 12062002
DR GEO; GSM1346846
DR GEO; GSM1448137
RX PubMed=1427983;
RX PubMed=19378335;
RX PubMed=24755471;
RX PubMed=25926053;
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
CC Doubling time: 36 hours (PubMed=142798).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Liver.
DI NCIt; C5105; Colorectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LIM2358
AC CVCL_G358
SY LIM 2358; LIM-2358
RX PubMed=1427983;
CC Doubling time: >4 days (PubMed=142798).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LIM2405
AC CVCL_4437
SY LIM 2405; LIM-2405
DR CBA; CBA-0165
DR Cosmic; 1238054
DR Cosmic; 1482518
DR Cosmic; 1486137
DR Cosmic; 1524339
DR Cosmic; 1676726
DR Cosmic; 1805261
DR Cosmic; 2301994
DR ECACC; 12062003
DR GEO; GSM1346880
DR GEO; GSM1448126
DR PRIDE; PXD000120
RX PubMed=1427983;
RX PubMed=19378335;
RX PubMed=23458625;
RX PubMed=24295106;
RX PubMed=24755471;
RX PubMed=25926053;
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
CC Doubling time: 24 hours (PubMed=142798).
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Deep glycome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LIM2408
AC CVCL_4438
SY LIM 2408; LIM-2408
DR Cosmic; 1238055
DR Cosmic; 1486138
RX PubMed=1427983;
RX PubMed=19378335;
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
CC Doubling time: >4 days (PubMed=142798).
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0166 but was never distributed.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LIM2412
AC CVCL_4439
SY Lim2412; LIM 2412; LIM-2412
DR BTO; BTO:0001917
DR Cosmic; 1482519
DR Cosmic; 1524340
DR GEO; GSM741245
DR GEO; GSM1448075
RX PubMed=1427983;
RX PubMed=25926053;
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
CC Doubling time: 30 hours (PubMed=142798).
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LIM2463
AC CVCL_4440
SY LIM 2463; LIM-2463
RX PubMed=1676989;
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0167 but was never distributed.
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LIM2463B
AC CVCL_A456
SY LIM-2463B; LIM 2463B
DR Cosmic; 1238056
RX PubMed=19378335;
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4440 ! LIM2463
CA Cancer cell line
//
ID LIM2537
AC CVCL_4441
SY LIM 2537; LIM-2537
DR CBA; CBA-0168
DR Cosmic; 1238057
DR Cosmic; 1482514
DR Cosmic; 1486139
DR Cosmic; 1524338
DR GEO; GSM1448135
RX PubMed=11606375;
RX PubMed=19378335;
RX PubMed=25926053;
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
CC Doubling time: 30 hours (CBA).
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C5105; Colorectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LIM2550
AC CVCL_4442
SY LIM 2550; LIM-2550
DR CBA; CBA-0169
DR Cosmic; 1238058
DR Cosmic; 1486140
DR Cosmic; 1805262
DR ECACC; 12070504
DR GEO; GSM1448168
RX PubMed=19378335;
RX PubMed=25926053;
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
CC Microsatellite instability: Instable (MSI) (PubMed=19378335; PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LIM2551
AC CVCL_4443
SY LIM 2551; LIM-2551
DR CBA; CBA-0170
DR Cosmic; 1238059
DR Cosmic; 1486141
DR Cosmic; 1803947
DR Cosmic; 2301995
DR ECACC; 12070505
DR GEO; GSM1346881
DR GEO; GSM1448076
RX PubMed=19378335;
RX PubMed=24755471;
RX PubMed=25926053;
CC From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia.
CC Microsatellite instability: Instable (MSI) (PubMed=19378335; PubMed=25926053).
CC Omics: Transcriptome analysis.
CC Miscellaneous: Gender from original lab book of Whitehead R.H. and from patient surgeon through a personal communication of Cape-Davis A.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LiM6
AC CVCL_D240
SY LIM6; LiM-6; LS-LiM6; Ls-LiM6; LS LiM6; LSLiM6
DR BTO; BTO:0004866
DR Cosmic; 1132697
RX PubMed=3032811;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1384 ! LS174T
SX Female
CA Cancer cell line
//
ID LIMM-NBE1
AC CVCL_9Y83
SY NBE1; Leeds Institute of Molecular Medicine - Normal Bronchal Epithelium 1
RX PubMed=23226101;
RX PubMed=24244370;
CC Transfected with: HGNC; 11730; TERT.
CC Omics: Deep RNAseq analysis.
CC Omics: Genome sequenced (low read coverage).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID Line 1
AC CVCL_5V03
RX PubMed=1691690;
RX PubMed=4366938;
RX PubMed=9347924;
CC Breed/subspecies: BALB/c.
DI NCIt; C21762; Adenoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Line 14
AC CVCL_V123
DR CLO; CLO_0007317
DR CLDB; cl3207
DR IHW; IHW81O4
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID Line C
AC CVCL_Z861
SY C
RX DOI=10.1016/B978-012229460-0/50004-X;
RX PubMed=5002052;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Male
CA Spontaneously immortalized cell line
//
ID Line K
AC CVCL_Z832
SY K
RX PubMed=4976834;
RX PubMed=5002052;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Female
CA Spontaneously immortalized cell line
//
ID Lipo-DUE1
AC CVCL_4U68
RX PubMed=26373732;
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Lipo191
AC CVCL_4U70
RX PubMed=21060307;
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Lipo203
AC CVCL_4U71
RX PubMed=21060307;
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Lipo224
AC CVCL_4U72
SY lipo224
RX PubMed=21060307;
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Lipo246
AC CVCL_4U73
SY lipo246
RX PubMed=21060307;
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lipo256
AC CVCL_4U74
RX PubMed=21060307;
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Lipo276
AC CVCL_4U75
RX PubMed=21060307;
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lipo314
AC CVCL_4U76
RX PubMed=21060307;
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Lipo355
AC CVCL_4U77
RX PubMed=21060307;
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Lipo502
AC CVCL_4U78
RX PubMed=21060307;
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Lipo514
AC CVCL_4U79
RX PubMed=21060307;
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lipo573
AC CVCL_4U80
RX PubMed=21060307;
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lipo585
AC CVCL_4U81
RX PubMed=21060307;
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Lipo601
AC CVCL_4U82
RX PubMed=21060307;
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lipo624
AC CVCL_4U83
RX PubMed=21060307;
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Lipo651
AC CVCL_4U84
RX PubMed=21060307;
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lipo675
AC CVCL_4U85
RX PubMed=21060307;
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lipo723
AC CVCL_4U86
RX PubMed=21060307;
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lipo815
AC CVCL_4U87
RX PubMed=21060307;
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lipo863
AC CVCL_4U88
RX PubMed=21060307;
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lipo956
AC CVCL_4U89
RX PubMed=21060307;
DI NCIt; C4250; Well differentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LIS-3/SV40
AC CVCL_V301
RX PubMed=8020967;
RX PubMed=8428517;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C27781; Myxoid liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LIS-3/SV40/A9-B4
AC CVCL_V310
RX PubMed=8428517;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3984 ! A-9
HI CVCL_V301 ! LIS-3/SV40
CA Hybrid cell line
//
ID Lis01_HEFX
AC CVCL_B923
DR ISCR; 1095
RX PubMed=20186514;
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=797
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0329.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Lis02_FXS2
AC CVCL_B924
SY Lis02_FXS_2
DR ISCR; 1096
RX PubMed=20186514;
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=798
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0330.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis03_FXS4
AC CVCL_B925
SY Lis03_FXS_4
DR ISCR; 1097
RX PubMed=20186514;
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=799
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0331.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis04_Twist1
AC CVCL_B926
SY Lis04_Twist
DR ISCR; 1098
RX PubMed=20186514;
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=800
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0332.
DI NCIt; C75034; Type III acrocephalosyndactyly
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis05_t(11,22)
AC CVCL_B927
DR ISCR; 1099
RX PubMed=20186514;
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=801
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0333.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Lis06_Gaucher1
AC CVCL_B928
SY Lis06_Gaucher_1
DR ISCR; 1100
RX PubMed=20186514;
RX PubMed=21585244;
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis07_AIS1
AC CVCL_B929
SY Lis07_AIS_1
DR ISCR; 1101
RX PubMed=20186514;
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=803
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0334.
DI NCIt; C27226; Androgen insensitivity syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis08_AIS2
AC CVCL_B930
SY Lis08_AIS_2
DR ISCR; 1102
RX PubMed=20186514;
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=804
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0335.
DI NCIt; C27226; Androgen insensitivity syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis09_DYS1
AC CVCL_B931
SY Lis09_DYS_1
DR ISCR; 1103
RX PubMed=20186514;
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=805
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0336.
DI NCIt; C118780; Autosomal dominant torsion dystonia 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis1
AC CVCL_B932
DR ISCR; 1104
RX PubMed=20186514;
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis10_DMD1
AC CVCL_B933
SY Lis10_DMD_1
DR ISCR; 1105
RX PubMed=20186514;
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=806
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0337.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis11_DMD2
AC CVCL_B934
SY Lis11_DMD_2
DR ISCR; 1106
RX PubMed=20186514;
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=807
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0338.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Lis12_DM1
AC CVCL_B935
SY Lis12_DM_1
DR ISCR; 1107
RX PubMed=20186514;
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=808
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0339.
DI NCIt; C84679; Dystrophia myotonica 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis13_Alport2
AC CVCL_B936
SY Lis13_Alport_2
DR ISCR; 1108
RX PubMed=20186514;
RX PubMed=21585244;
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
DI NCIt; C34842; Alport syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis14_Alport3
AC CVCL_B937
SY Lis14_Alport_3
DR ISCR; 1109
RX PubMed=20186514;
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=810
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0340.
DI NCIt; C34842; Alport syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis15_t(1;12)
AC CVCL_Y342
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=811
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0341.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis17_Connexin1
AC CVCL_Y343
SY Lis17_Connexin_1
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=812
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0342.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis18_Connexin2
AC CVCL_Y344
SY Lis18_Connexin_2
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=813
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0343.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis19_DM2
AC CVCL_Y345
SY Lis19_DM_2
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=814
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0344.
DI NCIt; C84679; Dystrophia myotonica 1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis20_DMD3
AC CVCL_Y346
SY Lis20_DMD_3
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=815
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0345.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis21_Noonan1
AC CVCL_Y347
SY Lis21_Noonan_1; Lis21_noonan
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=816
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0346.
DI NCIt; C34854; Noonan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis22_DMD4
AC CVCL_Y348
SY Lis22_DMD_4
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=817
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0347.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis23_DMD5
AC CVCL_Y349
SY Lis23_DMD_5
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=820
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0328.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Lis24_FXS5
AC CVCL_Y350
SY Lis24_FXS_5
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=818
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0348.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis25_FAP1
AC CVCL_Y351
SY Lis25_FAP_1; Lis25_FAP
RX PubMed=21585244;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=819
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0349.
DI NCIt; C3339; Familial adenomatous polyposis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Lis26_FXS6
AC CVCL_Y352
SY Lis26_FXS_6
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=821
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0350.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis27_t(Y;14)1
AC CVCL_Y353
SY Lis27_t(Y;14)_1
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=822
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0351.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Lis28_t(Y;14)2
AC CVCL_Y354
SY Lis28_t(Y;14)_2
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=795
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0327.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Lis29_FXS7
AC CVCL_Y355
SY Lis29_FXS_7
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=794
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0326.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis30_FAP2
AC CVCL_Y356
SY Lis30_FAP_2
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=793
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0325.
DI NCIt; C3339; Familial adenomatous polyposis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis31_DM3
AC CVCL_Y357
SY Lis31_DM_3
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
DI NCIt; C84679; Dystrophia myotonica 1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis32_DM4
AC CVCL_Y358
SY Lis32_DM_4
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
DI NCIt; C84679; Dystrophia myotonica 1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis33_Norrie
AC CVCL_Y359
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
DI NCIt; C118634; Norrie syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis34_FAP3
AC CVCL_Y360
SY Lis34_FAP_3
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=789
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0324.
DI NCIt; C3339; Familial adenomatous polyposis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis35_Hydrocephaly1
AC CVCL_Y361
SY Lis35_Hydrocephaly_1
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=788
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0323.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis36_t(11;20)N
AC CVCL_Y362
SY Lis36_t(11;20)_N
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=787
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0322.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis37_FXS10
AC CVCL_Y363
SY Lis37_FXS_10
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=786
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0321.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis38_FXS7N
AC CVCL_Y364
SY Lis38_FXS_7_N
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=785
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0320.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis39_FXS8N
AC CVCL_Y365
SY Lis39_FXS_8_N
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=784
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0319.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis40_t(13;14)N
AC CVCL_Y366
SY Lis40_t(13;14)_N
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=783
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0318.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis41_LTBL_N
AC CVCL_Y367
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=782
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0317.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis42_NF1_1N
AC CVCL_Y368
SY Lis42_NF1_1_N
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=781
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0316.
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis43_Connexin3N
AC CVCL_Y369
SY Lis43_Connexin_3_N
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=780
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0315.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis44_t(13;14)2N
AC CVCL_Y370
SY Lis44_t(13;14)_2_N
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis45_Ichthyosis1N
AC CVCL_Y371
SY Lis45_Ichthyosis_1_N
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=778
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0314.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis46_Ichthyosis2N
AC CVCL_Y372
SY Lis46_Ichthyosis_2_N
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=777
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0313.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis47_NF1_2N
AC CVCL_Y373
SY Lis47_NF1_2_N
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=776
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0312.
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis48_DMD6N
AC CVCL_Y374
SY Lis48_DMD_6_N
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=775
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0311.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis49_Hydrocephaly2N
AC CVCL_Y375
SY Lis49_Hydrocephaly_2_N
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=774
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0310.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis50_Hydrocephaly3N
AC CVCL_Y376
SY Lis50_Hydrocephaly_3_N
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=772
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0308.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Lis51_FXS9N
AC CVCL_Y377
SY Lis51_FXS_9_N
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=773
CC From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0309.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LiSa-2
AC CVCL_M821
SY LISA-2
DR Cosmic; 2307721
DR GEO; GSE3643
DR GEO; GSM482515
RX PubMed=11093810;
RX PubMed=18283285;
RX PubMed=22911243;
RX PubMed=24726063;
CC Characteristics: Can be differentiated into mature adipocytes.
CC Omics: Transcriptome analysis.
DI NCIt; C3705; Pleomorphic liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LISP-1
AC CVCL_9U24
SY Lisp-1; LISP-I; LISP1
DR Cosmic; 1184336
RX PubMed=1389533;
RX PubMed=11323753;
RX PubMed=11414198;
CC Derived from metastatic site: Liver.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LISP-A10
AC CVCL_9U25
RX PubMed=11323753;
CC Derived from metastatic site: Liver.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9U24 ! LISP-1
CA Cancer cell line
//
ID LISP-E11
AC CVCL_9U26
RX PubMed=11323753;
CC Derived from metastatic site: Liver.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9U24 ! LISP-1
CA Cancer cell line
//
ID Liv-BL
AC CVCL_W939
SY LIV-BL; LIV; Liv
RX PubMed=2824665;
RX PubMed=2943927;
RX PubMed=2985508;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LIX 7
AC CVCL_0F76
SY LIX7
DR ATCC; CRL-2793
RX PubMed=3136074;
CC Group: Human/rodent somatic cell hybrid.
CC Discontinued: ATCC; CRL-2793; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_N128 ! GM04618
HI CVCL_3575 ! RAG
CA Hybrid cell line
//
ID LIXC002
AC CVCL_V627
SY LIXC-002
RX Patent=CN102465113A;
RX PubMed=24416385;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C201072.
ST Source(s): PubMed=24416385
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8,14
ST D16S539: 11
ST D5S818: 12,13
ST D7S820: 11
ST TH01: 8,9
ST TPOX: 11
ST vWA: 14
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LIXC003
AC CVCL_V628
RX PubMed=24416385;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C201112.
ST Source(s): PubMed=24416385
ST Amelogenin: X,Y
ST CSF1PO: 9,10
ST D13S317: 10
ST D16S539: 11
ST D5S818: 11
ST D7S820: 12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 14,16
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LIXC004
AC CVCL_V629
RX PubMed=24416385;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C201073.
ST Source(s): PubMed=24416385
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 18,20
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LIXC006
AC CVCL_V630
RX PubMed=24416385;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C2013182.
ST Source(s): PubMed=24416385
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 11
ST D16S539: 9
ST D5S818: 9,11
ST D7S820: 7,10
ST TH01: 8
ST TPOX: 7
ST vWA: 13,15
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LIXC011
AC CVCL_V631
RX PubMed=24416385;
ST Source(s): PubMed=24416385
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 11
ST D5S818: 13
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LIXC012
AC CVCL_V632
RX PubMed=24416385;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C201114.
ST Source(s): PubMed=24416385
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,12
ST D16S539: 8
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 7,10
ST vWA: 13,17
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LJH-1
AC CVCL_Z510
SY Lateolabrax Japonicus Heart-1
RX DOI=10.1111/j.1095-8649.2006.01155.x;
CC Group: Fish cell line.
OX NCBI_TaxID=8164; ! Lateolabrax japonicus
OI CVCL_Z511 ! LJH-2
OI CVCL_Z512 ! LJHK
OI CVCL_Z513 ! LJL
OI CVCL_Z514 ! LJS
CA Embryonic stem cell
//
ID LJH-2
AC CVCL_Z511
SY Lateolabrax Japonicus Heart-2
RX DOI=10.1111/j.1095-8649.2006.01155.x;
CC Group: Fish cell line.
OX NCBI_TaxID=8164; ! Lateolabrax japonicus
OI CVCL_Z510 ! LJH-1
OI CVCL_Z512 ! LJHK
OI CVCL_Z513 ! LJL
OI CVCL_Z514 ! LJS
CA Embryonic stem cell
//
ID LJHK
AC CVCL_Z512
SY Lateolabrax Japonicus Head Kidney
RX DOI=10.1111/j.1095-8649.2006.01155.x;
CC Group: Fish cell line.
OX NCBI_TaxID=8164; ! Lateolabrax japonicus
OI CVCL_Z510 ! LJH-1
OI CVCL_Z511 ! LJH-2
OI CVCL_Z513 ! LJL
OI CVCL_Z514 ! LJS
CA Embryonic stem cell
//
ID LJL
AC CVCL_Z513
SY Lateolabrax Japonicus Liver
RX DOI=10.1111/j.1095-8649.2006.01155.x;
CC Group: Fish cell line.
OX NCBI_TaxID=8164; ! Lateolabrax japonicus
OI CVCL_Z510 ! LJH-1
OI CVCL_Z511 ! LJH-2
OI CVCL_Z512 ! LJHK
OI CVCL_Z514 ! LJS
CA Embryonic stem cell
//
ID LJS
AC CVCL_Z514
SY Lateolabrax Japonicus Spleen
RX DOI=10.1111/j.1095-8649.2006.01155.x;
CC Group: Fish cell line.
OX NCBI_TaxID=8164; ! Lateolabrax japonicus
OI CVCL_Z510 ! LJH-1
OI CVCL_Z511 ! LJH-2
OI CVCL_Z512 ! LJHK
OI CVCL_Z513 ! LJL
CA Embryonic stem cell
//
ID LJES1
AC CVCL_M753
SY Lateolabrax Japonicus Embryonic Stem cell 1
RX DOI=10.1016/S0044-8486(02)00570-7;
CC Group: Fish cell line.
OX NCBI_TaxID=8164; ! Lateolabrax japonicus
SX Sex undetermined
CA Embryonic stem cell
//
ID LK 35.2
AC CVCL_9473
SY LK-35.2
DR CLO; CLO_0007318
DR ATCC; HB-98
RX PubMed=6980413;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K166 ! L10.A 2J
CA Hybridoma
//
ID LK-1
AC CVCL_8652
SY LK1
DR Cosmic; 1656902
RX PubMed=22313637;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LK-17
AC CVCL_W487
RX PubMed=8297820;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LK-2
AC CVCL_1377
SY LK 2; LK2
DR CLO; CLO_0050064
DR EFO; EFO_0003141
DR BioSample; SAMN01821697
DR BioSample; SAMN03472522
DR CCLE; LK2_LUNG
DR CGH-DB; 189-1
DR CGH-DB; 9174-4
DR ChEMBL-Cells; CHEMBL3308472
DR ChEMBL-Targets; CHEMBL1075490
DR Cosmic; 687787
DR Cosmic; 889104
DR Cosmic; 946071
DR Cosmic; 1048221
DR Cosmic; 1219073
DR Cosmic; 1239907
DR Cosmic; 1336878
DR Cosmic; 1571742
DR Cosmic; 1656906
DR Cosmic; 1995483
DR Cosmic; 2060534
DR Cosmic; 2125267
DR Cosmic-CLP; 687787
DR GDSC; 687787
DR GEO; GSM784281
DR GEO; GSM827376
DR GEO; GSM887267
DR GEO; GSM888342
DR GEO; GSM1374619
DR GEO; GSM1670047
DR JCRB; JCRB0829
DR RCB; RCB1970
DR TKG; TKG 0494
DR TOKU-E; 4154
RX PubMed=9290701;
RX PubMed=14581340;
RX PubMed=15746151;
RX PubMed=19472407;
RX PubMed=22313637;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 32 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 8
ST D16S539: 9
ST D5S818: 12 (Cosmic-CLP; JCRB; RCB)
ST D5S818: 12,15 (TKG)
ST D7S820: 8
ST TH01: 6
ST TPOX: 9
ST vWA: 16,17
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LK-4
AC CVCL_G208
DR CLO; CLO_0007319
DR ATCC; CRL-2345
RX PubMed=1384161;
CC Monoclonal antibody target: UniProtKB; P05106; Human ITGB3/CD61.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID LK-52
AC CVCL_W488
RX PubMed=1467328;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LK0412
AC CVCL_DG35
DR GEO; GSM966999
DR GEO; GSM967000
DR GEO; GSM967001
DR GEO; GSM967002
DR GEO; GSM967003
DR GEO; GSM967004
RX CelloPub=CLPUB00346;
RX PubMed=18452551;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LK1
AC CVCL_W131
SY LK-1
DR Cosmic; 724832
DR Cosmic; 1609534
DR GEO; GSM313698
RX PubMed=1892748;
RX PubMed=15677628;
CC Microsatellite instability: Stable (MSS) (PubMed=15677628).
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LK2
AC CVCL_W132
DR Cosmic; 1609531
DR GEO; GSM313666
RX PubMed=1892748;
RX PubMed=15677628;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LK63
AC CVCL_7986
SY Lk63; LK-63
DR BTO; BTO:0000606
DR Cosmic; 1130240
DR Cosmic; 2491070
RX PubMed=1378917;
RX PubMed=9067587;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LK707
AC CVCL_E757
DR dbMHC; 48952
DR ECACC; 94071417
DR IHW; IHW9280
DR IMGT/HLA; 10999
WW http://bioinformatics.hsanmartino.it/ecbr/cl280.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LK79
AC CVCL_A645
SY LK-79
DR Cosmic; 889091
DR Cosmic; 946072
DR Cosmic; 1066162
DR Cosmic; 1656905
RX PubMed=22313637;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LK87
AC CVCL_A646
SY LK-87
DR Cosmic; 889092
DR Cosmic; 946055
DR Cosmic; 1066163
DR Cosmic; 1656901
RX PubMed=22313637;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LL-5
AC CVCL_Z842
SY LL5
RX PubMed=6842527;
RX PubMed=11126533;
CC Group: Insect cell line.
OX NCBI_TaxID=7200; ! Lutzomyia longipalpis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LL/2 (LLC1)
AC CVCL_4358
SY LL/2 (LLc1); LL/2(LLc1); LL/2; LL2; LLC1; LLC; Lewis lung carcinoma line 1; Lewis lung carcinoma; Lewis-Lung; Lewis Lung
DR BTO; BTO:0000181
DR BTO; BTO:0000588
DR CLO; CLO_0007325
DR CLO; CLO_0050167
DR CLDB; cl3208
DR ATCC; CRL-1642
DR BCRC; 60050
DR BCRJ; 0145
DR ChEMBL-Cells; CHEMBL3307859
DR ChEMBL-Cells; CHEMBL3308622
DR ChEMBL-Targets; CHEMBL614088
DR ChEMBL-Targets; CHEMBL614693
DR CLS; 400263/p546_Lewis-Lung
DR ECACC; 90020104
DR IZSLER; BS TCL 216
DR KCB; KCB 200781YJ
DR NCBI_Iran; C587
DR RCB; RCB0558
DR TKG; TKG 0153
DR TOKU-E; 2205
RX DOI=10.4051/ibc.2010.2.4.0014;
RX PubMed=7226139;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-352.html
CC Caution: Could be identical to 3LL (CVCL_5653).
CC Breed/subspecies: C57BL/6.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID LL/2-luc-M38
AC CVCL_5J40
SY LL2/luc-M38
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: PerkinElmer; Catalog number 119267.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4358 ! LL/2 (LLC1)
CA Cancer cell line
//
ID LL/2-Red-FLuc
AC CVCL_5J02
SY LL/2 Red-FLuc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW119267
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4358 ! LL/2 (LLC1)
CA Cancer cell line
//
ID LL24
AC CVCL_2575
SY LL 24
DR BTO; BTO:0005077
DR CLO; CLO_0007320
DR CLO; CLO_0007326
DR CLDB; cl3209
DR ATCC; CCL-151
DR BioSample; SAMN03471456
DR ECACC; 90073001
DR KCLB; 10151
RX PubMed=7065527;
CC Characteristics: Can undergo 25 PDL.
ST Source(s): ATCC; KCLB
ST Amelogenin: X,Y
ST CSF1PO: 9,12
ST D13S317: 8,11
ST D16S539: 9,12
ST D3S1358: 14,16
ST D5S818: 10,11
ST D7S820: 11,12
ST FGA: 18.2,24
ST TH01: 7
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID LL29 (AnHa)
AC CVCL_2576
SY LL29; LL 29 (AnHa); LL 29
DR CLO; CLO_0007321
DR CLO; CLO_0007327
DR CLDB; cl3210
DR ATCC; CCL-134
DR BioSample; SAMN03472707
DR ECACC; 87112508
DR KCLB; 10134
RX PubMed=7065527;
CC Characteristics: Can undergo 9 PDL.
ST Source(s): ATCC; ECACC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 9,11
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C35716; Idiopathic pulmonary fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID LL47 (MaDo)
AC CVCL_2577
SY LL47; LL 47 (MaDo); LL 47
DR CLO; CLO_0007322
DR CLO; CLO_0007328
DR CLDB; cl3211
DR ATCC; CCL-135
DR BioSample; SAMN03472708
DR ECACC; 90102538
DR GEO; GSM426291
DR KCLB; 10135
RX PubMed=7065527;
RX PubMed=19727395;
CC Characteristics: Can undergo 15 PDL.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 10135; probable.
ST Source(s): ATCC; ECACC
ST Amelogenin: X,Y
ST CSF1PO: 7,12
ST D13S317: 9,11
ST D16S539: 11
ST D5S818: 12,13
ST D7S820: 8,10
ST TH01: 7,9.3
ST TPOX: 9,10
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID LL58
AC CVCL_8258
DR ATCC; CRL-9693
DR NIH-ARP; 811-65
RX Patent=US5178999;
RX PubMed=3033285;
CC Doubling time: 24-48 hours (NIH-ARP).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-9693; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8277 ! X50-7
CA Transformed cell line
//
ID LL86 (LeSa)
AC CVCL_2578
SY LL86; LL 86 (LeSa); LL 86
DR CLO; CLO_0007323
DR CLO; CLO_0007329
DR CLDB; cl3212
DR ATCC; CCL-190
DR BioSample; SAMN03472823
DR ECACC; 90102541
DR GEO; GSM426292
DR KCLB; 10190
RX PubMed=7065527;
RX PubMed=19727395;
CC Characteristics: Can undergo 10 PDL.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; ECACC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9,13
ST D5S818: 12,13
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID LL97A (AlMy)
AC CVCL_3736
SY LL97A; LL 97A (AlMy); LL 97A
DR CLO; CLO_0007324
DR ATCC; CCL-191
DR BioSample; SAMN03472824
RX PubMed=7065527;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 11,13
ST D5S818: 13
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 10,11
ST vWA: 14,17
DI NCIt; C35716; Idiopathic pulmonary fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID LLAK
AC CVCL_H949
RX PubMed=3474463;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4358 ! LL/2 (LLC1)
CA Cancer cell line
//
ID LLC-15MB
AC CVCL_B055
DR BioSample; SAMN03151830
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=20143388).
CC Derived from metastatic site: Subcutaneous; right buttock.
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1395 ! M14
SX Male
CA Cancer cell line
//
ID LLC-GA5
AC CVCL_U206
RX PubMed=1359120;
RX PubMed=1360010;
CC Transfected with: HGNC; 40; ABCB1.
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_0391 ! LLC-PK1
SX Male
CA Spontaneously immortalized cell line
//
ID LLC-GA5-CoL150
AC CVCL_U207
DR CLO; CLO_0050906
DR RCB; RCB0871
RX PubMed=1359120;
CC Transfected with: HGNC; 40; ABCB1.
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_U206 ! LLC-GA5
SX Male
CA Spontaneously immortalized cell line
//
ID LLC-GA5-CoL300
AC CVCL_U208
DR CLO; CLO_0050907
DR RCB; RCB0872
RX PubMed=1360010;
CC Transfected with: HGNC; 40; ABCB1.
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_U206 ! LLC-GA5
SX Male
CA Spontaneously immortalized cell line
//
ID LLC-MK1
AC CVCL_L987
SY Llc-Mk1; LLCMK1; Lilly Laboratories Cell - Monkey Kidney 1
RX PubMed=14449901;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
CA Spontaneously immortalized cell line
//
ID LLC-MK2
AC CVCL_3009
SY Llc-Mk2; LLC-MK-2; LLCMK2; LLcMK2; Lilly Laboratories Cell - Monkey Kidney 2
DR CLO; CLO_0007330
DR CLDB; cl3214
DR CLDB; cl3215
DR CLDB; cl3218
DR CLDB; cl3219
DR CLDB; cl3220
DR ATCC; CCL-7
DR ATCC; CCL-7.1
DR BCRC; 60092
DR BCRC; 60365
DR BCRJ; 0146
DR CCRID; 3111C0002000000078
DR CCRID; 3131C0001000400006
DR ChEMBL-Cells; CHEMBL3307684
DR ChEMBL-Targets; CHEMBL614691
DR ECACC; 85062804
DR IZSLER; BS CL 57
DR Lonza; 128
RX PubMed=4203458;
RX PubMed=14449901;
WW http://fluoview.magnet.fsu.edu/gallery/cells/llcmk2/llcmk2cells.html
WW http://en.vircell.com/products/llc-mk2-cell-line/
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
CA Spontaneously immortalized cell line
//
ID LLC-PK1
AC CVCL_0391
AS CVCL_K238
SY LLC-PK(1); LLC-PK-1; LLc-PK1; LLC PK1; LLCPK1; Lilly Laboratories Cell - Porcine Kidney 1
DR BTO; BTO:0000760
DR CLO; CLO_0007331
DR MCCL; MCC:0000286
DR CLDB; cl3221
DR CLDB; cl3223
DR CLDB; cl5221
DR ATCC; CL-101
DR ATCC; CRL-1392
DR BCRC; 60080
DR BCRJ; 0147
DR CCRID; 3111C0001CCC000111
DR ChEMBL-Cells; CHEMBL3307655
DR ChEMBL-Targets; CHEMBL614577
DR CLS; 607264/p631_LLC-PK1
DR DSMZ; ACC-637
DR ECACC; 86121112
DR IZSLER; BS CL 111
DR JCRB; JCRB0060
DR Lonza; 844
DR MeSH; D018374
DR TOKU-E; 2208
DR Wikidata; Q28334936
RX PubMed=828141;
RX PubMed=19508353;
RX PubMed=20555413;
WW http://www.atcc.org/support/faqs/118f6/ATCC%20CL101%20vs%20ATCC%20CL1011-956.aspx
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/llcpk1/llcpk1cells.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-150.html
CC Doubling time: ~24 hours (DSMZ).
CC Discontinued: ATCC; CRL-1392; true.
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Male
CA Spontaneously immortalized cell line
//
ID LLC-PK1/Cl4
AC CVCL_IP75
SY LLC-PK1-Cl4; LLC-PK1-CL4; LLC-PK1/Cl 4; LLC-PK1/clone 4; LLC-PK1 clone 4; CL4
RX PubMed=2578475;
RX PubMed=2845797;
RX PubMed=3022596;
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_0391 ! LLC-PK1
SX Male
CA Spontaneously immortalized cell line
//
ID LLC-PK1-GR101
AC CVCL_U970
SY LLC-PK-1-GR101; LLC-PK(1)-GR101
DR BTO; BTO:0002538
RX PubMed=9227432;
RX PubMed=14612386;
CC Transfected with: RGD; 2741; Nr3c1.
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_0391 ! LLC-PK1
SX Male
CA Spontaneously immortalized cell line
//
ID LLC-PK1/BCRP
AC CVCL_IJ30
RX PubMed=23460964;
CC Transfected with: HGNC; 74; ABCG2.
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_0391 ! LLC-PK1
SX Male
CA Spontaneously immortalized cell line
//
ID LLC-PK10
AC CVCL_9577
SY LLC-PK(10)
DR Lonza; 357
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_0391 ! LLC-PK1
SX Male
CA Spontaneously immortalized cell line
//
ID LLC-PK1A
AC CVCL_6331
DR CLO; CLO_0007332
DR ATCC; CL-101.1
RX PubMed=828141;
WW http://www.atcc.org/support/faqs/118f6/ATCC%20CL101%20vs%20ATCC%20CL1011-956.aspx
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_0391 ! LLC-PK1
SX Male
CA Spontaneously immortalized cell line
//
ID LLC-RK1
AC CVCL_2579
SY Lilly Laboratories Cell - Rabbit Kidney 1
DR BTO; BTO:0002175
DR CLO; CLO_0007333
DR CLO; CLO_0007334
DR CLDB; cl3222
DR ATCC; CCL-106
DR BCRC; 60329
DR ECACC; 89050907
DR IZSLER; BS CL 58
DR JCRB; JCRB9034
DR KCLB; 10106
RX PubMed=14277663;
CC Breed/subspecies: New Zealand white.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Spontaneously immortalized cell line
//
ID LLC-WRC 256
AC CVCL_3537
SY Walker/LLC-WRC 256; Walker-256; Walker-Ca.256; Walker 256; W256
DR BTO; BTO:0005080
DR CLO; CLO_0007335
DR CLDB; cl3224
DR CLDB; cl3225
DR ATCC; CCL-38
DR CLS; 500375/NA
DR ECACC; 87061101
DR CCRID; 3142C0001000000059
DR ChEMBL-Cells; CHEMBL3307248
DR ChEMBL-Targets; CHEMBL612803
DR IZSLER; BS TCL 36
DR TKG; TKG 0138
CC Discontinued: CLS; 500375; true.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID LLTC
AC CVCL_H948
DR ChEMBL-Cells; CHEMBL3307861
DR ChEMBL-Targets; CHEMBL614093
RX PubMed=3474463;
CC Selected for resistance to: ChEBI; CHEBI:90239; Tiazofurine.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4358 ! LL/2 (LLC1)
CA Cancer cell line
//
ID LM-1
AC CVCL_V416
RX PubMed=6940833;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LM-100/SV40
AC CVCL_V302
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3434; Uterine corpus leiomyoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM-30.1/SV40
AC CVCL_V303
RX PubMed=1884354;
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3434; Uterine corpus leiomyoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM-5.1/SV40
AC CVCL_V304
RX PubMed=1884354;
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3434; Uterine corpus leiomyoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM-600/SV40
AC CVCL_V305
RX PubMed=1884354;
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3434; Uterine corpus leiomyoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM-605/SV40
AC CVCL_V306
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3434; Uterine corpus leiomyoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM-608/SV40
AC CVCL_V307
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3434; Uterine corpus leiomyoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM-609/SV40
AC CVCL_V308
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3434; Uterine corpus leiomyoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM-65/SV40
AC CVCL_V309
RX PubMed=8020967;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3434; Uterine corpus leiomyoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00001
AC CVCL_9Z21
DR CLO; CLO_0030021
DR Coriell; LM00001
WW https://catalog.coriell.org/0/PDF/LMS/LM00001.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00001; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00002
AC CVCL_9Z22
DR CLO; CLO_0030009
DR Coriell; LM00002
WW https://catalog.coriell.org/0/PDF/LMS/LM00002.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00002; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00004
AC CVCL_9Z23
DR CLO; CLO_0030012
DR Coriell; LM00004
WW https://catalog.coriell.org/0/PDF/LMS/LM00004.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00004; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00005
AC CVCL_9Z24
DR CLO; CLO_0030014
DR Coriell; LM00005
WW https://catalog.coriell.org/0/PDF/LMS/LM00005.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00005; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LM00006
AC CVCL_9Z25
DR CLO; CLO_0030016
DR Coriell; LM00006
WW https://catalog.coriell.org/0/PDF/LMS/LM00006.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00006; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00007
AC CVCL_9Z26
DR CLO; CLO_0030023
DR Coriell; LM00007
WW https://catalog.coriell.org/0/PDF/LMS/LM00007.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00007; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00008
AC CVCL_9Z27
DR CLO; CLO_0030025
DR Coriell; LM00008
WW https://catalog.coriell.org/0/PDF/LMS/LM00008.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00008; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00010
AC CVCL_9Z28
DR CLO; CLO_0030084
DR Coriell; LM00010
WW https://catalog.coriell.org/0/PDF/LMS/LM00010.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00010; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00011
AC CVCL_9Z29
DR CLO; CLO_0030092
DR Coriell; LM00011
WW https://catalog.coriell.org/0/PDF/LMS/LM00011.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00011; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00013
AC CVCL_9Z30
DR CLO; CLO_0030091
DR Coriell; LM00013
WW https://catalog.coriell.org/0/PDF/LMS/LM00013.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00013; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LM00014
AC CVCL_9Z31
DR CLO; CLO_0030090
DR Coriell; LM00014
WW https://catalog.coriell.org/0/PDF/LMS/LM00014.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00014; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00015
AC CVCL_9Z32
DR CLO; CLO_0030089
DR Coriell; LM00015
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00015; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00016
AC CVCL_9Z33
DR CLO; CLO_0030097
DR Coriell; LM00016
WW https://catalog.coriell.org/0/PDF/LMS/LM00016.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00016; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00020
AC CVCL_9Z34
DR CLO; CLO_0030095
DR Coriell; LM00020
WW https://catalog.coriell.org/0/PDF/LMS/LM00020.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00020; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00021
AC CVCL_9Z35
DR CLO; CLO_0030094
DR Coriell; LM00021
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00021; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00023
AC CVCL_9Z36
DR CLO; CLO_0030093
DR Coriell; LM00023
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00023; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00024
AC CVCL_9Z37
DR CLO; CLO_0030088
DR Coriell; LM00024
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00024; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00027
AC CVCL_9Z38
DR CLO; CLO_0030056
DR Coriell; LM00027
WW https://catalog.coriell.org/0/PDF/LMS/LM00027.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00027; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM00031
AC CVCL_9Z39
DR CLO; CLO_0030061
DR Coriell; LM00031
WW https://catalog.coriell.org/0/PDF/LMS/LM00031.pdf
CC Part of: Leiomyosarcoma cell and DNA repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; LM00031; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LM1
AC CVCL_5V01
RX PubMed=9347924;
CC Breed/subspecies: A/J.
DI NCIt; C21762; Adenoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID LM17
AC CVCL_0A66
RX PubMed=11089883;
CC Breed/subspecies: BALB/c.
DI NCIt; C120044; Mouse colon adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7256 ! CT26.WT
CA Cancer cell line
//
ID LM2
AC CVCL_5V02
RX PubMed=9347924;
CC Breed/subspecies: A/J.
DI NCIt; C21762; Adenoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID LM2/1.6.11
AC CVCL_J833
SY LM2/1
DR CLO; CLO_0007355
DR ATCC; HB-204
DR NCBI_Iran; H159
RX PubMed=2428876;
CC Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID LM3
AC CVCL_D269
RX PubMed=21528237;
CC Breed/subspecies: BALB/c.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_D270 ! LMM3
SX Female
CA Cancer cell line
//
ID LM8
AC CVCL_6669
DR CLO; CLO_0050199
DR RCB; RCB1450
RX PubMed=9579581;
CC Breed/subspecies: C3H/HeJ.
DI NCIt; C24021; Mouse osteosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W629 ! Dunn osteosarcoma
SX Female
CA Cancer cell line
//
ID LMBG
AC CVCL_Y084
SY LargeMouth Bass Gonad
RX PubMed=25229492;
CC Group: Fish cell line.
OX NCBI_TaxID=27706; ! Micropterus salmoides
SX Female
CA Spontaneously immortalized cell line
//
ID LmcMF
AC CVCL_T066
RX PubMed=23674870;
CC Doubling time: 19.1 hours (PubMed=23674870).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID LMeC
AC CVCL_L361
RX PubMed=15585963;
CC Breed/subspecies: Beagle.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID LMF3
AC CVCL_W514
RX PubMed=2585303;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1288 ! HSC-3
SX Male
CA Cancer cell line
//
ID LMF4
AC CVCL_W515
RX PubMed=2585303;
RX PubMed=11755821;
RX PubMed=16127291;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1288 ! HSC-3
SX Male
CA Cancer cell line
//
ID LMF5
AC CVCL_W516
RX PubMed=2585303;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1288 ! HSC-3
SX Male
CA Cancer cell line
//
ID LMH
AC CVCL_2580
SY Leghorn Male Hepatoma cell line
DR CLO; CLO_0007359
DR ATCC; CRL-2117
DR BCRC; 60320
DR BCRJ; 0361
DR CCLV; CCLV-RIE 0417
DR CLS; 601411/p717_LMH
DR JCRB; JCRB0237
DR NCBI_Iran; C592
DR TOKU-E; 2215
RX PubMed=3607775;
RX PubMed=19941903;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-71.html
CC Group: Bird cell line.
CC Transformant: ChEBI; CHEBI:34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC Breed/subspecies: White Leghorn L-M.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID LMH/2A
AC CVCL_3465
SY LMH2A
DR CLO; CLO_0007360
DR ATCC; CRL-2118
RX PubMed=2330000;
CC Group: Bird cell line.
CC Transfected with: UniProtKB; P06212; Chicken ESR1.
CC Transformant: ChEBI; CHEBI:34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC Breed/subspecies: White Leghorn L-M.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_2580 ! LMH
SX Male
CA Cancer cell line
//
ID LMM3
AC CVCL_D270
DR ChEMBL-Cells; CHEMBL3307862
DR ChEMBL-Targets; CHEMBL614095
RX PubMed=21528237;
CC Breed/subspecies: BALB/c.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_D269 ! LM3
SX Female
CA Cancer cell line
//
ID LMS03
AC CVCL_5H98
DR Cosmic; 1834894
RX PubMed=19706776;
RX PubMed=22919280;
DI NCIt; C3158; Leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LMS04
AC CVCL_5H99
DR Cosmic; 1834893
RX PubMed=22294416;
RX PubMed=22919280;
DI NCIt; C27904; Retroperitoneal leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LMS05
AC CVCL_5I00
DR Cosmic; 1834892
DR GEO; GSM482504
RX PubMed=22294416;
RX PubMed=22919280;
DI NCIt; C3158; Leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LMS148L
AC CVCL_M822
DR Cosmic; 1608986
DR GEO; GSM623743
RX PubMed=19276386;
RX PubMed=22080063;
CC Omics: Transcriptome analysis.
DI NCIt; C27904; Retroperitoneal leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LMSU
AC CVCL_4849
DR CLO; CLO_0050800
DR BioSample; SAMN03472154
DR CCLE; LMSU_STOMACH
DR GEO; GSM887268
DR GEO; GSM888343
DR RCB; RCB1062
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 10
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 9
ST vWA: 16
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LN 14832
AC CVCL_1T05
DR ATCC; CRL-12231
RX Patent=US6994861;
CC Group: Non-human primate cell line.
CC Problematic cell line: Misidentified. Great-parent cell line (MA-104) has been shown to be from African Green monkey instead of Rhesus macaque.
CC Characteristics: In vitro infected by the NC-1 strain of Neospora caninum.
CC Discontinued: ATCC; CRL-12231; true.
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_4540 ! MARC-145
CA Spontaneously immortalized cell line
//
ID LN-18
AC CVCL_0392
SY LN 18; LN18; LN018
DR BTO; BTO:0002005
DR CLO; CLO_0007362
DR EFO; EFO_0006636
DR MCCL; MCC:0000287
DR ATCC; CRL-2610
DR BioSample; SAMN03471122
DR CCLE; LN18_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 849858
DR Cosmic; 1746957
DR Cosmic; 1995484
DR Cosmic; 2302322
DR Cosmic; 2367489
DR Cosmic; 2491101
DR Cosmic-CLP; 1240168
DR GDSC; 1240168
DR GEO; GSM326196
DR GEO; GSM397661
DR GEO; GSM397662
DR GEO; GSM887269
DR GEO; GSM888344
DR GEO; GSM1374620
DR GEO; GSM1670048
DR PRIDE; PXD000589
RX PubMed=7211194;
RX PubMed=10416987;
RX PubMed=21406405;
RX PubMed=22460905;
RX PubMed=22570425;
RX PubMed=25485619;
RX PubMed=25894527;
RX PubMed=26496030;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Cell surface proteome.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=22570425; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,13
ST D16S539: 11,13
ST D18S51: 17,19
ST D21S11: 28
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 8,10
ST D8S1179: 12,14
ST FGA: 19,23
ST Penta D: 11
ST Penta E: 7,10
ST TH01: 9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-215
AC CVCL_3954
SY LN 215; LN215
DR BTO; BTO:0004456
DR CCLE; LN215_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 849860
DR Cosmic; 2367490
DR Cosmic; 2516024
DR GEO; GSM397663
DR GEO; GSM397664
RX PubMed=2990147;
RX PubMed=10416987;
RX PubMed=21406405;
RX PubMed=22570425;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 28 hours (PubMed=25984343).
CC Omics: shRNA library screening.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=22570425
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 14
ST D16S539: 9,12
ST D18S51: 14,16
ST D21S11: 29
ST D3S1358: 14,17
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 10,14
ST FGA: 22,25
ST Penta D: 9,13
ST Penta E: 7,11
ST TH01: 8
ST TPOX: 8
ST vWA: 18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LN-2207
AC CVCL_S442
RX PubMed=22570425;
ST Source(s): PubMed=22570425
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 11,14
ST D21S11: 30,31
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 8
ST D8S1179: 11,13
ST FGA: 22,23
ST Penta D: 12,13
ST Penta E: 11,12
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-229
AC CVCL_0393
SY LN 229; LN229; LNT-229
DR BTO; BTO:0002004
DR CLO; CLO_0007363
DR EFO; EFO_0006637
DR MCCL; MCC:0000288
DR ATCC; CRL-2611
DR BioSample; SAMN03471191
DR BioSample; SAMN03471692
DR CCLE; LN229_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 849861
DR Cosmic; 1746958
DR Cosmic; 1995485
DR Cosmic; 2302323
DR Cosmic; 2367492
DR Cosmic; 2491102
DR Cosmic; 2516025
DR Cosmic-CLP; 1240169
DR GDSC; 1240169
DR GEO; GSM326200
DR GEO; GSM397665
DR GEO; GSM397666
DR GEO; GSM481416
DR GEO; GSM887270
DR GEO; GSM888345
DR GEO; GSM1374621
DR GEO; GSM1670049
DR Lonza; 1322
DR PRIDE; PXD000589
RX PubMed=10416987;
RX PubMed=19365568;
RX PubMed=20504876;
RX PubMed=21406405;
RX PubMed=22460905;
RX PubMed=22570425;
RX PubMed=25485619;
RX PubMed=25894527;
RX PubMed=25984343;
RX PubMed=26496030;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 31 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Cell surface proteome.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=22570425; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,11
ST D16S539: 12
ST D18S51: 13,15
ST D21S11: 29,30
ST D3S1358: 16,17
ST D5S818: 11,12 (ATCC; Cosmic-CLP; PubMed=22570425)
ST D5S818: 11 (PubMed=25877200)
ST D7S820: 8,11 (ATCC; Cosmic-CLP; PubMed=22570425)
ST D7S820: 11 (PubMed=25877200)
ST D8S1179: 13,14
ST FGA: 23
ST Penta D: 10,11
ST Penta E: 7,16
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LN-235
AC CVCL_3957
SY LN 235; LN235
DR BTO; BTO:0004448
DR CCLE; LN235_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 849862
DR Cosmic; 2367491
DR Cosmic; 2516026
RX PubMed=2990147;
RX PubMed=10416987;
RX PubMed=22570425;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 37 hours (PubMed=25984343).
CC Omics: shRNA library screening.
ST Source(s): PubMed=22570425
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9
ST D16S539: 11
ST D18S51: 13,16
ST D21S11: 29,32.2
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 14,15
ST FGA: 22
ST Penta D: 11,12
ST Penta E: 14,15
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-2669
AC CVCL_S443
RX PubMed=22570425;
ST Source(s): PubMed=22570425
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 11,12
ST D16S539: 10,13
ST D18S51: 16
ST D21S11: 30,31.2
ST D3S1358: 14,15,16
ST D5S818: 11,12
ST D7S820: 8,9
ST D8S1179: 11,13
ST FGA: 24
ST Penta D: 13
ST Penta E: 12
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-308
AC CVCL_0394
SY LN 308; LN308; LNZ-308; LNZ 308; LNZ308; LN-Z308
DR BTO; BTO:0004457
DR MCCL; MCC:0000289
DR CCLE; LNZ308_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 849863
DR Cosmic; 2367499
DR Cosmic; 2516023
RX PubMed=2990147;
RX PubMed=10416987;
RX PubMed=11351043;
RX PubMed=20504876;
RX PubMed=22570425;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 30 hours (PubMed=25984343).
CC Omics: Array-based CGH.
CC Omics: shRNA library screening.
ST Source(s): PubMed=22570425
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D16S539: 9,12
ST D18S51: 13,19
ST D21S11: 31,31.2
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 8,13
ST FGA: 18,20
ST Penta D: 9,11
ST Penta E: 7,10
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-319
AC CVCL_3958
SY LN 319; LN319
DR BTO; BTO:0002215
DR BioSample; SAMN03151824
DR CCLE; LN319_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 849864
DR Cosmic; 2367493
DR Cosmic; 2516027
DR GEO; GSM397667
DR GEO; GSM397668
RX PubMed=10416987;
RX PubMed=21406405;
RX PubMed=22570425;
RX PubMed=25984343;
WW http://www.addexbio.com/productdetail?pid=54
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a LN-992 derivative (PubMed=22570425).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 45 hours (PubMed=25984343).
CC Omics: shRNA library screening.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=22570425
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 14,19
ST D21S11: 30,31
ST D3S1358: 16,17
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 12
ST FGA: 19,26
ST Penta D: 9,13
ST Penta E: 15,17
ST TH01: 9,9.3
ST TPOX: 8,12
ST vWA: 15,18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6845 ! LN-992
SX Male
CA Cancer cell line
//
ID LN-340
AC CVCL_3955
SY LN 340; LN340
DR BTO; BTO:0004458
DR CCLE; LN340_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 849865
DR Cosmic; 2367494
DR Cosmic; 2516028
RX PubMed=10416987;
RX PubMed=22570425;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 30 hours (PubMed=25984343).
CC Omics: shRNA library screening.
ST Source(s): PubMed=22570425
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11,14
ST D18S51: 14,18
ST D21S11: 28,32.2
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 14
ST FGA: 21,25
ST Penta D: 12,15
ST Penta E: 5,9
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-382
AC CVCL_3956
SY LN 382; LN382
DR BTO; BTO:0004459
DR CCLE; LN382_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 2516029
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 52 hours (PubMed=25984343).
CC Omics: shRNA library screening.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-382T
AC CVCL_6839
SY LN 382T; LN382T
DR Cosmic; 849866
DR Cosmic; 2367495
RX PubMed=10416987;
RX PubMed=22570425;
ST Source(s): PubMed=22570425
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 9,12
ST D18S51: 15,16
ST D21S11: 30,31.2
ST D3S1358: 14,18
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 9,13
ST FGA: 24,25
ST Penta D: 12
ST Penta E: 10
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3956 ! LN-382
SX Male
CA Cancer cell line
//
ID LN-401
AC CVCL_6840
SY LN 401; LN401
DR Cosmic; 849867
RX PubMed=10416987;
RX PubMed=22570425;
ST Source(s): PubMed=22570425
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12,13
ST D16S539: 9
ST D18S51: 18
ST D21S11: 31.2
ST D3S1358: 16,17
ST D5S818: 12,13
ST D7S820: 9,10
ST D8S1179: 10,13
ST FGA: 22,24
ST Penta D: 13
ST Penta E: 13,15
ST TH01: 7,8
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-405
AC CVCL_1378
SY LN 405; LN405
DR CLO; CLO_0007364
DR CLDB; cl3242
DR BioSample; SAMN03473369
DR ChEMBL-Cells; CHEMBL3308756
DR ChEMBL-Targets; CHEMBL1075491
DR Cosmic; 687578
DR Cosmic; 849868
DR Cosmic; 910694
DR Cosmic; 1746949
DR Cosmic; 2302332
DR Cosmic; 2367536
DR Cosmic-CLP; 910694
DR DSMZ; ACC-189
DR GDSC; 910694
DR GEO; GSM326241
DR GEO; GSM1670050
RX PubMed=10416987;
RX PubMed=21406405;
RX PubMed=22570425;
RX PubMed=27397505;
CC Doubling time: ~60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=11416159; PubMed=22570425
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 10
ST D18S51: 12,15
ST D21S11: 29,31.2
ST D3S1358: 14
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 13
ST FGA: 22,24
ST Penta D: 8,11
ST Penta E: 17
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LN-427
AC CVCL_6841
SY LN 427; LN427
DR Cosmic; 849869
RX PubMed=10416987;
RX PubMed=22570425;
ST Source(s): PubMed=22570425
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 12,15
ST D21S11: 28
ST D3S1358: 15,16
ST D5S818: 10,12
ST D7S820: 8,9
ST D8S1179: 11,13
ST FGA: 23,24
ST Penta D: 8,9
ST Penta E: 11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-428
AC CVCL_3959
SY LN 428; LN428
DR BTO; BTO:0002216
DR CCLE; LN428_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 849870
DR Cosmic; 2516030
RX PubMed=10416987;
RX PubMed=22570425;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 24 hours (PubMed=25984343).
CC Omics: shRNA library screening.
ST Source(s): PubMed=22570425
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 9
ST D18S51: 13,17
ST D21S11: 30,31
ST D3S1358: 16,17
ST D5S818: 11,13
ST D7S820: 8,12
ST D8S1179: 12,13
ST FGA: 20,25
ST Penta D: 13
ST Penta E: 14,16
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-443
AC CVCL_3960
SY LN 443; LN443
DR BTO; BTO:0004449
DR BioSample; SAMN03151823
DR CCLE; LN443_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 849871
DR Cosmic; 2367496
DR Cosmic; 2516031
RX PubMed=10416987;
RX PubMed=22570425;
RX PubMed=25984343;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a LN-444 derivative (PubMed=22570425).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 40 hours (PubMed=25984343).
CC Omics: shRNA library screening.
ST Source(s): PubMed=22570425
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 10,11
ST D18S51: 15,16
ST D21S11: 28,30
ST D3S1358: 15,17
ST D5S818: 9,12
ST D7S820: 10
ST D8S1179: 13,14
ST FGA: 21,23
ST Penta D: 11,12
ST Penta E: 7,13
ST TH01: 7,9
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3961 ! LN-444
SX Female
CA Cancer cell line
//
ID LN-444
AC CVCL_3961
SY LN 444; LN444
DR BTO; BTO:0004450
DR Cosmic; 849872
DR Cosmic; 2367497
RX PubMed=10416987;
RX PubMed=22570425;
ST Source(s): PubMed=22570425
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 10,11
ST D18S51: 15,16
ST D21S11: 28,30
ST D3S1358: 15,17
ST D5S818: 9,12
ST D7S820: 10
ST D8S1179: 13,14
ST FGA: 21,23
ST Penta D: 11,12
ST Penta E: 7,13
ST TH01: 7,9
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LN-464
AC CVCL_3962
SY LN 464; LN464
DR BTO; BTO:0004451
DR CCLE; LN464_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 849873
DR Cosmic; 2367498
DR Cosmic; 2516032
RX PubMed=10416987;
RX PubMed=22570425;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 35 hours (PubMed=25984343).
CC Omics: shRNA library screening.
ST Source(s): PubMed=22570425
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,13
ST D16S539: 11
ST D18S51: 16
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 10,13
ST D8S1179: 12,13
ST FGA: 22
ST Penta D: 9
ST Penta E: 10,14
ST TH01: 9
ST TPOX: 9,12
ST vWA: 14,17,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-702
AC CVCL_3963
SY LN 702; LN702
DR BTO; BTO:0004452
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LN-71
AC CVCL_6842
SY LN 71; LN71
DR BTO; BTO:0005776
DR Cosmic; 849859
RX PubMed=10416987;
RX PubMed=21406405;
RX PubMed=22570425;
ST Source(s): PubMed=22570425
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,13
ST D16S539: 9,11
ST D18S51: 13
ST D21S11: 29,31.2
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 15
ST FGA: 21,22
ST Penta D: 10,13
ST Penta E: 12,14
ST TH01: 8
ST TPOX: 8
ST vWA: 19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-751
AC CVCL_3964
SY LN 751; LN751
DR BTO; BTO:0004453
DR Cosmic; 849874
RX PubMed=10416987;
RX PubMed=22570425;
ST Source(s): PubMed=22570425
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 12,14
ST D21S11: 30,32.2,33.2
ST D3S1358: 17
ST D5S818: 9,11
ST D7S820: 9,10,12
ST D8S1179: 13,14
ST FGA: 18,22
ST Penta D: 11,13.1,14
ST Penta E: 14,15
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 17,18,20
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-774
AC CVCL_3965
SY LN 774; LN774
DR BTO; BTO:0004454
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LN-784
AC CVCL_3966
SY LN 784; LN784
DR BTO; BTO:0004455
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LN-827
AC CVCL_6843
SY LN 827; LN827
DR Cosmic; 849875
RX PubMed=10416987;
RX PubMed=22570425;
ST Source(s): PubMed=22570425
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 12
ST D21S11: 28,32
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 9,12
ST D8S1179: 12
ST FGA: 23
ST Penta D: 10,13
ST Penta E: 10,12
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 17,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LN-859
AC CVCL_6844
SY LN 859; LN859
DR Cosmic; 849876
RX PubMed=10416987;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN-992
AC CVCL_6845
SY LN 992; LN992
DR Cosmic; 849877
RX PubMed=2990147;
RX PubMed=10416987;
RX PubMed=22570425;
ST Source(s): PubMed=22570425
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 14,19
ST D21S11: 30
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 12,12.2
ST FGA: 19
ST Penta D: 9,13
ST Penta E: 15,17
ST TH01: 9,9.3
ST TPOX: 8,12
ST vWA: 15,18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LN1
AC CVCL_9U28
RX PubMed=9196889;
DI NCIt; C9192; Ovarian carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LN1590
AC CVCL_0C60
RX PubMed=11156375;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4025; Esophageal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0C61 ! PT1590
SX Female
CA Cancer cell line
//
ID LN6216c
AC CVCL_0C58
DR Cosmic; 2218355
RX PubMed=25070024;
CC Derived from metastatic site: Subcarinal lymph node.
DI NCIt; C4025; Esophageal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0C59 ! PT6216
CA Cancer cell line
//
ID LNC
AC CVCL_9578
DR Lonza; 1305
RX PubMed=8046247;
CC Breed/subspecies: NZB.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID LNC.2
AC CVCL_E120
RX PubMed=2120063;
CC Characteristics: IL2 dependent.
CC Breed/subspecies: BALB/cAnN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID LNC.4
AC CVCL_E121
RX PubMed=2120063;
CC Characteristics: IL4 dependent.
CC Breed/subspecies: BALB/cAnN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID LNCaP
AC CVCL_0395
SY LNCAP; LNCap
DR BTO; BTO:0001321
DR CLO; CLO_0007365
DR EFO; EFO_0002071
DR MCCL; MCC:0000290
DR CLDB; cl3243
DR BioSample; SAMN03472386
DR CCRID; 3111C0001CCC000040
DR ChEMBL-Cells; CHEMBL3307965
DR ChEMBL-Targets; CHEMBL612518
DR CLS; 300265/p761_LNCaP
DR Cosmic; 704848
DR Cosmic; 721368
DR Cosmic; 721555
DR Cosmic; 755298
DR Cosmic; 759895
DR Cosmic; 801348
DR Cosmic; 850413
DR Cosmic; 850745
DR Cosmic; 850821
DR Cosmic; 869155
DR Cosmic; 918500
DR Cosmic; 920967
DR Cosmic; 921047
DR Cosmic; 922553
DR Cosmic; 923955
DR Cosmic; 943176
DR Cosmic; 948076
DR Cosmic; 949248
DR Cosmic; 1028648
DR Cosmic; 1028701
DR Cosmic; 1066237
DR Cosmic; 1070886
DR Cosmic; 1071481
DR Cosmic; 1071906
DR Cosmic; 1075275
DR Cosmic; 1172626
DR Cosmic; 1176618
DR Cosmic; 1330909
DR Cosmic; 1556120
DR Cosmic; 1689708
DR Cosmic; 1995486
DR Cosmic; 2537792
DR Cosmic; 2580128
DR Cosmic; 2585151
DR Cosmic; 2585228
DR DSMZ; ACC-256
DR GEO; GSM91927
DR GEO; GSM482669
DR GEO; GSM525800
DR GEO; GSM784790
DR GEO; GSM816637
DR GEO; GSM816634
DR GEO; GSM844579
DR GEO; GSM945240
DR GEO; GSM945282
DR GEO; GSM1029460
DR GEO; GSM1029461
DR GEO; GSM1029462
DR GEO; GSM1029463
DR GEO; GSM1029464
DR GEO; GSM1029465
DR GEO; GSM1029466
DR GEO; GSM1029467
DR GEO; GSM1374622
DR GEO; GSM1374626
DR Lonza; 109
DR PRIDE; PXD000985
DR PRIDE; PXD002107
DR PRIDE; PXD002395
DR PRIDE; PXD003105
DR PRIDE; PXD003262
DR TOKU-E; 3599
DR Wikidata; Q6459234
RX PubMed=8687134;
RX PubMed=9018337;
RX PubMed=10702678;
RX PubMed=10972993;
RX PubMed=11135431;
RX PubMed=11172901;
RX PubMed=11414198;
RX PubMed=12725112;
RX PubMed=14518029;
RX PubMed=15486987;
RX PubMed=22278370;
RX PubMed=23671654;
RX PubMed=24618588;
RX PubMed=25485619;
RX PubMed=26256267;
RX PubMed=26972028;
RX PubMed=27141528;
WW http://lncap.com/
WW https://en.wikipedia.org/wiki/LNCaP
WW http://141.61.102.20/mxdb/project/show/9191407937500
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/LNCaP_Crawford_protocol.pdf
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-136.html
CC Part of: ENCODE project common cell types; tier 3.
CC Doubling time: ~60 hours (DSMZ).
CC Microsatellite instability: Instable (MSI) (PubMed=23671654).
CC Omics: Array-based CGH.
CC Omics: Deep glycome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using proteomics.
CC Derived from metastatic site: Left supraclavicular lymph node.
ST Source(s): CLS; DSMZ; PubMed=11416159; PubMed=25877200
ST Amelogenin: X (CLS)
ST Amelogenin: X,Y (DSMZ; PubMed=11416159; PubMed=25877200)
ST CSF1PO: 10,11
ST D13S317: 10,12
ST D16S539: 11
ST D18S51: 11,12
ST D21S11: 29,31.2 (CLS)
ST D21S11: 29,31.2,32.2 (PubMed=11416159)
ST D21S11: 28,29,31.2 (PubMed=25877200)
ST D3S1358: 16
ST D5S818: 11,12,13 (CLS; PubMed=25877200)
ST D5S818: 11,12 (DSMZ)
ST D7S820: 9.1,10.3 (CLS; DSMZ)
ST D7S820: 8.1,9.1,10.3 (PubMed=25877200)
ST D8S1179: 12,14 (CLS; PubMed=25877200)
ST D8S1179: 12,13,14 (PubMed=11416159)
ST FGA: 19,20 (CLS; PubMed=25877200)
ST FGA: 19,20,21 (PubMed=11416159)
ST Penta D: 12,12.4
ST Penta E: 12,16 (CLS)
ST Penta E: 16 (PubMed=25877200)
ST TH01: 9
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LNCaP 104-R1
AC CVCL_M127
SY LNCaP-104-R1; 104-R1; LNCaP 104-R; 104-R
RX PubMed=7511045;
RX PubMed=9658399;
RX PubMed=16015608;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M126 ! LNCaP 104-S
SX Male
CA Cancer cell line
//
ID LNCaP 104-R2
AC CVCL_M128
SY LNCaP-104-R2; 104-R2
RX PubMed=9658399;
RX PubMed=16015608;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M127 ! LNCaP 104-R1
SX Male
CA Cancer cell line
//
ID LNCaP 104-S
AC CVCL_M126
SY LNCaP-104S; LNCaP 104S; LNCaP104S; 104-S
DR Cosmic; 2580129
DR GEO; GSM525801
RX PubMed=7511045;
RX PubMed=9658399;
RX PubMed=16015608;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP C-33
AC CVCL_M129
SY LNCaP-C33; C-33; C33
RX PubMed=11705865;
RX PubMed=11870800;
RX PubMed=17977648;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP C4
AC CVCL_4783
SY LNCaP-C4; LNCaPC4; LNCaP subline C4; C4
DR BTO; BTO:0005868
RX PubMed=8169003;
RX PubMed=12725112;
WW https://en.wikipedia.org/wiki/LNCaP
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP C4-2
AC CVCL_4782
SY LNCaP-C4-2; LNCaP subline C4-2; C4-2; C42; Sp 2817
DR BTO; BTO:0005672
DR Cosmic; 1330914
RX PubMed=8169003;
WW https://en.wikipedia.org/wiki/LNCaP
WW http://capcelllines.ca/details.asp?id=52
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-464.html
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4783 ! LNCaP C4
SX Male
CA Cancer cell line
//
ID LNCaP C4-2B
AC CVCL_4784
SY C4-2B; C4-2 B; C4-2 Bone metastatic
DR BTO; BTO:0004959
DR EFO; EFO_0006365
DR Cosmic; 1689709
DR GEO; GSM648816
RX PubMed=8168083;
WW https://en.wikipedia.org/wiki/LNCaP
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4782 ! LNCaP C4-2
SX Male
CA Cancer cell line
//
ID LNCaP C4-2B2
AC CVCL_4785
SY LNCaP-C4-2 B2; C4-2B2; Sp 2815
RX PubMed=10881018;
WW http://capcelllines.ca/details.asp?id=165
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4784 ! LNCaP C4-2B
SX Male
CA Cancer cell line
//
ID LNCaP C4-2B3
AC CVCL_4786
SY LNCaP-C4-2 B3; C4-2B3; Sp 2672
RX PubMed=10881018;
WW http://capcelllines.ca/details.asp?id=165
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4784 ! LNCaP C4-2B
SX Male
CA Cancer cell line
//
ID LNCaP C4-2B4
AC CVCL_4787
SY LNCaP-C4-2 B4; LNCaP-C42B4; C4-2B4; Sp 2816
RX PubMed=10881018;
WW http://capcelllines.ca/details.asp?id=165
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4784 ! LNCaP C4-2B
SX Male
CA Cancer cell line
//
ID LNCaP C4-2B5
AC CVCL_4788
SY LNCaP-C4-2 B5; C4-2B5; Sp 2670
RX PubMed=10881018;
WW http://capcelllines.ca/details.asp?id=165
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4784 ! LNCaP C4-2B
SX Male
CA Cancer cell line
//
ID LNCaP C4-2Ln
AC CVCL_6E92
SY C4-2Ln; C4-2 Ln; C4-2 Lymph node metastasis
RX PubMed=8168083;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4782 ! LNCaP C4-2
SX Male
CA Cancer cell line
//
ID LNCaP C4-2Pr
AC CVCL_6E93
SY C4-2Pr; C4-2 Pr; C4-2 Primary tumor
RX PubMed=8168083;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4782 ! LNCaP C4-2
SX Male
CA Cancer cell line
//
ID LNCaP C5
AC CVCL_M132
SY LNCaP-C5; LNCaP subline C5; C5
RX PubMed=8169003;
WW https://en.wikipedia.org/wiki/LNCaP
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP C-51
AC CVCL_M130
SY LNCaP-C51 C-51; C51
RX PubMed=11705865;
RX PubMed=11870800;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M129 ! LNCaP C-33
SX Male
CA Cancer cell line
//
ID LNCaP C-81
AC CVCL_M131
SY LNCaP-C81 C-81; C81
RX PubMed=11705865;
RX PubMed=11870800;
RX PubMed=17977648;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M129 ! LNCaP C-33
SX Male
CA Cancer cell line
//
ID LNCaP clone FGC
AC CVCL_1379
SY LNCaP-Clone-FGC; LNCaP.FGC; LNCaP-FGC; LNCaP FGC
DR CLO; CLO_0007366
DR CLO; CLO_0007367
DR CLO; CLO_0051537
DR EFO; EFO_0005726
DR CLDB; cl3245
DR CLDB; cl4960
DR CLDB; cl5222
DR ATCC; CRL-1740
DR BCRC; 60088
DR BCRJ; 0149
DR BioSample; SAMN03471417
DR BioSample; SAMN03472018
DR CCLE; LNCAPCLONEFGC_PROSTATE
DR CCRID; 3131C0001000700031
DR ChEMBL-Cells; CHEMBL3308342
DR ChEMBL-Targets; CHEMBL2366172
DR Cosmic; 688117
DR Cosmic; 907788
DR Cosmic-CLP; 907788
DR ECACC; 89110211
DR ENCODE; ENCBS235TSM
DR ENCODE; ENCBS386ENC
DR ENCODE; ENCBS387ENC
DR ENCODE; ENCBS418ENC
DR ENCODE; ENCBS422ENC
DR GDSC; 907788
DR GEO; GSM651578
DR GEO; GSM651579
DR GEO; GSM827569
DR GEO; GSM887271
DR GEO; GSM888346
DR GEO; GSM1670051
DR ICLC; HTL99011
DR IZSLER; BS TCL 148
DR KCB; KCB 200732YJ
DR KCLB; 21740
DR RCB; RCB2144
DR TKG; TKG 0603
RX PubMed=11172901;
RX PubMed=12725112;
RX PubMed=22460905;
RX PubMed=23325432;
RX PubMed=27397505;
WW http://capcelllines.ca/details.asp?id=51
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'LNCaP.FCG'.
CC Derived from metastatic site: Left supraclavicular lymph node.
ST Source(s): ATCC; Cosmic-CLP; ECACC; KCLB; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10,12
ST D16S539: 11
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 9.1,10.3 (ATCC; TKG)
ST D7S820: 11 (Cosmic-CLP)
ST D7S820: 9,11 (ECACC; KCLB)
ST D7S820: 9 (RCB)
ST FGA: 19,20
ST TH01: 9
ST TPOX: 8,9
ST vWA: 16,18 (ATCC; Cosmic-CLP; ECACC; KCLB; TKG)
ST vWA: 16,17,18 (RCB)
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP clone FGC.10
AC CVCL_W668
SY LNCaP clone FGC-10; LNCaP-FGC-10; LNcap-FGC-10; LNCaP FGC-10
DR ATCC; CRL-10995
DR IZSLER; BS TCL 187
DR NCBI_Iran; C439
CC Discontinued: ATCC; CRL-10995; probable.
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1379 ! LNCaP clone FGC
SX Male
CA Cancer cell line
//
ID LNCaP M
AC CVCL_M133
SY LNCaP-M; LNCaP subline M; M
RX PubMed=8169003;
WW https://en.wikipedia.org/wiki/LNCaP
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP-17
AC CVCL_B413
DR BTO; BTO:0005044
RX PubMed=16908524;
CC Transfected with: HGNC; 5155; HPN.
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1379 ! LNCaP clone FGC
SX Male
CA Cancer cell line
//
ID LNCaP-34
AC CVCL_B414
DR BTO; BTO:0005045
RX PubMed=16908524;
CC Transfected with: HGNC; 5155; HPN.
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1379 ! LNCaP clone FGC
SX Male
CA Cancer cell line
//
ID LNCaP-abl
AC CVCL_4793
RX PubMed=10496349;
WW http://capcelllines.ca/details.asp?id=167
CC Characteristics: Established after 10 months of propagation of LNCaP in steroid-depleted medium.
CC Characteristics: Has lost chromosome Y.
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP-AI
AC CVCL_4791
SY LNCAPAI
DR GEO; GSM1374623
RX PubMed=10537131;
WW http://capcelllines.ca/details.asp?id=166
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1379 ! LNCaP clone FGC
SX Male
CA Cancer cell line
//
ID LNCaP-CL1
AC CVCL_3872
SY CL1; CL-1
DR BTO; BTO:0005673
RX PubMed=10992426;
WW http://capcelllines.ca/details.asp?id=168
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP-CL1-GFP
AC CVCL_4924
SY CL1-GFP
RX PubMed=10992426;
WW http://capcelllines.ca/details.asp?id=168
CC Transfected with: UniProtKB; P42212; GFP.
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3872 ! LNCaP-CL1
SX Male
CA Cancer cell line
//
ID LNCaP-CR
AC CVCL_8986
RX PubMed=16377078;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP-CS10
AC CVCL_V260
RX PubMed=19902465;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP-LN1
AC CVCL_L160
RX PubMed=9816342;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP-LN2
AC CVCL_L161
RX PubMed=9816342;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L160 ! LNCaP-LN1
SX Male
CA Cancer cell line
//
ID LNCaP-LN3
AC CVCL_L162
SY LNCaP-LN-3
DR KCLB; 80018
RX PubMed=9816342;
RX PubMed=12725112;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L161 ! LNCaP-LN2
SX Male
CA Cancer cell line
//
ID LNCaP-LN4
AC CVCL_L163
RX PubMed=9816342;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L162 ! LNCaP-LN3
SX Male
CA Cancer cell line
//
ID LNCaP-luc-M6
AC CVCL_5J30
RX PubMed=15042605;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: PerkinElmer; Catalog number 119271.
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1379 ! LNCaP clone FGC
SX Male
CA Cancer cell line
//
ID LNCaP-luc2
AC CVCL_5J24
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 125055.
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP-OM
AC CVCL_9U27
RX PubMed=9112118;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP-Pro1
AC CVCL_L164
RX PubMed=9816342;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP-Pro2
AC CVCL_L165
RX PubMed=9816342;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L164 ! LNCaP-Pro1
SX Male
CA Cancer cell line
//
ID LNCaP-Pro3
AC CVCL_L166
RX PubMed=9816342;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L165 ! LNCaP-Pro2
SX Male
CA Cancer cell line
//
ID LNCaP-Pro4
AC CVCL_L167
RX PubMed=9816342;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L166 ! LNCaP-Pro3
SX Male
CA Cancer cell line
//
ID LNCaP-Pro5
AC CVCL_L168
RX PubMed=9816342;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L167 ! LNCaP-Pro4
SX Male
CA Cancer cell line
//
ID LNCaP-Red-FLuc
AC CVCL_5J03
SY LNCaP Red-FLuc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW125055
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNCaP-Rf
AC CVCL_4792
RX PubMed=11861374;
WW http://capcelllines.ca/details.asp?id=175
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LND1
AC CVCL_J076
DR Cosmic; 2051679
WW http://www.gentaur.com/melanoma_hbl_lnd1.htm
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LND554SV.3
AC CVCL_AB83
RX PubMed=27345786;
DI NCIt; C84814; Leigh disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID LNGK9
AC CVCL_D575
SY LNGK-9 PCa; LNGK-9; LnGK9
DR BTO; BTO:0005217
RX PubMed=9365544;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID LNSc-iPS1
AC CVCL_C793
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C794 ! LNSc-iPS2
SX Female
CA Induced pluripotent stem cell
//
ID LNSc-iPS2
AC CVCL_C794
SY LNSC-IPS2
DR ISCR; 9
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C793 ! LNSc-iPS1
SX Female
CA Induced pluripotent stem cell
//
ID LNY1
AC CVCL_D229
SY LNY-1
RX PubMed=12060610;
RX PubMed=19818766;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LNZTA3WT11
AC CVCL_3539
SY LNZTA3p53WT11; WT11
DR CLO; CLO_0007370
DR ATCC; CRL-11544
CC Discontinued: ATCC; CRL-11544; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9,12
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0394 ! LN-308
SX Male
CA Cancer cell line
//
ID LNZTA3WT4
AC CVCL_3540
SY LNZTA3p53WT4; WT4
DR CLO; CLO_0007371
DR ATCC; CRL-11543
DR BioSample; SAMN03471340
DR Cosmic; 1995487
DR Cosmic-CLP; 1240170
DR GDSC; 1240170
DR GEO; GSM1670052
DR LINCS; 50028
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: ATCC; CRL-11543; true.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9,12
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0394 ! LN-308
SX Male
CA Cancer cell line
//
ID Lo Ren
AC CVCL_3541
DR CLO; CLO_0007372
DR ATCC; CRL-1130
DI NCIt; C125696; Ehlers-Danlos syndrome, type I
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Lo Wen
AC CVCL_3542
DR CLO; CLO_0007373
DR ATCC; CRL-1159
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID LO-22
AC CVCL_C519
DR CLO; CLO_0007374
DR ATCC; HB-8619
CC Discontinued: ATCC; HB-8619; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID LO1.Fas
AC CVCL_S324
SY LO1Faa
DR ATCC; CRL-6554
CC Group: Reptilian cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6554; true.
OX NCBI_TaxID=27788; ! Lepidochelys olivacea
OI CVCL_S325 ! LO1.GAK
OI CVCL_S326 ! LO1.HT
OI CVCL_S327 ! LO1.Lu
OI CVCL_S328 ! LO1.Mu
SX Sex undetermined
CA Finite cell line
//
ID LO1.GAK
AC CVCL_S325
SY LO1GAK
DR ATCC; CRL-6555
CC Group: Reptilian cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6555; true.
OX NCBI_TaxID=27788; ! Lepidochelys olivacea
OI CVCL_S324 ! LO1.Fas
OI CVCL_S326 ! LO1.HT
OI CVCL_S327 ! LO1.Lu
OI CVCL_S328 ! LO1.Mu
SX Sex undetermined
CA Finite cell line
//
ID LO1.HT
AC CVCL_S326
SY LO1HT
DR ATCC; CRL-6556
CC Group: Reptilian cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6556; true.
OX NCBI_TaxID=27788; ! Lepidochelys olivacea
OI CVCL_S324 ! LO1.Fas
OI CVCL_S325 ! LO1.GAK
OI CVCL_S327 ! LO1.Lu
OI CVCL_S328 ! LO1.Mu
SX Sex undetermined
CA Finite cell line
//
ID LO1.Lu
AC CVCL_S327
SY LO1Lu
DR ATCC; CRL-6557
CC Group: Reptilian cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6557; true.
OX NCBI_TaxID=27788; ! Lepidochelys olivacea
OI CVCL_S324 ! LO1.Fas
OI CVCL_S325 ! LO1.GAK
OI CVCL_S326 ! LO1.HT
OI CVCL_S328 ! LO1.Mu
SX Sex undetermined
CA Finite cell line
//
ID LO1.Mu
AC CVCL_S328
SY LO1Mu
DR ATCC; CRL-6558
CC Group: Reptilian cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6558; true.
OX NCBI_TaxID=27788; ! Lepidochelys olivacea
OI CVCL_S324 ! LO1.Fas
OI CVCL_S325 ! LO1.GAK
OI CVCL_S326 ! LO1.HT
OI CVCL_S327 ! LO1.Lu
SX Sex undetermined
CA Finite cell line
//
ID LO541265
AC CVCL_E758
SY L0541265
DR dbMHC; 48940
DR ECACC; 95052211
DR IHW; IHW9086
DR IMGT/HLA; 11639
WW http://bioinformatics.hsanmartino.it/ecbr/cl86.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LO68
AC CVCL_2581
DR CBA; CBA-0141
DR Cosmic; 1522778
DR Cosmic; 1963330
DR ECACC; 10092311
DR GEO; GSM726273
RX PubMed=1703129;
RX PubMed=21642991;
CC Omics: SNP array analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LOC
AC CVCL_K268
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/aloc.htm
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID Lof(11-10)
AC CVCL_E555
RX PubMed=11725070;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-gpt].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LoKe
AC CVCL_F001
DR Cosmic; 1699821
RX PubMed=22363598;
DI NCIt; C9231; Merkel cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LOPRA-1
AC CVCL_M481
SY LOPRA1
RX PubMed=3136791;
CC Caution: Not cloned cell line. Two cloned cell lines were derived, LOPRA-1/4 (CVCL_M482) and LOPRA-1/5 (CVCL_M483), the later being most probably the cell line distributed by DSMZ as LOPRA-1.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LOPRA-1/4
AC CVCL_M482
RX PubMed=3136791;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M481 ! LOPRA-1
SX Female
CA Cancer cell line
//
ID LOPRA-1/5
AC CVCL_M483
SY LOPRA-1
DR DSMZ; ACC-778
RX PubMed=3136791;
RX PubMed=10936422;
CC Doubling time: ~5 days (DSMZ).
CC Caution: On the basis of its characteristics it seems that LOPRA-1 from DSMZ correspond to the clone described as LOPRA-1/5 in the original publication (PubMed=3136791).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 14
ST D5S818: 12
ST D7S820: 8,10
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M481 ! LOPRA-1
SX Female
CA Cancer cell line
//
ID LOPRA-2
AC CVCL_M533
SY LOPRA2
RX CelloPub=CLPUB00073;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LOTPD-iPSC
AC CVCL_0H84
SY Late-onset-type-PD-iPSC
DR SKIP; SKIP000578
RX PubMed=24642446;
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0H81 ! GM11661
SX Male
CA Induced pluripotent stem cell
//
ID LOU-NH91
AC CVCL_2104
SY LOU-NH-91; LOUNH91; LouNH91
DR CLO; CLO_0007376
DR EFO; EFO_0006638
DR BioSample; SAMN03473186
DR CCLE; LOUNH91_LUNG
DR Cosmic; 1146949
DR Cosmic; 2060535
DR Cosmic-CLP; 1298226
DR DSMZ; ACC-393
DR GDSC; 1298226
DR GEO; GSM434289
DR GEO; GSM827577
DR GEO; GSM887273
DR GEO; GSM888348
DR GEO; GSM1670054
DR IGRhCellID; LouNH91GEO
DR PRIDE; PXD002556
RX PubMed=7692946;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=26361996;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~80 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 13
ST D18S51: 12
ST D21S11: 30
ST D3S1358: 17
ST D5S818: 12,13
ST D7S820: 10,11
ST D8S1179: 11
ST FGA: 21
ST Penta D: 15
ST Penta E: 5
ST TH01: 9.3
ST TPOX: 11
ST vWA: 17
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Loucy
AC CVCL_1380
SY LOUCY
DR CLO; CLO_0007375
DR EFO; EFO_0007112
DR ATCC; CRL-2629
DR BioSample; SAMN03471756
DR BioSample; SAMN03473575
DR CCLE; LOUCY_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308208
DR ChEMBL-Targets; CHEMBL2366252
DR Cosmic; 907789
DR Cosmic; 913420
DR Cosmic; 1115598
DR Cosmic; 1151784
DR Cosmic; 1175133
DR Cosmic; 1330496
DR Cosmic; 1524802
DR Cosmic; 1641381
DR Cosmic; 1664525
DR Cosmic; 1760527
DR Cosmic; 2165717
DR Cosmic-CLP; 907789
DR DSMZ; ACC-394
DR ENCODE; ENCBS080PZG
DR ENCODE; ENCBS170DPY
DR ENCODE; ENCBS708EFA
DR GDSC; 907789
DR GEO; GSM887272
DR GEO; GSM888347
DR GEO; GSM1670053
RX PubMed=19166587;
RX PubMed=22460905;
RX PubMed=22675565;
RX PubMed=27397505;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/Loucy_Bernstein_protocol.pdf
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Doubling time: ~60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D16S539: 11
ST D5S818: 12 (ATCC; Cosmic-CLP)
ST D5S818: 11,12 (DSMZ)
ST D7S820: 9,10
ST TH01: 8,9.3
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Loukes
AC CVCL_8259
SY LOUCKES; Louckes; Loucks
DR NCBI_Iran; C160
RX PubMed=1915267;
RX PubMed=6112750;
RX PubMed=9973220;
RX PubMed=17254797;
CC Characteristics: EBV-negative.
CC Characteristics: Has a TP53 p.Cys238Tyr mutation.
CC Misspelling: 'Luckes' in PubMed=17254797 and NCBI_Iran C160.
ST Source(s): PubMed=17254797
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 12,13
ST D18S51: 15
ST D21S11: 29,30
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 12
ST FGA: 19,20
ST TH01: 8,10,11
ST TPOX: 9
ST vWA: 16,19
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LoVo
AC CVCL_0399
SY LOVO
DR BTO; BTO:0000666
DR CLO; CLO_0007377
DR CLO; CLO_0007378
DR CLO; CLO_0050632
DR EFO; EFO_0006639
DR MCCL; MCC:0000293
DR CLDB; cl3248
DR CLDB; cl3249
DR CLDB; cl3250
DR CLDB; cl4981
DR ATCC; CCL-229
DR BCRC; 60148
DR BCRJ; 0332
DR BioSample; SAMN03470964
DR BioSample; SAMN03471476
DR BioSample; SAMN03472104
DR BioSample; SAMN03472362
DR BioSample; SAMN03473360
DR CCLE; LOVO_LARGE_INTESTINE
DR CCLV; CCLV-RIE 1151
DR CCRID; 3111C0001CCC000164
DR CCRID; 3131C0001000700082
DR ChEMBL-Cells; CHEMBL3307691
DR ChEMBL-Targets; CHEMBL614721
DR CLS; 300266/p487_LOVO
DR Cosmic; 711256
DR Cosmic; 720330
DR Cosmic; 724842
DR Cosmic; 738931
DR Cosmic; 873702
DR Cosmic; 876724
DR Cosmic; 887220
DR Cosmic; 889534
DR Cosmic; 897741
DR Cosmic; 905003
DR Cosmic; 907790
DR Cosmic; 913886
DR Cosmic; 948858
DR Cosmic; 985997
DR Cosmic; 995396
DR Cosmic; 1043567
DR Cosmic; 1057754
DR Cosmic; 1066209
DR Cosmic; 1122327
DR Cosmic; 1132566
DR Cosmic; 1132691
DR Cosmic; 1184084
DR Cosmic; 1184329
DR Cosmic; 1187308
DR Cosmic; 1223145
DR Cosmic; 1312303
DR Cosmic; 1466817
DR Cosmic; 1479597
DR Cosmic; 1482522
DR Cosmic; 1486133
DR Cosmic; 1524331
DR Cosmic; 1552182
DR Cosmic; 1571770
DR Cosmic; 1676729
DR Cosmic; 1609489
DR Cosmic; 1708412
DR Cosmic; 1803948
DR Cosmic; 1927244
DR Cosmic; 1945867
DR Cosmic; 1995488
DR Cosmic; 2267319
DR Cosmic; 2301996
DR Cosmic-CLP; 907790
DR DSMZ; ACC-350
DR ECACC; 87060101
DR ENCODE; ENCBS024NHD
DR ENCODE; ENCBS080BPN
DR GDSC; 907790
DR GEO; GSM206517
DR GEO; GSM513820
DR GEO; GSM514296
DR GEO; GSM741268
DR GEO; GSM784014
DR GEO; GSM887274
DR GEO; GSM888349
DR GEO; GSM1346882
DR GEO; GSM1374627
DR GEO; GSM1374628
DR GEO; GSM1374629
DR GEO; GSM1374630
DR GEO; GSM1448163
DR GEO; GSM1670055
DR ICLC; HTL99028
DR IFO; IFO50067
DR IZSLER; BS TCL 205
DR JCRB; JCRB9083
DR KCLB; 10229
DR Lonza; 1021
DR RCB; RCB1639
DR SKY/M-FISH/CGH; 2878
DR TKG; TKG 0344
RX PubMed=1260746;
RX PubMed=7104989;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=9290701;
RX PubMed=9515795;
RX PubMed=10612807;
RX PubMed=10674020;
RX PubMed=10737795;
RX PubMed=11226274;
RX PubMed=11314036;
RX PubMed=11414198;
RX PubMed=11526487;
RX PubMed=12584437;
RX PubMed=12661003;
RX PubMed=15771911;
RX PubMed=19927377;
RX PubMed=19941903;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24042735;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=26537799;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/LoVo.html
WW http://www.addexbio.com/productdetail?pid=380
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-208.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 37 hours (PubMed=1260746); 52 hours (PubMed=25984343); ~48 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (PubMed=9000147; PubMed=10674020; PubMed=12661003; PubMed=24042735; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: TKG; TKG 0344; probable.
CC Derived from metastatic site: Left supraclavicular lymph node.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; PubMed=11416159; PubMed=15771911; PubMed=25877200; RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,13,14 (ATCC; ECACC; JCRB)
ST CSF1PO: 11,14 (Cosmic-CLP)
ST CSF1PO: 11,12,14 (DSMZ)
ST CSF1PO: 10,11,13,14 (CLS; PubMed=25877200)
ST CSF1PO: 10,14 (KCLB)
ST CSF1PO: 11,12,13 (RCB)
ST D13S317: 8,11
ST D16S539: 9,12 (ATCC; CLS; Cosmic-CLP; ECACC; JCRB; PubMed=15771911; PubMed=25877200; RCB)
ST D16S539: 9,11,12 (DSMZ)
ST D18S51: 13,18 (CLS; PubMed=15771911; PubMed=25877200)
ST D18S51: 13,17,18 (PubMed=11416159)
ST D19S433: 14,15 (PubMed=25877200)
ST D19S433: 15 (PubMed=15771911)
ST D21S11: 29,31.2,32.2 (CLS)
ST D21S11: 29,31.2 (PubMed=15771911; PubMed=25877200)
ST D2S1338: 16,17,18 (PubMed=15771911)
ST D2S1338: 17,18 (PubMed=25877200)
ST D3S1358: 14,18 (KCLB; PubMed=25877200_584429)
ST D3S1358: 14,16 (PubMed=15771911)
ST D3S1358: 14,17 (PubMed=25877200_130903)
ST D5S818: 11,12,13 (ATCC; DSMZ; JCRB; RCB)
ST D5S818: 11,13 (CLS; Cosmic-CLP; ECACC; KCLB; PubMed=25877200)
ST D7S820: 9.3,10,11 (ATCC; DSMZ; PubMed=25877200)
ST D7S820: 10,11 (CLS; Cosmic-CLP; ECACC; JCRB; KCLB; RCB)
ST D8S1179: 9,10 (PubMed=15771911)
ST D8S1179: 10 (PubMed=25877200)
ST FGA: 18,20
ST Penta D: 9,10,14 (CLS)
ST Penta D: 10,14 (PubMed=25877200)
ST Penta E: 10,16
ST SE33: 19.2,20.2,25.2
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 17,18 (ATCC; CLS; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=11416159; PubMed=25877200; RCB)
ST vWA: 16,17,19 (DSMZ)
ST vWA: 17,19 (PubMed=15771911)
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lovo-143X19
AC CVCL_6A75
SY 143X19
RX PubMed=8632910;
RX PubMed=9989828;
CC Transfected with: HGNC; 11998; TP53 (with A-143).
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5237 ! LoVo-92
SX Male
CA Cancer cell line
//
ID Lovo-143X3
AC CVCL_6A76
SY 143X3
RX PubMed=8632910;
RX PubMed=9989828;
CC Transfected with: HGNC; 11998; TP53 (with A-143).
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5237 ! LoVo-92
SX Male
CA Cancer cell line
//
ID Lovo-175X2
AC CVCL_5235
SY Lovo 175X2; Lovo175X2; Lovo175x2; 175X2
DR BTO; BTO:0004143
RX PubMed=8632910;
RX PubMed=17339891;
RX PubMed=18600534;
CC Transfected with: HGNC; 11998; TP53 (with H-175).
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5237 ! LoVo-92
SX Male
CA Cancer cell line
//
ID Lovo-273X17
AC CVCL_5236
SY Lovo273X17; 273X17
DR BTO; BTO:0004144
RX PubMed=8632910;
RX PubMed=18600534;
CC Transfected with: HGNC; 11998; TP53 (with H-273).
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5237 ! LoVo-92
SX Male
CA Cancer cell line
//
ID LoVo-6-luc-1
AC CVCL_5J42
SY LOVO-6-Luc-1
RX CelloPub=CLPUB00279;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: PerkinElmer; Catalog number 119265.
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0399 ! LoVo
SX Male
CA Cancer cell line
//
ID LoVo-92
AC CVCL_5237
SY Lovo-92; Lovo 92; Lovo92
DR BTO; BTO:0004146
DR GEO; GSM503149
RX PubMed=8632910;
RX PubMed=9989828;
RX PubMed=17339891;
RX PubMed=18600534;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0399 ! LoVo
SX Male
CA Cancer cell line
//
ID LoVo-li
AC CVCL_5238
SY Lovo-li; LoVo-Li; Lovo li
DR BTO; BTO:0004145
DR GEO; GSM503256
RX PubMed=8632910;
RX PubMed=17339891;
RX PubMed=18600534;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5237 ! LoVo-92
SX Male
CA Cancer cell line
//
ID LoVo-Luc#2
AC CVCL_4Y03
DR JCRB; JCRB1537
DR JCRB; NIHS0717
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Left supraclavicular lymph node.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,13,14
ST D13S317: 8,11
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 9.3,10,11
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0399 ! LoVo
SX Male
CA Cancer cell line
//
ID LoVo-MEK-R
AC CVCL_V402
DR Cosmic; 1927245
RX PubMed=22402123;
CC Selected for resistance to: ChEBI; CHEBI:88249; 391210-10-9 (PD0325901).
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0399 ! LoVo
SX Male
CA Cancer cell line
//
ID LoVo/DR5
AC CVCL_6C49
RX PubMed=1673331;
RX PubMed=2896069;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0399 ! LoVo
SX Male
CA Cancer cell line
//
ID LoVo/irinotecan
AC CVCL_4V50
RX PubMed=21289438;
CC Selected for resistance to: ChEBI; CHEBI:80630; Irinotecan (Camptothecin-11; CPT-11).
CC Omics: Proteome analysis by 2D-DE/MS.
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0399 ! LoVo
SX Male
CA Cancer cell line
//
ID LoVo/L-OHP
AC CVCL_4V75
RX PubMed=20591218;
CC Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0399 ! LoVo
SX Male
CA Cancer cell line
//
ID LOX-IMVI
AC CVCL_1381
SY LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX
DR BTO; BTO:0004151
DR EFO; EFO_0006284
DR BioSample; SAMN03470824
DR CCLE; LOXIMVI_SKIN
DR ChEMBL-Cells; CHEMBL3307535
DR ChEMBL-Targets; CHEMBL614096
DR Cosmic; 687446
DR Cosmic; 875883
DR Cosmic; 897466
DR Cosmic; 905974
DR Cosmic; 922393
DR Cosmic; 974255
DR Cosmic; 1044264
DR Cosmic; 1092610
DR Cosmic; 1175868
DR Cosmic; 1238117
DR Cosmic; 1303039
DR Cosmic; 1305363
DR Cosmic; 1312346
DR Cosmic; 1436046
DR Cosmic; 1477412
DR Cosmic; 1669121
DR Cosmic; 1998452
DR Cosmic; 2060808
DR Cosmic-CLP; 905974
DR GDSC; 905974
DR GEO; GSM50200
DR GEO; GSM50262
DR GEO; GSM206518
DR GEO; GSM750808
DR GEO; GSM799351
DR GEO; GSM799414
DR GEO; GSM846362
DR GEO; GSM887275
DR GEO; GSM888350
DR GEO; GSM1153421
DR GEO; GSM1181291
DR GEO; GSM1181335
DR GEO; GSM1670056
DR LINCS; 50988
DR SKY/M-FISH/CGH; 2812
RX PubMed=2041050;
RX PubMed=3346110;
RX PubMed=7999427;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=19727395;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=43
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 20.5 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'LOXMVII' in Cosmic 1044264.
CC Misspelling: 'LOXIN-VI' in Cosmic 687446 and Cosmic 897466.
CC Derived from metastatic site: Axillary lymph node.
ST Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 10,12
ST D18S51: 15,18
ST D19S433: 14.2
ST D21S11: 28,31
ST D2S1338: 18,24
ST D3S1358: 14,15
ST D5S818: 11,13
ST D7S820: 9,11
ST D8S1179: 11,13
ST FGA: 22
ST Penta D: 9,11
ST Penta E: 5,7
ST TH01: 7,9.3
ST TPOX: 9,11
ST vWA: 14,17
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LP
AC CVCL_U761
DR Cosmic; 802239
RX PubMed=9671307;
DI NCIt; C8715; Rhabdoid tumor of the kidney
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LP-1
AC CVCL_0012
SY LP1
DR BTO; BTO:0005912
DR CLO; CLO_0007379
DR EFO; EFO_0003055
DR CLDB; cl3252
DR BioSample; SAMN03472929
DR CCLE; LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308171
DR ChEMBL-Targets; CHEMBL2366066
DR Cosmic; 720763
DR Cosmic; 759910
DR Cosmic; 907791
DR Cosmic; 2081397
DR Cosmic; 2367290
DR Cosmic; 2391810
DR Cosmic-CLP; 907791
DR DSMZ; ACC-41
DR GDSC; 907791
DR GEO; GSM143335
DR GEO; GSM290302
DR GEO; GSM887276
DR GEO; GSM888351
DR GEO; GSM1374631
DR GEO; GSM1670057
DR Lonza; 129
RX PubMed=2784066;
RX PubMed=10583232;
RX PubMed=10936422;
RX PubMed=16956823;
RX PubMed=17171682;
RX PubMed=18700954;
RX PubMed=21173094;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.proteinatlas.org/learn/cellines
WW http://www.addexbio.com/productdetail?pid=55
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 48 hours (PubMed=25984343); 35-80 hours, depending on cell density (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 18
ST D21S11: 30,31
ST D3S1358: 16,18
ST D5S818: 11
ST D7S820: 11,12
ST D8S1179: 13,15
ST FGA: 20,21
ST Penta D: 12
ST Penta E: 10,11
ST TH01: 7,8
ST TPOX: 11
ST vWA: 17
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LP-2
AC CVCL_0N49
RX PubMed=6186388;
RX PubMed=6192933;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID LP-3
AC CVCL_0N48
SY AG07090
DR CLO; CLO_0035654
DR Coriell; AG07090
RX PubMed=6186388;
RX PubMed=6192933;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID LP-9
AC CVCL_E109
SY LP9; AG07086
DR CLO; CLO_0035653
DR Coriell; AG07086
RX PubMed=6186388;
RX PubMed=6192933;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID LP07
AC CVCL_W868
RX PubMed=11179499;
CC Breed/subspecies: BALB/c.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID Lp1 MAB 1
AC CVCL_E982
DR CLO; CLO_0007380
DR ATCC; CRL-1765
RX PubMed=6356714;
CC Monoclonal antibody target: Legionella pneumophila serogroup 1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Lp1 MAB 2
AC CVCL_E983
DR CLO; CLO_0007381
DR ATCC; CRL-1770
RX PubMed=6356714;
CC Monoclonal antibody target: Legionella pneumophila serogroup 1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Lp1 MAB 3
AC CVCL_E984
DR CLO; CLO_0007382
DR ATCC; CRL-1767
RX PubMed=6356714;
CC Monoclonal antibody target: Legionella pneumophila serogroup 1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LP3IIG2
AC CVCL_J834
SY LP3-IIG2
DR CLO; CLO_0007383
DR ATCC; HB-8472
RX Patent=US4851333;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID LP4.4
AC CVCL_J835
SY LP4
DR CLO; CLO_0007384
DR ATCC; HB-232
RX PubMed=1701760;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID LP6
AC CVCL_V413
RX PubMed=21930930;
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LP9/TERT-1
AC CVCL_E108
RX PubMed=10648628;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E109 ! LP-9
SX Female
CA Telomerase immortalized cell line
//
ID LPC-Aa98-19
AC CVCL_Z322
RX PubMed=11212139;
CC Group: Insect cell line.
OX NCBI_TaxID=57095; ! Anacridium aegyptium
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LPC-Aa98-20
AC CVCL_Z323
RX PubMed=11212139;
CC Group: Insect cell line.
OX NCBI_TaxID=57095; ! Anacridium aegyptium
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LPC1p
AC CVCL_1Y53
DR Cosmic; 947634
RX PubMed=9892110;
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LPC10m
AC CVCL_1Y62
DR Cosmic; 947643
RX PubMed=9892110;
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
CC Derived from metastatic site: Not specified.
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LPC11m
AC CVCL_1Y63
DR Cosmic; 947633
RX PubMed=9892110;
RX PubMed=15126341;
CC Omics: Array-based CGH.
CC Derived from metastatic site: Not specified.
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1Y64 ! LPC11p
SX Male
CA Cancer cell line
//
ID LPC11p
AC CVCL_1Y64
DR Cosmic; 947632
RX PubMed=9892110;
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1Y63 ! LPC11m
SX Male
CA Cancer cell line
//
ID LPC12m
AC CVCL_1Y65
DR Cosmic; 947644
RX PubMed=9892110;
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
CC Derived from metastatic site: Not specified.
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LPC13p
AC CVCL_1Y66
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LPC14p
AC CVCL_1Y67
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LPC15p
AC CVCL_1Y68
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LPC2p
AC CVCL_1Y54
DR Cosmic; 947635
RX PubMed=9892110;
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LPC3p
AC CVCL_1Y55
DR Cosmic; 947636
RX PubMed=9892110;
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
DI NCIt; C38342; Pancreatic intraductal papillary-mucinous neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LPC4p
AC CVCL_1Y56
DR Cosmic; 947637
RX PubMed=9892110;
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LPC5m
AC CVCL_1Y57
DR Cosmic; 947638
RX PubMed=9892110;
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
CC Derived from metastatic site: Not specified.
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LPC6p
AC CVCL_1Y58
DR Cosmic; 947639
RX PubMed=9892110;
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LPC7m
AC CVCL_1Y59
DR Cosmic; 947640
RX PubMed=9892110;
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
CC Derived from metastatic site: Not specified.
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LPC8p
AC CVCL_1Y60
DR Cosmic; 947641
RX PubMed=9892110;
RX PubMed=15126341;
RX PubMed=15688027;
CC Omics: Array-based CGH.
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LPC9p
AC CVCL_1Y61
DR Cosmic; 947642
RX PubMed=9892110;
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LPP 3-6
AC CVCL_V124
DR CLO; CLO_0007386
DR CLDB; cl3254
DR IHW; IHW8304
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LPRB3 112
AC CVCL_V125
DR CLO; CLO_0007387
DR CLDB; cl3255
DR IHW; IHW8106
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LPS141
AC CVCL_M823
SY LS141
DR GEO; GSM529098
DR GEO; GSM1228009
DR GEO; GSM1676337
DR GEO; GSM1701669
RX PubMed=19449367;
RX PubMed=20713527;
RX PubMed=21335544;
RX PubMed=22170698;
RX PubMed=22911243;
RX PubMed=26351324;
CC From: Fletcher J.A.; Department of Pathology; Brigham and Women's Hospital; Harvard Medical School; Boston; USA.
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LPS224
AC CVCL_AU06
WW https://www.mdanderson.org/education-and-research/resources-for-professionals/scientific-resources/core-facilities-and-services/characterized-cell-line-core-facility/services/cclc-list-to-distribute-updated.xlsx
DI NCIt; C3194; Liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LPS246
AC CVCL_AU07
WW https://www.mdanderson.org/education-and-research/resources-for-professionals/scientific-resources/core-facilities-and-services/characterized-cell-line-core-facility/services/cclc-list-to-distribute-updated.xlsx
DI NCIt; C3194; Liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LPS510
AC CVCL_V414
RX PubMed=23549872;
CC From: Fletcher J.A.; Department of Pathology; Brigham and Women's Hospital; Harvard Medical School; Boston; USA.
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LPS853
AC CVCL_V415
CC From: Fletcher J.A.; Department of Pathology; Brigham and Women's Hospital; Harvard Medical School; Boston; USA.
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LPS863
AC CVCL_AU08
WW https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Characterized%20Cell%20Line%20Core%20Facility/CCLC%20Cell%20Line%20List%20to%20Distribute.pdf
DI NCIt; C3194; Liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LQ0001
AC CVCL_8Y10
DR ECACC; 99072145
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LQT1
AC CVCL_B938
DR ISCR; 1767
RX PubMed=20660394;
CC From: Technical University of Munich; Munich; Germany.
DI NCIt; C85049; Romano-Ward syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID LQTS1-iPSC a1
AC CVCL_T879
SY LQTS1 a1
DR SKIP; SKIP000200
RX PubMed=22739119;
CC Discontinued: SKIP; SKIP000200; probable.
DI NCIt; C85049; Romano-Ward syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T880 ! LQTS1-iPSC k1
SX Male
CA Induced pluripotent stem cell
//
ID LQTS1-iPSC k1
AC CVCL_T880
SY LQTS1 k1
DR SKIP; SKIP000201
RX PubMed=22739119;
CC Discontinued: SKIP; SKIP000201; probable.
DI NCIt; C85049; Romano-Ward syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T879 ! LQTS1-iPSC a1
SX Male
CA Induced pluripotent stem cell
//
ID LR-3
AC CVCL_J836
DR ECACC; 93062221
CC Monoclonal antibody target: UniProtKB; P24807; Mouse Cd24.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID LR0001
AC CVCL_8Y11
DR ECACC; 99073034
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LR10.6
AC CVCL_8260
DR BioSample; SAMN03151851
RX PubMed=9204988;
RX PubMed=10508494;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a NALM-6 derivative (PubMed=10508494, PubMed=12592342, PubMed=20143388).
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID LR3.1/3
AC CVCL_V126
DR CLO; CLO_0007388
DR CLDB; cl3256
DR IHW; IHW8113
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LR6.2/52a
AC CVCL_V127
DR CLO; CLO_0007389
DR CLDB; cl3257
DR IHW; IHW8132
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LR6.3/52C
AC CVCL_V128
DR CLO; CLO_0007390
DR CLDB; cl3258
DR IHW; IHW8136
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LRB01
AC CVCL_B236
SY LRB001; KUe001-A
DR hPSCreg; KUe001-A
DR ISCR; 1574
RX PubMed=17623545;
RX PubMed=22140133;
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID LRB02
AC CVCL_B237
SY LRB002; KUe002-A
DR hPSCreg; KUe002-A
DR ISCR; 1575
RX PubMed=17623545;
RX PubMed=22140133;
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID LRB03
AC CVCL_B238
SY LRB003; KUe003-A
DR hPSCreg; KUe003-A
DR ISCR; 1576
RX PubMed=17623545;
RX PubMed=22140133;
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC08-16.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID LRB04
AC CVCL_B239
SY LRB004; KUe004-A
DR hPSCreg; KUe004-A
DR ISCR; 1577
RX PubMed=17623545;
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID LRB05
AC CVCL_B240
SY LRB005; KUe005-A
DR hPSCreg; KUe005-A
DR ISCR; 1578
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LRB06
AC CVCL_B241
SY LRB006; KUe006-A
DR hPSCreg; KUe006-A
DR ISCR; 1579
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LRB07
AC CVCL_B242
SY LRB007; KUe007-A
DR hPSCreg; KUe007-A
DR ISCR; 1580
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LRB08
AC CVCL_B243
SY LRB008; KUe008-A
DR hPSCreg; KUe008-A
DR ISCR; 1581
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC10-05.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID LRB09
AC CVCL_B244
SY LRB009; KUe009-A
DR hPSCreg; KUe009-A
DR ISCR; 1582
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LRB10
AC CVCL_B245
SY LRB010
DR ISCR; 1583
RX PubMed=22140133;
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-51.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LRB11
AC CVCL_B246
SY LRB011; KUe010-A
DR hPSCreg; KUe010-A
DR ISCR; 1584
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-51.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LRB13
AC CVCL_B247
SY LRB013; KUe011-A
DR hPSCreg; KUe011-A
DR ISCR; 1585
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LRB14
AC CVCL_B248
SY LRB014; KUe012-A
DR hPSCreg; KUe012-A
DR ISCR; 1586
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LRB16
AC CVCL_B249
SY LRB016; KUe013-A
DR hPSCreg; KUe013-A
DR ISCR; 1587
RX PubMed=22140133;
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LRB17
AC CVCL_B250
SY LRB017; KUe014-A
DR hPSCreg; KUe014-A
DR ISCR; 1588
RX PubMed=22140133;
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LRB18
AC CVCL_B251
SY LRB018; KUe015-A
DR hPSCreg; KUe015-A
DR ISCR; 1589
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LRB21
AC CVCL_BW87
SY LRB021
CC From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC10-25.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LRD
AC CVCL_5T96
RX PubMed=2098280;
CC Breed/subspecies: C3H/J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID LRG
AC CVCL_R827
SY Labeo Rohita Gill
RX PubMed=23224722;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=23
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC023.
OX NCBI_TaxID=84645; ! Labeo rohita
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LRPM
AC CVCL_T033
SY Labeo Rohita Peritoneal Macrophages
RX PubMed=24248274;
CC Group: Fish cell line.
OX NCBI_TaxID=84645; ! Labeo rohita
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LRTM
AC CVCL_R828
SY Labeo Rohita Thymic Macrophages
RX PubMed=23955429;
CC Group: Fish cell line.
OX NCBI_TaxID=84645; ! Labeo rohita
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LS
AC CVCL_2105
DR BioSample; SAMN03473430
DR Cosmic; 2058108
DR DSMZ; ACC-675
RX PubMed=2026421;
CC Doubling time: ~45 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 10,11
ST D5S818: 12,13
ST D7S820: 8,10
ST TH01: 6,8
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LS 102.9
AC CVCL_K220
SY LS-102.9
DR CLO; CLO_0007391
DR ATCC; HB-97
RX PubMed=6980413;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K166 ! L10.A 2J
CA Hybridoma
//
ID LS-136
AC CVCL_J814
SY LS 136
DR CLO; CLO_0007402
DR ATCC; TIB-157
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID LS-CLS
AC CVCL_5789
DR CLS; 605390/p2552_LS-CLS
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Cancer cell line
//
ID LS030609
AC CVCL_IW35
SY LPS2
RX PubMed=23978446;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C3194; Liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LS060208
AC CVCL_IW36
SY LPS1
RX PubMed=23978446;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C3194; Liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LS1034
AC CVCL_1382
SY LS 1034; LS-1034
DR CLO; CLO_0007396
DR EFO; EFO_0002226
DR ATCC; CRL-2158
DR BCRC; 60353
DR BioSample; SAMN03472348
DR CCLE; LS1034_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3308846
DR ChEMBL-Targets; CHEMBL2366072
DR Cosmic; 711266
DR Cosmic; 887236
DR Cosmic; 917486
DR Cosmic; 948850
DR Cosmic; 983741
DR Cosmic; 985655
DR Cosmic; 986015
DR Cosmic; 995409
DR Cosmic; 1043819
DR Cosmic; 1310933
DR Cosmic; 1479603
DR Cosmic; 1609483
DR Cosmic; 1708400
DR Cosmic; 1995489
DR Cosmic-CLP; 917486
DR GDSC; 917486
DR GEO; GSM206519
DR GEO; GSM463045
DR GEO; GSM513912
DR GEO; GSM514298
DR GEO; GSM784018
DR GEO; GSM887277
DR GEO; GSM888352
DR GEO; GSM1448112
DR GEO; GSM1670058
DR IGRhCellID; LS1034
DR KCLB; 22158
RX PubMed=1389533;
RX PubMed=1617643;
RX PubMed=8895552;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=10737795;
RX PubMed=11414198;
RX PubMed=11526487;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24042735;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'LS103A' in GEO GSM784018.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,11
ST D18S51: 20
ST D21S11: 29,30
ST D3S1358: 15,18
ST D5S818: 12,13
ST D7S820: 8,12
ST D8S1179: 13
ST FGA: 20
ST Penta D: 11,13
ST Penta E: 5,13
ST TH01: 7
ST TPOX: 9,11
ST vWA: 17
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LS106
AC CVCL_1D76
RX CelloPub=CLPUB00250;
RX PubMed=10523844;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LS111
AC CVCL_1D77
RX CelloPub=CLPUB00250;
RX PubMed=10523844;
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LS112
AC CVCL_1D79
RX CelloPub=CLPUB00250;
CC Derived from metastatic site: Skin.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LS123
AC CVCL_1383
SY Ls123; LS 123; LS-123
DR CLO; CLO_0007392
DR CLO; CLO_0007397
DR CLDB; cl3260
DR ATCC; CCL-255
DR BCRC; 60536
DR BioSample; SAMN03470983
DR CCLE; LS123_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3308874
DR ChEMBL-Targets; CHEMBL2366334
DR Cosmic; 687530
DR Cosmic; 907792
DR Cosmic; 1187309
DR Cosmic; 1310934
DR Cosmic; 1312304
DR Cosmic; 1466818
DR Cosmic; 1708399
DR Cosmic; 1995490
DR Cosmic-CLP; 907792
DR ECACC; 94120801
DR GDSC; 907792
DR GEO; GSM784016
DR GEO; GSM827450
DR GEO; GSM844580
DR GEO; GSM844581
DR GEO; GSM887278
DR GEO; GSM888353
DR GEO; GSM1448138
DR GEO; GSM1670059
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=25926053;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'LS153' in GEO GSM844581.
ST Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,13
ST D16S539: 13
ST D18S51: 16
ST D19S433: 14
ST D21S11: 30
ST D2S1338: 19
ST D3S1358: 16,18
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 13,16
ST FGA: 22
ST Penta D: 9,11
ST Penta E: 5,12
ST TH01: 7,8
ST TPOX: 9
ST vWA: 16,17 (ATCC; Cosmic-CLP; PubMed=25877200)
ST vWA: 16 (ECACC)
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LS125-2D4-11-10-1
AC CVCL_L599
SY LS-125-2D4-11-10-1; 2D4
DR CLO; CLO_0007398
DR ATCC; HB-12644
RX Patent=US6329510;
CC Monoclonal antibody target: UniProtKB; P32246; Human CCR1/CD191.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LS129-3C3-E3-1
AC CVCL_L600
SY 3C3
DR CLO; CLO_0007399
DR ATCC; HB-12653
RX Patent=US6329159;
CC Monoclonal antibody target: UniProtKB; P51686; Human CCR9/CDw199.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LS132.1D9
AC CVCL_L540
SY 1D9
DR CLO; CLO_0007400
DR ATCC; HB-12549
RX Patent=US6312689;
CC Monoclonal antibody target: UniProtKB; P41597; Human CCR2/CD192.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LS132.8G2
AC CVCL_L541
SY 8G2
DR CLO; CLO_0007401
DR ATCC; HB-12550
RX Patent=US6312689;
CC Monoclonal antibody target: UniProtKB; P41597; Human CCR2/CD192.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LS14
AC CVCL_DH87
DR GEO; GSM482561
RX PubMed=16195405;
RX PubMed=17426441;
DI NCIt; C3194; Liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LS141-1G1-65-15-1
AC CVCL_DC02
SY 1G1
DR CLO; CLO_0001164
DR ATCC; HB-12624
RX Patent=US6488930;
CC Monoclonal antibody target: UniProtKB; P51679; Human CCR4/CD194.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LS174T
AC CVCL_1384
AS CVCL_D190
SY Ls174T; LS174t; Ls-174-T; LS 174 T; LS-174T; Ls-174T; LS 174T; LS-174; LS174
DR BTO; BTO:0001553
DR CLO; CLO_0007393
DR CLO; CLO_0007403
DR EFO; EFO_0002227
DR MCCL; MCC:0000504
DR CLDB; cl3261
DR ATCC; CL-188
DR ATCC; CCL-188
DR BCRC; 60053
DR BioSample; SAMN03470826
DR BioSample; SAMN03471296
DR CCRID; 3111C0001CCC000248
DR CCRID; 3131C0001000700032
DR CCRID; 3142C0001000000129
DR ChEMBL-Cells; CHEMBL3307536
DR ChEMBL-Targets; CHEMBL614097
DR CLS; 300392/p720_LS-174T
DR Cosmic; 711255
DR Cosmic; 719679
DR Cosmic; 724843
DR Cosmic; 738927
DR Cosmic; 873703
DR Cosmic; 875424
DR Cosmic; 876717
DR Cosmic; 887219
DR Cosmic; 889533
DR Cosmic; 907793
DR Cosmic; 934563
DR Cosmic; 948131
DR Cosmic; 948856
DR Cosmic; 985998
DR Cosmic; 995405
DR Cosmic; 1043822
DR Cosmic; 1057755
DR Cosmic; 1066210
DR Cosmic; 1122328
DR Cosmic; 1132565
DR Cosmic; 1132692
DR Cosmic; 1187310
DR Cosmic; 1184087
DR Cosmic; 1184334
DR Cosmic; 1312305
DR Cosmic; 1479573
DR Cosmic; 1486134
DR Cosmic; 1524341
DR Cosmic; 1676738
DR Cosmic; 1708419
DR Cosmic; 1805263
DR Cosmic; 2301546
DR Cosmic; 2301997
DR DSMZ; ACC-759
DR ECACC; 87060401
DR GEO; GSM513911
DR GEO; GSM514297
DR GEO; GSM741264
DR GEO; GSM784021
DR GEO; GSM827345
DR GEO; GSM1346883
DR GEO; GSM1374632
DR GEO; GSM1374633
DR GEO; GSM1448164
DR IGRhCellID; LS174T
DR KCB; KCB 200829YJ
DR KCLB; 10188
DR NCBI_Iran; C568
DR TKG; TKG 0406
DR TOKU-E; 2235
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=1262041;
RX PubMed=3349466;
RX PubMed=6652615;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=8422623;
RX PubMed=8895552;
RX PubMed=9000147;
RX PubMed=9290701;
RX PubMed=10674020;
RX PubMed=10737795;
RX PubMed=11226274;
RX PubMed=11414198;
RX PubMed=11526487;
RX PubMed=19132987;
RX PubMed=20606684;
RX PubMed=24042735;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=26537799;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/LS174T.html
WW http://www.addexbio.com/productdetail?pid=379
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~30-40 hours (DSMZ).
CC Microsatellite instability: Instable (MSI) (PubMed=9000147; PubMed=10674020; PubMed=24042735; PubMed=25926053).
CC Omics: Deep glycome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'LV1747' in Cosmic 1187310 and PubMed=19132987.
CC Discontinued: ATCC; CCL-188; probable.
ST Source(s): ATCC; CLS; DSMZ; KCLB; PubMed=11416159; PubMed=25877200; TKG
ST Amelogenin: X
ST CSF1PO: 10,13,14 (ATCC)
ST CSF1PO: 10,11,14 (DSMZ)
ST CSF1PO: 10,14 (CLS; KCLB; PubMed=25877200; TKG)
ST D13S317: 10 (ATCC; PubMed=25877200)
ST D13S317: 9,10,11 (DSMZ)
ST D13S317: 10,11 (CLS; KCLB; TKG)
ST D16S539: 11,13 (ATCC; CLS; PubMed=25877200; TKG)
ST D16S539: 11,12,13 (DSMZ)
ST D18S51: 11,13
ST D21S11: 29,31
ST D3S1358: 15,17
ST D5S818: 11,15 (CLS; KCLB; PubMed=25877200; TKG)
ST D5S818: 11,15,16 (ATCC)
ST D5S818: 11,14,15 (DSMZ)
ST D7S820: 10.3,11 (ATCC; DSMZ; PubMed=25877200)
ST D7S820: 11 (CLS; KCLB)
ST D7S820: 10,10.3 (TKG)
ST D8S1179: 12,16
ST FGA: 21,22
ST Penta D: 10
ST Penta E: 15,16
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 15,17,18 (ATCC)
ST vWA: 15,17 (CLS; KCLB; PubMed=11416159; PubMed=25877200; TKG)
ST vWA: 15,16,18 (DSMZ)
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0397 ! LS180
SX Female
CA Cancer cell line
//
ID LS174T-HM3
AC CVCL_0306
SY HM3; HM3-MUC2
DR MCCL; MCC:0000198
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1384 ! LS174T
SX Female
CA Cancer cell line
//
ID LS174T-HM7
AC CVCL_6670
SY HM7; HM-7
DR BTO; BTO:0002921
DR EFO; EFO_0006787
DR BioSample; SAMN03472364
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 10,11
ST D16S539: 11,13
ST D18S51: 11,12
ST D21S11: 29,31
ST D3S1358: 16,17
ST D5S818: 11,16
ST D7S820: 10.3,11
ST D8S1179: 12,16
ST FGA: 21,22
ST Penta D: 10
ST Penta E: 15,16
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1384 ! LS174T
SX Female
CA Cancer cell line
//
ID LS174T-W4
AC CVCL_J074
SY Ls174T-W4; W4
RX PubMed=19386264;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1384 ! LS174T
SX Female
CA Cancer cell line
//
ID LS180
AC CVCL_0397
SY LS-180; LS 180
DR BTO; BTO:0001609
DR CLO; CLO_0007394
DR CLO; CLO_0007404
DR EFO; EFO_0006640
DR MCCL; MCC:0000291
DR CLDB; cl3262
DR CLDB; cl3263
DR CLDB; cl7120
DR ATCC; CL-187
DR ATCC; CCL-187
DR BCRC; 60100
DR BioSample; SAMN03472231
DR CCLE; LS180_LARGE_INTESTINE
DR CCRID; 3111C0001CCC000284
DR Cosmic; 869793
DR Cosmic; 913893
DR Cosmic; 948854
DR Cosmic; 995378
DR Cosmic; 1043820
DR Cosmic; 1184098
DR Cosmic; 1187311
DR Cosmic; 1466819
DR Cosmic; 1479574
DR Cosmic; 1708417
DR Cosmic; 2052595
DR Cosmic; 2301998
DR Cosmic-CLP; 998189
DR ECACC; 87021202
DR GDSC; 998189
DR GEO; GSM206520
DR GEO; GSM513928
DR GEO; GSM514299
DR GEO; GSM741271
DR GEO; GSM784017
DR GEO; GSM827346
DR GEO; GSM887279
DR GEO; GSM888354
DR GEO; GSM1346847
DR GEO; GSM1374634
DR GEO; GSM1374635
DR GEO; GSM1374636
DR GEO; GSM1448139
DR GEO; GSM1670060
DR ICLC; HTL01016
DR IZSLER; BS TCL 82
DR Lonza; 348
DR NCBI_Iran; C508
RX PubMed=1262041;
RX PubMed=6652615;
RX PubMed=9515795;
RX PubMed=10737795;
RX PubMed=11314036;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=26537799;
RX PubMed=27397505;
WW http://www.addexbio.com/productdetail?pid=56
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC Microsatellite instability: Instable (MSI-high) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CCL-187; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 10
ST D16S539: 11,13
ST D18S51: 11,13
ST D21S11: 29,31
ST D3S1358: 15,17
ST D5S818: 10,15
ST D7S820: 9.3,11
ST D8S1179: 12,16
ST FGA: 21,22
ST Penta D: 10
ST Penta E: 15,16
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1384 ! LS174T
SX Female
CA Cancer cell line
//
ID LS185-2B10-4-1
AC CVCL_DC03
SY 2B10
DR ATCC; HB-12625
RX Patent=US6488930;
CC Monoclonal antibody target: UniProtKB; P51679; Human CCR4/CD194.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LS212-4A11-30-8
AC CVCL_U729
SY 4A11
DR ATCC; CRL-13015
DR ATCC; PTA-991
RX Patent=US6319675;
CC Monoclonal antibody target: UniProtKB; O00574; Human CXCR6/CD186/Bonzo.
CC Discontinued: ATCC; CRL-13015; true.
CC Discontinued: ATCC; PTA-991; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LS212-7A2-32-1
AC CVCL_U719
SY 7A2
DR ATCC; CRL-13016
DR ATCC; PTA-992
RX Patent=US6319675;
CC Monoclonal antibody target: UniProtKB; O00574; Human CXCR6/CD186/Bonzo.
CC Discontinued: ATCC; CRL-13016; true.
CC Discontinued: ATCC; PTA-992; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LS212-7F3-8-7
AC CVCL_U730
SY 7F3
DR ATCC; CRL-13014
DR ATCC; PTA-990
RX Patent=US6319675;
CC Monoclonal antibody target: UniProtKB; O00574; Human CXCR6/CD186/Bonzo.
CC Discontinued: ATCC; CRL-13014; true.
CC Discontinued: ATCC; PTA-990; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LS212-9G2-7-2
AC CVCL_U731
SY 9G2
RX Patent=US6319675;
CC Monoclonal antibody target: UniProtKB; O00574; Human CXCR6/CD186/Bonzo.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LS274
AC CVCL_N595
RX CelloPub=CLPUB00250;
RX PubMed=10523844;
CC Derived from metastatic site: Skin nodule.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N596 ! LS310
CA Cancer cell line
//
ID LS277
AC CVCL_1D78
RX CelloPub=CLPUB00250;
RX PubMed=10523844;
CC Derived from metastatic site: Skin nodule.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LS310
AC CVCL_N596
RX CelloPub=CLPUB00250;
RX PubMed=10523844;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N595 ! LS274
CA Cancer cell line
//
ID LS40
AC CVCL_E759
DR dbMHC; 48955
DR ECACC; 85102910
DR IHW; IHW9300
DR IMGT/HLA; 11007
WW http://bioinformatics.hsanmartino.it/ecbr/cl300.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID LS411N
AC CVCL_1385
SY LS-411N; LS-411; LS411
DR CLO; CLO_0007406
DR ATCC; CRL-2159
DR BioSample; SAMN03472557
DR CCLE; LS411N_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3308268
DR ChEMBL-Targets; CHEMBL2366189
DR Cosmic; 685868
DR Cosmic; 887215
DR Cosmic; 907794
DR Cosmic; 948862
DR Cosmic; 985999
DR Cosmic; 995401
DR Cosmic; 1043821
DR Cosmic; 1310951
DR Cosmic; 1312306
DR Cosmic; 1479613
DR Cosmic; 1995491
DR Cosmic; 2301999
DR Cosmic-CLP; 907794
DR GDSC; 907794
DR GEO; GSM513913
DR GEO; GSM514300
DR GEO; GSM741269
DR GEO; GSM887280
DR GEO; GSM888355
DR GEO; GSM1346848
DR GEO; GSM1374637
DR GEO; GSM1448140
DR GEO; GSM1670061
DR SKY/M-FISH/CGH; 5011
RX PubMed=1389533;
RX PubMed=1617643;
RX PubMed=8895552;
RX PubMed=10737795;
RX PubMed=11226274;
RX PubMed=11414198;
RX PubMed=19927377;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=26537799;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/LS411.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 23 hours (PubMed=25984343).
CC Microsatellite instability: Instable (MSI-high) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,13,14,16 (ATCC)
ST D13S317: 12,13,14 (Cosmic-CLP)
ST D16S539: 11,12
ST D5S818: 9,15,16,17 (ATCC)
ST D5S818: 9,15 (Cosmic-CLP)
ST D7S820: 7.3,9.3 (ATCC)
ST D7S820: 8,10 (Cosmic-CLP)
ST TH01: 6
ST TPOX: 8,9
ST vWA: 15,16,17 (ATCC)
ST vWA: 15,16 (Cosmic-CLP)
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LS513
AC CVCL_1386
SY LS-513; LS 513
DR CLO; CLO_0007407
DR ATCC; CRL-2134
DR BioSample; SAMN03472554
DR CCLE; LS513_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3308841
DR ChEMBL-Targets; CHEMBL2366311
DR CLS; 300457/p707_LS-513
DR Cosmic; 711275
DR Cosmic; 724844
DR Cosmic; 887230
DR Cosmic; 907795
DR Cosmic; 983740
DR Cosmic; 1132570
DR Cosmic; 1310942
DR Cosmic; 1479582
DR Cosmic; 1609478
DR Cosmic; 1708410
DR Cosmic; 1995492
DR Cosmic; 2302000
DR Cosmic-CLP; 907795
DR GDSC; 907795
DR GEO; GSM513914
DR GEO; GSM514301
DR GEO; GSM887281
DR GEO; GSM888356
DR GEO; GSM1346849
DR GEO; GSM1374638
DR GEO; GSM1448141
DR GEO; GSM1670062
DR KCLB; 22134
RX PubMed=1389533;
RX PubMed=1617643;
RX PubMed=8895552;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=11414198;
RX PubMed=11526487;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 20 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP; KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10,13 (ATCC; Cosmic-CLP; KCLB)
ST CSF1PO: 10 (CLS)
ST D13S317: 9,10
ST D16S539: 12,13
ST D18S51: 12,18
ST D21S11: 30
ST D3S1358: 15
ST D5S818: 9,11 (ATCC; Cosmic-CLP; KCLB)
ST D5S818: 11 (CLS)
ST D7S820: 8,11
ST FGA: 19,21
ST Penta D: 9,14
ST Penta E: 5,18
ST TH01: 8
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LS77-1C6
AC CVCL_J161
SY 1C6
DR CLO; CLO_0001159
DR ATCC; HB-12330
RX Patent=US6184358;
CC Monoclonal antibody target: UniProtKB; P49682; Human CXCR3/CD183.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LSA-1
AC CVCL_U410
RX PubMed=3006326;
OX NCBI_TaxID=9685; ! Felis catus
CA Cancer cell line
//
ID LSB-AA695BB
AC CVCL_Z279
RX PubMed=9302423;
CC Group: Insect cell line.
OX NCBI_TaxID=7167; ! Anopheles albimanus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSC-1
AC CVCL_9U29
RX PubMed=26722391;
CC Doubling time: 46 hours (PubMed=26722391).
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID LSC-AXC-C/3
AC CVCL_5H89
SY C/3; C3
RX PubMed=2786746;
RX PubMed=6713398;
CC Breed/subspecies: AXC.
DI NCIt; C64013; Adenocarcinoma of the rat prostate
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID LSC-AXC-T/5
AC CVCL_5H88
SY T/5; T5
DR ChEMBL-Cells; CHEMBL3307913
DR ChEMBL-Targets; CHEMBL614306
RX PubMed=2786746;
RX PubMed=6713398;
CC Breed/subspecies: AXC.
DI NCIt; C64013; Adenocarcinoma of the rat prostate
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID Lscc-02
AC CVCL_E320
RX PubMed=16383303;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LSCC-1104B1
AC CVCL_T678
SY LSCC-1104-B1; LSCC-1104-B-1; 1104B-1; 1104B1; 1104B
RX PubMed=4375792;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
OI CVCL_T679 ! LSCC-1104X5
SX Male
CA Cancer cell line
//
ID LSCC-1104X5
AC CVCL_T679
SY 1104-X-5; 1104-X5
RX PubMed=4375792;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
OI CVCL_T678 ! LSCC-1104B1
SX Male
CA Cancer cell line
//
ID LSCC-BK2
AC CVCL_T475
SY BK 4480; BK2
RX PubMed=6268044;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID LSCC-BK3
AC CVCL_T476
SY BK 4484; BK3
RX PubMed=6268044;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID LSCC-BK3A
AC CVCL_T680
SY LSCC-BK3 clone A; BK3A
RX PubMed=9524935;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_T476 ! LSCC-BK3
SX Male
CA Cancer cell line
//
ID LSCC-BK3C2
AC CVCL_T681
SY LSCC-BK3 clone C2; BK3C2
RX PubMed=9524935;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_T476 ! LSCC-BK3
SX Male
CA Cancer cell line
//
ID LSCC-H32
AC CVCL_D161
RX PubMed=2581511;
RX PubMed=6293961;
RX PubMed=10954914;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Problematic cell line: Misidentified. Originally thought to be of chicken origin but found to be from quail (PubMed=10954914).
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
HI CVCL_D160 ! CEC-32
CA Spontaneously immortalized cell line
//
ID LSCC-HD11
AC CVCL_4685
SY LSCC HD11; HD-11; HD11
DR BTO; BTO:0003643
DR BCRJ; 0099
RX PubMed=227607;
WW http://www.infarktforschung.de/macrophages_cell_lines.html
CC Group: Bird cell line.
CC Breed/subspecies: White Leghorn SPAFAS.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Transformed cell line
//
ID LSCC-HD2
AC CVCL_6A89
SY LSCC HD2; HD2
RX PubMed=6279674;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Breed/subspecies: White Leghorn SPAFAS.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Transformed cell line
//
ID LSCC-HD3
AC CVCL_H256
SY LSCC HD3; HD3
RX PubMed=6279674;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Breed/subspecies: White Leghorn SPAFAS.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Transformed cell line
//
ID LSCC-HD4
AC CVCL_6A90
SY LSCC HD4; HD4
RX PubMed=6279674;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Breed/subspecies: White Leghorn SPAFAS.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Transformed cell line
//
ID LSCC-NV1
AC CVCL_T643
RX PubMed=6605442;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID LSCC-PR2
AC CVCL_T644
SY PR2
RX PubMed=18770161;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID LSCC-RP12
AC CVCL_T443
SY RP12; RP-12
RX PubMed=18766641;
RX PubMed=18770270;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
OI CVCL_T444 ! LSCC-RP9
SX Male
CA Cancer cell line
//
ID LSCC-RP9
AC CVCL_T444
SY RP9; RP-9
RX PubMed=18770270;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
OI CVCL_T443 ! LSCC-RP12
SX Male
CA Cancer cell line
//
ID LSCC-SF-Mc29
AC CVCL_T445
SY LSCC-SF-MC29; LSCC-SF(Mc29)
RX CelloPub=CLPUB00134;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11868; Avian myelocytomatosis virus MC29.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID LSCC-VA1
AC CVCL_T478
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11868; Avian myelocytomatosis virus MC29.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Transformed cell line
//
ID LSCC-VA2
AC CVCL_T479
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Transformed cell line
//
ID LSCEF61
AC CVCL_X636
RX PubMed=20447061;
CC Group: Bird cell line.
CC Doubling time: 49.5 hours (PubMed=20447061).
CC Breed/subspecies: Langshan.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Finite cell line
//
ID LSHM7
AC CVCL_J319
DR Cosmic; 687533
RX PubMed=12068308;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LSJ-1
AC CVCL_EG97
SY LSJ1
RX PubMed=18442641;
WW https://med.stanford.edu/hesc/research/corefacility/distributions.html
CC From: Stanford University Center for Human Embryonic Stem Cell Research and Education; Stanford; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID LSJ-2
AC CVCL_EG98
SY LSJ2
DR GEO; GSM738199
DR GEO; GSM738202
RX PubMed=18442641;
WW https://med.stanford.edu/hesc/research/corefacility/distributions.html
CC From: Stanford University Center for Human Embryonic Stem Cell Research and Education; Stanford; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID LSJ-3
AC CVCL_EG99
CC From: Stanford University Center for Human Embryonic Stem Cell Research and Education; Stanford; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LSJ-4
AC CVCL_EH00
CC From: Stanford University Center for Human Embryonic Stem Cell Research and Education; Stanford; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID LSM 2.7
AC CVCL_IU06
DR ATCC; HB-8121
RX Patent=US4529694;
RX PubMed=6365856;
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC Discontinued: ATCC; HB-8121; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2516 ! HS-Sultan
CA Hybrid cell line
//
ID LSP.M2
AC CVCL_EG59
SY LSP M2; LSPM2
DR GEO; GSM78846
DR GEO; GSM78847
DR GEO; GSM78848
DR GEO; GSM78849
DR GEO; GSM78850
DR GEO; GSM78851
CC From: Boyd A.; Queensland Institute of Medical Research; Brisbane; Australia.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LSQC-1
AC CVCL_T631
RX PubMed=6202653;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID LSQC-11
AC CVCL_T638
RX PubMed=6202653;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID LSQC-14
AC CVCL_T639
RX PubMed=6202653;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID LSQC-17
AC CVCL_T640
RX PubMed=6202653;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID LSQC-18
AC CVCL_T641
RX PubMed=6202653;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID LSQC-1C
AC CVCL_T632
RX PubMed=6202653;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID LSQC-2
AC CVCL_T633
RX PubMed=6202653;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID LSQC-23
AC CVCL_T642
RX PubMed=6202653;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID LSQC-3C
AC CVCL_T634
RX PubMed=6202653;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID LSQC-6
AC CVCL_T635
RX PubMed=6202653;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID LSQC-7
AC CVCL_T636
RX PubMed=6202653;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID LSQC-9C
AC CVCL_T637
SY OK10 QDP 9C; 9C
RX PubMed=6202653;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID LSQC-OK10QB5
AC CVCL_9Y57
SY OK10 QB5; OK10 Q B5
RX PubMed=6158166;
RX PubMed=6202653;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID LSR-SF (SR)
AC CVCL_0J67
SY LSR-SF-SR
RX CelloPub=CLPUB00235;
RX PubMed=8678827;
CC Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID LST-R1
AC CVCL_E054
SY Laterally Spreading Tumor-Rectum 1
RX PubMed=18300345;
CC Doubling time: 36 hours (PubMed=18300345).
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LSTM-AA-20
AC CVCL_Z353
SY Mos. 20; Mos 20; Mos-20; Mos20; Mosquito tissue culture No. 20; A20
RX PubMed=5360492;
RX DOI=10.1007/BF00919719;
CC Group: Insect cell line.
OX NCBI_TaxID=7159; ! Aedes aegypti
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-AA-20A
AC CVCL_Z354
SY Mos. 20A; Mos 20(A); Mos 20 A; Mos 20A; Mos-20A; Mosquito tissue culture No. 20A; AA-20A
RX PubMed=5360492;
RX DOI=10.1007/BF00919719;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/spinless/smos_20_a.htm
CC Group: Insect cell line.
OX NCBI_TaxID=7159; ! Aedes aegypti
HI CVCL_Z353 ! LSTM-AA-20
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-AA-29
AC CVCL_Z355
SY Mos. 29; Mos 29; Mos-29; Mosquito tissue culture No. 29
RX PubMed=5360492;
RX DOI=10.1007/BF00919719;
CC Group: Insect cell line.
OX NCBI_TaxID=7159; ! Aedes aegypti
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-AA-63
AC CVCL_Z363
RX DOI=10.1007/BF00919719;
CC Group: Insect cell line.
OX NCBI_TaxID=7159; ! Aedes aegypti
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-AG-55
AC CVCL_Z360
SY Mos. 55; Mos 55; Mos-55; Mos55; MOS-55; Mosquito tissue culture No. 55; AG-55; Ag55
RX PubMed=5048073;
RX DOI=10.1007/BF00919719;
WW https://www.vectorbase.org/data/anopheles-gambiae-mos55-agdnv-cell-line-avcl
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7165; ! Anopheles gambiae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-AM-60
AC CVCL_Z361
SY Mos. 60; Mos 60; Mos-60; Mosquito tissue culture No. 60; AM-60; AM60
RX PubMed=4458148;
RX DOI=10.1007/BF00919719;
CC Group: Insect cell line.
OX NCBI_TaxID=1424567; ! Aedes malayensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-AP-61
AC CVCL_Z362
SY Mos. 61; Mos 61; Mos-61; Mosquito tissue culture No. 61; AP-61; AP61
RX DOI=10.1007/BF00919719;
RX PubMed=5385;
RX PubMed=2861916;
RX PubMed=4458148;
RX PubMed=6137452;
RX PubMed=9768212;
CC Group: Insect cell line.
OX NCBI_TaxID=316597; ! Aedes pseudoscutellaris
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-AS-43
AC CVCL_Z356
SY Mos. 43; Mos 43; Mos-43; Mosquito tissue culture No. 43; MSQ43; AS-43; As43
RX PubMed=5545029;
RX DOI=10.1007/BF00919719;
WW https://www.vectorbase.org/data/anopheles-stephensi-msq43-cell-line-avcl
WW http://www.mr4.org/MR4ReagentsSearch/hybridomaCellLines/MRA-858.aspx
CC Group: Insect cell line.
CC Registration: BEI Resources Repository, Malaria Research and Reference Reagent Resource Center; MRA-858.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=30069; ! Anopheles stephensi
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-AS-44
AC CVCL_Z357
SY Mos. 44; Mos 44; Mos-44; Mosquito tissue culture No. 44
RX DOI=10.1007/BF00919719;
CC Group: Insect cell line.
OX NCBI_TaxID=30069; ! Anopheles stephensi
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-AS-45
AC CVCL_Z358
SY Mos. 45; Mos 45; Mos-45; Mosquito tissue culture No. 45
RX DOI=10.1007/BF00919719;
CC Group: Insect cell line.
OX NCBI_TaxID=30069; ! Anopheles stephensi
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-AS-46
AC CVCL_Z359
SY Mos. 46; Mos 46; Mos-46; Mosquito tissue culture No. 46
RX DOI=10.1007/BF00919719;
CC Group: Insect cell line.
OX NCBI_TaxID=30069; ! Anopheles stephensi
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-BM-256
AC CVCL_Z139
SY BM-256; TTC-256
RX PubMed=4760627;
CC Group: Tick cell line.
CC Miscellaneous: Cell line no longer available (personal communication of Pudney M. to Bell-Sakyi L.).
OX NCBI_TaxID=6941; ! Rhipicephalus microplus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-BM-270
AC CVCL_Z138
SY BM-270; BM270
RX DOI=10.1007/BF00919720;
CC Group: Tick cell line.
CC Miscellaneous: Cell line no longer available (personal communication of Pudney M. to Bell-Sakyi L.).
OX NCBI_TaxID=6941; ! Rhipicephalus microplus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-RA-219
AC CVCL_Z135
SY RA-219; TTC-219
RX PubMed=1123829;
CC Group: Tick cell line.
CC Miscellaneous: Cell line probably no longer available; no published report since 1987 (personal communication of Bell-Sakyi L.).
OX NCBI_TaxID=34631; ! Rhipicephalus appendiculatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-RA-243
AC CVCL_Z136
SY RA-243; RA 243; RA243; TTC-243; TTC 243
DR TCB; 3066
RX DOI=10.1007/BF00919720;
RX PubMed=1123829;
RX PubMed=7131199;
RX PubMed=17662657;
RX PubMed=22743047;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
CC Group: Tick cell line.
OX NCBI_TaxID=34631; ! Rhipicephalus appendiculatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-RA-257
AC CVCL_Z137
SY RA-257; RA257; TTC-257
RX PubMed=1123829;
RX PubMed=17662657;
RX PubMed=22743047;
CC Group: Tick cell line.
OX NCBI_TaxID=34631; ! Rhipicephalus appendiculatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTM-TI-32
AC CVCL_Z352
SY BTC-32
RX DOI=10.1111/j.1550-7408.1983.tb05338.x;
RX PubMed=322623;
RX PubMed=3333490;
CC Group: Insect cell line.
CC Doubling time: 48 hours (PubMed=322623).
OX NCBI_TaxID=30076; ! Triatoma infestans
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LSTRA
AC CVCL_J301
RX PubMed=185295;
RX PubMed=564410;
RX PubMed=4867923;
RX PubMed=6327281;
RX PubMed=6543243;
CC Breed/subspecies: BALB/c.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID LT
AC CVCL_8891
DR CLO; CLO_0007408
DR ECACC; 96061947
CC Discontinued: ECACC; 96061947; probable.
DI NCIt; C38153; Lung lymphangioleiomyomatosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID LT C-7
AC CVCL_Z618
SY LT-C7
RX PubMed=196393;
RX PubMed=6287221;
CC Group: Insect cell line.
OX NCBI_TaxID=7160; ! Aedes albopictus
HI CVCL_Z223 ! ATC-15
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LT-1 [Contaminated frog cell line]
AC CVCL_1R49
DR BioSample; SAMN03151968
RX PubMed=304896;
RX PubMed=4367239;
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Group: Fish cell line.
CC Group: Reptilian cell line.
CC Problematic cell line: Misidentified/contaminated. Originally thought to be of Lithobates pipiens (frog) origin but found to be a complex mixture of Pimephales promelas FHM and Terrapene carolina TH-1 (PubMed=304896, PubMed=6451928, PubMed=20143388).
OX NCBI_TaxID=90988; ! Pimephales promelas
OX NCBI_TaxID=158814; ! Terrapene carolina
HI CVCL_3820 ! FHM
HI CVCL_4324 ! TH-1 subline B1
CA Hybrid cell line
//
ID LT-1 [Mouse]
AC CVCL_8062
RX PubMed=2785856;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=LT-1
CC Transfected with: MGI; MGI:96556; Il4.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3949 ! J558L
CA Cancer cell line
//
ID LT1/41-H1
AC CVCL_9Y76
DR ATCC; CRL-9128
RX Patent=US5087557;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LT12
AC CVCL_D271
SY LT-12; IPC-81
DR ChEMBL-Cells; CHEMBL3307863
DR ChEMBL-Targets; CHEMBL614098
RX PubMed=2195239;
RX PubMed=3480794;
RX PubMed=6574296;
CC Breed/subspecies: Brown Norway.
DI NCIt; C60428; Rat leukemia
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID LT1e-OLIG2GFP
AC CVCL_U170
SY R-Olig2
DR ISCR; 2181
RX PubMed=19544414;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/lt1e-olig2gfp.cmsx
CC Characteristics: An EGFP cassette is inserted to the OLIG2 locus via homologous recombination.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
ST Source(s): WiCell
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 10,12
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9726 ! BG01
SX Male
CA Embryonic stem cell
//
ID LT2 [Human immortalized pancreatic mesenchymal]
AC CVCL_E923
DR Millipore; SCR013
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID LT2 [Human vulvar squamous cell carcinoma]
AC CVCL_HX23
RX PubMed=686047;
CC Doubling time: ~32 hours (PubMed=686047).
CC Derived from metastatic site: Right inguinal lymph node.
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LT2e-H9CAGGFP
AC CVCL_U171
RX PubMed=21699412;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/lt2e-h9caggfp.cmsx
CC Transfected with: UniProtKB; P42212; GFP.
ST Source(s): WiCell
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 9,11
ST TH01: 9.3
ST TPOX: 10,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9773 ! WA09
SX Female
CA Embryonic stem cell
//
ID LT4
AC CVCL_T727
RX PubMed=3079807;
CC Characteristics: IL3 dependent.
CC Breed/subspecies: DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Factor-dependent cell line
//
ID LT4Tr
AC CVCL_T728
DR CLO; CLO_0050772
DR RCB; RCB0120
CC Characteristics: IL3 dependent.
CC Breed/subspecies: DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_T727 ! LT4
SX Female
CA Factor-dependent cell line
//
ID LTAg2B
AC CVCL_M430
RX PubMed=1724784;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LTC 86
AC CVCL_6D55
SY LTC86
RX PubMed=16089086;
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60376; Rat chondrosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_S123 ! RCS-LTC
CA Cancer cell line
//
ID LTC 93
AC CVCL_6D56
SY LTC93
RX PubMed=16089086;
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60376; Rat chondrosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_S123 ! RCS-LTC
CA Cancer cell line
//
ID LTC clone Ng
AC CVCL_6D57
SY Ng
RX PubMed=12874833;
RX PubMed=16089086;
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60376; Rat chondrosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_S123 ! RCS-LTC
CA Cancer cell line
//
ID LTC clone Rex
AC CVCL_6D58
SY Rex
RX PubMed=12874833;
RX PubMed=16089086;
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60376; Rat chondrosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_S123 ! RCS-LTC
CA Cancer cell line
//
ID LTC-14
AC CVCL_DF07
RX PubMed=14977634;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Lewis LEW.1W.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID LTC-7
AC CVCL_DF08
RX PubMed=14977634;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Lewis LEW.1W.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID LTEP-78
AC CVCL_6927
SY LTEP78
RX PubMed=7297395;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LTEP-a1
AC CVCL_6928
SY LTEP-A1; LTEP-a-1
RX PubMed=2988714;
RX PubMed=3471311;
RX PubMed=6872840;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LTEP-a2
AC CVCL_6929
SY LTEP-A2; LTEP-a-2; LTEPa2
DR CCRID; 3131C0001000700033
RX PubMed=1889334;
RX PubMed=2988714;
RX PubMed=3471311;
RX PubMed=6872840;
WW http://www.tiandz.com/product/14508.html
ST Source(s): Tiandz
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D18S51: 16
ST D19S433: 13,14
ST D21S11: 27,28
ST D2S1338: 17
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 12
ST FGA: 21
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LTEP-a3
AC CVCL_HA47
RX PubMed=2988714;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LTEP-s
AC CVCL_6930
DR CCRID; 3111C0001CCC000285
DR CCRID; 3111C0001CCC000330
RX PubMed=2988714;
WW http://www.tiandz.com/product/14510.html
ST Source(s): Tiandz
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 8,9
ST D18S51: 14
ST D19S433: 13
ST D21S11: 32.2,33.2
ST D2S1338: 20,25
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 15,17
ST FGA: 24
ST TH01: 7
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LTEP-sm
AC CVCL_6931
SY LTEP-sm 1; LTEPsm
DR CCRID; 3111C0001CCC000286
RX PubMed=1966333;
RX PubMed=2854776;
RX PubMed=2988714;
WW http://www.tiandz.com/product/14509.html
ST Source(s): Tiandz
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11
ST D18S51: 13,14
ST D19S433: 13
ST D21S11: 30
ST D2S1338: 23
ST D3S1358: 16,17
ST D5S818: 10
ST D7S820: 12
ST D8S1179: 12,15
ST FGA: 20,27
ST TH01: 7
ST TPOX: 9,11
ST vWA: 19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LTK
AC CVCL_R978
SY Lake Trout Kidney
RX DOI=10.1577/1548-8667(1993)005<0119:DOCCDF>2.3.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8040; ! Salvelinus namaycush
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LTK-
AC CVCL_3392
DR CLO; CLO_0007411
DR CLO; CLO_0050232
DR CLDB; cl3267
DR CLDB; cl3268
DR ECACC; 85011432
DR ICLC; AL97001
DR KCB; KCB 87015YJ
DR KCB; KCB 94012YJ
DR RCB; RCB0208
RX PubMed=3558490;
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4535 ! L-M
SX Male
CA Transformed cell line
//
ID Ltk-11
AC CVCL_3738
DR CLO; CLO_0007412
DR ATCC; CRL-10422
DR CCRID; 3111C0001CCC000194
RX Patent=US6706716;
CC Transfected with: HGNC; 5289; HTR1D.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID Ltk-8-30-84
AC CVCL_K239
DR ATCC; CRL-10421
RX Patent=US6706716;
CC Transfected with: HGNC; 5287; HTR1B.
CC Discontinued: ATCC; CRL-10421; probable.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID LTL
AC CVCL_R979
SY Lake Trout Liver
RX DOI=10.1577/1548-8667(1993)005<0119:DOCCDF>2.3.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8040; ! Salvelinus namaycush
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LTPA
AC CVCL_3538
DR CLO; CLO_0007413
DR ATCC; CRL-2389
RX PubMed=205354;
RX PubMed=25492535;
CC Omics: Mitochondrial genome sequenced.
CC Caution: The authors of PubMed=25492535 indicate that they have sequenced the mitochondrial genome of the 'rat' cell line LTPA. Their submitted DNA sequence (KM820833.1) is indeed a rat sequence but is labelled as originating from 'rat isolate 671'.
CC Breed/subspecies: LT/Sv.
DI NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID LTR228
AC CVCL_6416
SY LTR 228; LTR 228-TG; LTR 228 TG
DR CLO; CLO_0007414
DR ATCC; HB-8502
RX Patent=US4624921;
CC Group: Hybridoma fusion partner cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 9,12
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 17,20
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2761 ! WIL2 NS
SX Male
CA Transformed cell line
//
ID LU
AC CVCL_M631
DR BioSample; SAMN03151738
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928, PubMed=20143388). Originally thought to originate from fetal lung.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID Lu 106
AC CVCL_8892
SY LU 106; Lu106; LU/106
DR BioSample; SAMN03151739
RX PubMed=5587101;
RX PubMed=6451928;
RX PubMed=13715157;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928, PubMed=20143388). Originally thought to originate from embryonic lung.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID Lu Gan
AC CVCL_U783
DR ATCC; CRL-1264
CC Discontinued: ATCC; CRL-1264; true.
DI NCIt; C84663; Cutis laxa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Lu Rob
AC CVCL_3010
DR CLO; CLO_0007415
DR ATCC; CRL-1397
DR BioSample; SAMN03472818
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 9,10
ST TH01: 9.3
ST TPOX: 9,12
ST vWA: 15,16
DI NCIt; C125699; Ehlers-Danlos syndrome, type IV
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Lu Vin
AC CVCL_3011
DR CLO; CLO_0007416
DR ATCC; CRL-1144
DI NCIt; C125696; Ehlers-Danlos syndrome, type I
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Lu-130
AC CVCL_6862
SY NCC-c-Lu-130; LU-130; Lu130
DR EFO; EFO_0003142
DR BioSample; SAMN03151826
DR CGH-DB; 89-1
DR CGH-DB; 9058-4
DR Cosmic; 809118
DR Cosmic; 844807
DR Cosmic; 918004
DR Cosmic; 1212192
DR Cosmic; 1571748
DR GEO; GSM17309
DR RCB; RCB0465
RX PubMed=3022030;
RX PubMed=12107105;
RX PubMed=15016488;
RX PubMed=16643607;
RX PubMed=20143388;
WW http://cell.brc.riken.jp/ja/quality/str/origin/confirm_report/confirm_table4
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a Lu-134-A (or Lu-134-B) derivative (PubMed=16643607, PubMed=20143388).
CC Omics: Transcriptome analysis.
CC Discontinued: RCB; RCB0465; true.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1387 ! Lu-134-A
SX Male
CA Cancer cell line
//
ID Lu-134-A
AC CVCL_1387
AS CVCL_2790
SY Lu-134-a; LU-134-A; LU-134A; Lu-134A; Lu134A; LU-134; Lu-134; Lu134; NCC-c-Lu-134-A-H; Lu-134-A-H; LU-134-A-H; Lu-134-AH; LU-134-AH; Lu134AH
DR CLO; CLO_0050028
DR BioSample; SAMN03471661
DR CGH-DB; 100-1
DR CGH-DB; 9059-4
DR ChEMBL-Cells; CHEMBL3308292
DR ChEMBL-Targets; CHEMBL2366236
DR Cosmic; 713881
DR Cosmic; 753588
DR Cosmic; 801604
DR Cosmic; 809119
DR Cosmic; 844808
DR Cosmic; 876158
DR Cosmic; 918005
DR Cosmic; 929157
DR Cosmic; 1212193
DR Cosmic; 1219094
DR Cosmic; 1239929
DR Cosmic; 1571749
DR Cosmic; 1995493
DR Cosmic; 2125172
DR Cosmic-CLP; 753588
DR GDSC; 753588
DR GEO; GSM17310
DR GEO; GSM1670063
DR JCRB; JCRB0235
DR RCB; RCB0466
RX DOI=10.5795/jjscc.24.451;
RX PubMed=3022030;
RX PubMed=6098504;
RX PubMed=11005564;
RX PubMed=12107105;
RX PubMed=15016488;
RX PubMed=19472407;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 9
ST D5S818: 11
ST D7S820: 11
ST TH01: 9
ST TPOX: 11
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1388 ! Lu-134-B
SX Male
CA Cancer cell line
//
ID Lu-134-B
AC CVCL_1388
SY NCC-c-Lu-134-B-S; Lu-134-b; LU-134-B; LU-134B; Lu-134B; Lu134B
DR BTO; BTO:0005439
DR CLO; CLO_0050029
DR CGH-DB; 90-1
DR CGH-DB; 9060-4
DR Cosmic; 1212194
DR Cosmic; 1571750
DR GEO; GSM827209
DR JCRB; JCRB0169
DR RCB; RCB0467
RX DOI=10.5795/jjscc.24.451;
RX PubMed=3022030;
RX PubMed=6098504;
RX PubMed=12107105;
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 9
ST D5S818: 11
ST D7S820: 11
ST TH01: 9
ST TPOX: 11
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1387 ! Lu-134-A
SX Male
CA Cancer cell line
//
ID Lu-135
AC CVCL_1389
SY NCC-c-Lu-135; LU-135; Lu135
DR CLO; CLO_0050030
DR EFO; EFO_0002828
DR BioSample; SAMN03470818
DR CGH-DB; 91-1
DR CGH-DB; 9061-4
DR ChEMBL-Cells; CHEMBL3308136
DR ChEMBL-Targets; CHEMBL1075492
DR Cosmic; 713899
DR Cosmic; 801605
DR Cosmic; 809120
DR Cosmic; 844821
DR Cosmic; 876157
DR Cosmic; 918006
DR Cosmic; 929159
DR Cosmic; 1239930
DR Cosmic; 1995494
DR Cosmic; 2125203
DR Cosmic-CLP; 713899
DR GDSC; 713899
DR GEO; GSM1670064
DR JCRB; JCRB0170
DR RCB; RCB0468
RX PubMed=3022030;
RX PubMed=11005564;
RX PubMed=12107105;
RX PubMed=19472407;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB; RCB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 7
ST D16S539: 11
ST D5S818: 13
ST D7S820: 11
ST TH01: 9
ST TPOX: 11
ST vWA: 16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lu-138
AC CVCL_3350
SY NCC-c-Lu-138
DR CLO; CLO_0050037
DR BioSample; SAMN03472077
DR CGH-DB; 92-1
DR CGH-DB; 9062-4
DR Cosmic; 801606
DR Cosmic; 809122
DR RCB; RCB1785
RX PubMed=3022030;
RX PubMed=12107105;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 10,12
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lu-139
AC CVCL_1390
SY NCC-c-Lu-139; LU-139; Lu139; LU139
DR CLO; CLO_0050031
DR BioSample; SAMN03472318
DR CGH-DB; 93-1
DR CGH-DB; 9063-4
DR ChEMBL-Cells; CHEMBL3308238
DR ChEMBL-Targets; CHEMBL2366248
DR Cosmic; 713878
DR Cosmic; 801607
DR Cosmic; 809123
DR Cosmic; 844822
DR Cosmic; 876156
DR Cosmic; 918007
DR Cosmic; 929158
DR Cosmic; 1212195
DR Cosmic; 1239931
DR Cosmic; 1571751
DR Cosmic; 1995495
DR Cosmic; 2125268
DR Cosmic-CLP; 713878
DR GDSC; 713878
DR GEO; GSM1670065
DR RCB; RCB0469
RX PubMed=3022030;
RX PubMed=11005564;
RX PubMed=12107105;
RX PubMed=19472407;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 9
ST D5S818: 13
ST D7S820: 12
ST TH01: 9
ST TPOX: 8,12
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lu-140
AC CVCL_3335
SY NCC-c-Lu-140; LU-140
DR CLO; CLO_0050032
DR BioSample; SAMN03472319
DR CGH-DB; 101-1
DR CGH-DB; 9064-4
DR Cosmic; 801608
DR Cosmic; 809124
DR Cosmic; 918008
DR Cosmic; 1212196
DR Cosmic; 1571752
DR RCB; RCB0470
RX PubMed=3022030;
RX PubMed=12107105;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 10
ST D5S818: 9
ST D7S820: 9,10
ST TH01: 7
ST TPOX: 11
ST vWA: 18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lu-141
AC CVCL_3347
SY LU-141; Lu141
DR CLO; CLO_0050070
DR BioSample; SAMN03472075
DR CGH-DB; 94-1
DR CGH-DB; 9065-4
DR Cosmic; 801609
DR Cosmic; 809125
DR Cosmic; 918009
DR Cosmic; 929981
DR RCB; RCB1772
RX PubMed=12107105;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 9
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Lu-143
AC CVCL_3348
DR CLO; CLO_0050036
DR BioSample; SAMN03472076
DR CGH-DB; 102-1
DR CGH-DB; 9066-4
DR Cosmic; 809126
DR RCB; RCB1773
RX PubMed=12107105;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 9
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 11
ST vWA: 17,20
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lu-165
AC CVCL_1391
SY LU-165; LU165
DR CLO; CLO_0050069
DR BioSample; SAMN03472172
DR CCRID; 3131C0001000700034
DR CGH-DB; 99-1
DR CGH-DB; 9067-4
DR ChEMBL-Cells; CHEMBL3308239
DR ChEMBL-Targets; CHEMBL2366132
DR Cosmic; 753589
DR Cosmic; 1212197
DR Cosmic; 1571740
DR Cosmic; 1995496
DR Cosmic; 2125173
DR Cosmic-CLP; 753589
DR GDSC; 753589
DR GEO; GSM1670066
DR RCB; RCB1184
RX PubMed=12107105;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10
ST D16S539: 9,11
ST D5S818: 9,13
ST D7S820: 12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lu-24
AC CVCL_3349
SY NCC-c-Lu-24; LU-24; Lu24
DR CLO; CLO_0050035
DR BioSample; SAMN03472074
DR CGH-DB; 98-1
DR CGH-DB; 9057-4
DR Cosmic; 801603
DR Cosmic; 809117
DR Cosmic; 844893
DR Cosmic; 876159
DR Cosmic; 918003
DR Cosmic; 1239928
DR Cosmic; 2125269
DR RCB; RCB1771
RX DOI=10.5795/jjscc.24.451;
RX PubMed=3022030;
RX PubMed=11005564;
RX PubMed=12107105;
RX PubMed=19472407;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 10
ST D5S818: 9
ST D7S820: 12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Lu-65
AC CVCL_1392
SY LU-65M; LU-65; LU65; Lu65; C-Lu65
DR CLO; CLO_0050059
DR BioSample; SAMN03471065
DR BioSample; SAMN03472047
DR CCLE; LU65_LUNG
DR CGH-DB; 197-1
DR CGH-DB; 9183-4
DR ChEMBL-Cells; CHEMBL3308209
DR ChEMBL-Cells; CHEMBL3308623
DR ChEMBL-Targets; CHEMBL614694
DR ChEMBL-Targets; CHEMBL2366270
DR Cosmic; 713875
DR Cosmic; 716171
DR Cosmic; 724863
DR Cosmic; 733170
DR Cosmic; 801584
DR Cosmic; 808502
DR Cosmic; 809127
DR Cosmic; 844827
DR Cosmic; 876175
DR Cosmic; 889093
DR Cosmic; 917989
DR Cosmic; 929151
DR Cosmic; 932930
DR Cosmic; 946067
DR Cosmic; 1066164
DR Cosmic; 1219074
DR Cosmic; 1239918
DR Cosmic; 1571732
DR Cosmic; 1995497
DR Cosmic; 2125204
DR Cosmic-CLP; 724863
DR GDSC; 724863
DR GEO; GSM827382
DR GEO; GSM887282
DR GEO; GSM888357
DR GEO; GSM1670067
DR JCRB; JCRB0079
DR RCB; RCB1967
DR TKG; TKG 0442
RX PubMed=3935627;
RX PubMed=7116286;
RX PubMed=9290701;
RX PubMed=11005564;
RX PubMed=12569360;
RX PubMed=15746151;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 10
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18 (Cosmic-CLP; JCRB; TKG)
ST vWA: 17,18 (RCB)
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lu-65A
AC CVCL_3012
SY LU-65A; LU65A
DR BioSample; SAMN03472811
DR Cosmic; 753590
DR Cosmic; 1001659
DR GEO; GSM827386
DR JCRB; JCRB0054
RX PubMed=9290701;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 10
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1392 ! Lu-65
SX Male
CA Cancer cell line
//
ID Lu-65B
AC CVCL_3013
SY LU-65B; LU65B
DR GEO; GSM827384
DR JCRB; JCRB0055
RX PubMed=9290701;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 10
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1392 ! Lu-65
SX Male
CA Cancer cell line
//
ID Lu-65C
AC CVCL_3014
SY LU-65C; LU65C
DR JCRB; JCRB0056
RX PubMed=9290701;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 10
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1392 ! Lu-65
SX Male
CA Cancer cell line
//
ID Lu-75(c)
AC CVCL_GS27
SY LU-75(c); Lu-75
RX PubMed=6956527;
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Lu-99
AC CVCL_3015
SY LU-99; Lu99; LU99; C-Lu99
DR CLO; CLO_0050038
DR BioSample; SAMN03471066
DR CCLE; LU99_LUNG
DR ChEMBL-Cells; CHEMBL3308600
DR ChEMBL-Targets; CHEMBL614651
DR Cosmic; 801578
DR Cosmic; 808503
DR Cosmic; 844828
DR Cosmic; 876174
DR Cosmic; 946068
DR Cosmic; 1048224
DR Cosmic; 1571756
DR Cosmic; 1656907
DR Cosmic; 2125270
DR GEO; GSM887283
DR GEO; GSM888358
DR JCRB; JCRB0080
DR RCB; RCB1900
DR TKG; TKG 0495
RX PubMed=3935627;
RX PubMed=9290701;
RX PubMed=11005564;
RX PubMed=12569360;
RX PubMed=22313637;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): JCRB; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10,15
ST D13S317: 10,11
ST D16S539: 9
ST D5S818: 12
ST D7S820: 11
ST TH01: 9
ST TPOX: 11
ST vWA: 18
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Lu-99A
AC CVCL_1393
SY LU-99A; Lu99A; LU99A
DR CGH-DB; 198-1
DR CGH-DB; 9187-4
DR ChEMBL-Cells; CHEMBL3308757
DR ChEMBL-Targets; CHEMBL1075493
DR Cosmic; 889094
DR Cosmic; 907796
DR Cosmic; 917980
DR Cosmic; 932925
DR Cosmic; 1066165
DR Cosmic; 1239919
DR Cosmic; 1995498
DR Cosmic-CLP; 907796
DR GDSC; 907796
DR GEO; GSM827578
DR GEO; GSM1670068
DR JCRB; JCRB0044
RX PubMed=9290701;
RX PubMed=15746151;
RX PubMed=19472407;
RX PubMed=27397505;
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 10,15
ST D13S317: 10,11
ST D16S539: 9
ST D5S818: 12
ST D7S820: 11
ST TH01: 9
ST TPOX: 11
ST vWA: 18
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3015 ! Lu-99
SX Male
CA Cancer cell line
//
ID Lu-99B
AC CVCL_2801
SY LU-99B; Lu99B; LU99B
DR CLO; CLO_0050042
DR Cosmic; 1066166
DR JCRB; JCRB0057
DR RCB; RCB1971
DR TKG; TKG 0496
RX PubMed=9290701;
ST Source(s): JCRB; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10,15
ST D13S317: 10,11
ST D16S539: 9
ST D5S818: 12
ST D7S820: 11
ST TH01: 9
ST TPOX: 11
ST vWA: 18
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3015 ! Lu-99
SX Male
CA Cancer cell line
//
ID Lu-99C
AC CVCL_2802
SY LU-99C; Lu99C; LU99C
DR JCRB; JCRB0058
RX PubMed=15185009;
RX PubMed=25120651;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,15
ST D13S317: 10,11
ST D16S539: 9
ST D5S818: 12
ST D7S820: 11
ST TH01: 9
ST TPOX: 11
ST vWA: 18
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3015 ! Lu-99
SX Male
CA Cancer cell line
//
ID LU-HNSCC-3
AC CVCL_L178
SY LU-HNSCC 3; LU-HNxSCC-3; HN-3
RX PubMed=19216775;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID LU-HNSCC-4
AC CVCL_L179
SY LU-HNSCC 4; LU-HNxSCC-4; HN-4
RX PubMed=19216775;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID LU-HNSCC-5
AC CVCL_L180
SY LU-HNSCC 5; LU-HNxSCC-5; HN-5
RX PubMed=19216775;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID LU-HNSCC-6
AC CVCL_L181
SY LU-HNSCC 6; LU-HNxSCC-6; HN-6
RX PubMed=19216775;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID LU-HNSCC-7
AC CVCL_L182
SY LU-HNSCC 7; LU-HNxSCC-7; HN-7
RX PubMed=19216775;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID LU-HNSCC-8
AC CVCL_L183
SY LU-HNSCC 8; LU-HNxSCC-8; HN-8
RX PubMed=19216775;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID Lu-YePa
AC CVCL_W819
RX PubMed=3652912;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Lu2
AC CVCL_T983
DR ECACC; 99043003
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID Lu6
AC CVCL_T984
DR ECACC; 99043004
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID LUBi001-B
AC CVCL_II98
SY RCFB58 c4.4; RCi194; PGRN8310; PGRN-8310
DR BioSamples; SAMEA4309630
DR EBiSC; LUBi001-B
DR ECACC; 66540258
DR hPSCreg; LUBi001-B
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_II99 ! LUBi001-C
SX Male
CA Induced pluripotent stem cell
//
ID LUBi001-C
AC CVCL_II99
SY RCFB58 c3.7; RCi200; PGRN8310; PGRN-8310
DR BioSamples; SAMEA4309665
DR EBiSC; LUBi001-C
DR ECACC; 66540259
DR hPSCreg; LUBi001-C
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_II98 ! LUBi001-B
SX Male
CA Induced pluripotent stem cell
//
ID Luc9.1
AC CVCL_GY95
RX PubMed=20504984;
CC Characteristics: Reporter cell line for rapid isolation and detection of replicating influenza A virus.
CC Transfected with: UniProtKB; P27652; Renilla-type luciferase.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID LuCaP 23.1
AC CVCL_4850
RX PubMed=9816265;
WW http://capcelllines.ca/details.asp?id=123
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4851 ! LuCaP 23.12
OI CVCL_4852 ! LuCaP 23.8
SX Male
CA Cancer cell line
//
ID LuCaP 23.12
AC CVCL_4851
RX PubMed=9816265;
WW http://capcelllines.ca/details.asp?id=123
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4850 ! LuCaP 23.1
OI CVCL_4852 ! LuCaP 23.8
SX Male
CA Cancer cell line
//
ID LuCaP 23.8
AC CVCL_4852
RX PubMed=9816265;
WW http://capcelllines.ca/details.asp?id=123
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4850 ! LuCaP 23.1
OI CVCL_4851 ! LuCaP 23.12
SX Male
CA Cancer cell line
//
ID LuCaP 35
AC CVCL_4853
SY LuCAP35
DR Cosmic; 2580125
RX PubMed=12712403;
WW http://capcelllines.ca/details.asp?id=129
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4854 ! LuCaP 35V
SX Male
CA Cancer cell line
//
ID LuCaP 35V
AC CVCL_4854
RX PubMed=12712403;
WW http://capcelllines.ca/details.asp?id=129
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4853 ! LuCaP 35
SX Male
CA Cancer cell line
//
ID LuCaP 41
AC CVCL_4855
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LuCaP 49
AC CVCL_4750
RX PubMed=12163395;
WW http://capcelllines.ca/details.asp?id=124
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LuCaP 58
AC CVCL_4857
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LuCap 73
AC CVCL_4858
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LUCC1
AC CVCL_W892
DR Cosmic; 1175828
DR Cosmic; 1286008
DR Cosmic; 2050449
RX PubMed=24367658;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LUCC2
AC CVCL_W893
DR Cosmic; 1175829
DR Cosmic; 1286009
DR Cosmic; 1819321
DR Cosmic; 2050450
RX PubMed=24367658;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LUCC3
AC CVCL_W894
DR Cosmic; 1286010
DR Cosmic; 2050451
RX PubMed=24367658;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LUCC4
AC CVCL_W895
DR Cosmic; 1286011
DR Cosmic; 2050452
RX PubMed=24367658;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LUCC5
AC CVCL_W896
DR Cosmic; 1286012
DR Cosmic; 2050453
RX PubMed=24367658;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LUCC6
AC CVCL_W897
DR Cosmic; 2050454
RX PubMed=24367658;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LUCC7
AC CVCL_W898
DR Cosmic; 2050455
RX PubMed=24367658;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LUCC8
AC CVCL_W899
DR Cosmic; 2050456
RX PubMed=24367658;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LUCC9
AC CVCL_W900
DR Cosmic; 2050457
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LUCE
AC CVCL_E760
DR dbMHC; 48956
DR IHW; IHW9393
DR IMGT/HLA; 17343
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID LUDLU-1
AC CVCL_2582
SY Ludlu-1; LUDLU 1; LUDLU1
DR CLO; CLO_0007417
DR CLDB; cl3269
DR BioSample; SAMN03473041
DR CCLE; LUDLU1_LUNG
DR Cosmic; 753591
DR Cosmic; 2060536
DR ECACC; 92012463
DR GEO; GSM827451
DR GEO; GSM887284
DR GEO; GSM888359
DR GEO; GSM1374639
RX PubMed=2577272;
RX PubMed=22460905;
RX PubMed=23226101;
RX PubMed=24244370;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep RNAseq analysis.
CC Omics: Genome sequenced.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 13,14
ST D18S51: 18
ST D21S11: 28
ST D3S1358: 16,18
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 8,15
ST FGA: 25
ST Penta D: 10
ST Penta E: 12,19
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2296 ! AGLCL [Human 1989]
SX Male
CA Cancer cell line
//
ID LUDLU-23
AC CVCL_E340
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2763 ! WILCL
CA Cancer cell line
//
ID LUHMES
AC CVCL_B056
SY LUnd Human MESencephalic
DR ATCC; CRL-2927
DR BioSample; SAMN03471701
RX PubMed=16000623;
RX PubMed=21434924;
RX PubMed=24173167;
WW https://www.abmgood.com/Immortalized-Dopaminergic-Neuronal-Precursor-Cells-(LUHMES)-T0284.html
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transformant: v-Myc.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 9,11
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 11,13
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B061 ! MESC2.10
SX Female
CA Conditionally immortalized cell line
//
ID Lulo
AC CVCL_Z241
RX PubMed=10656714;
CC Group: Insect cell line.
OX NCBI_TaxID=7200; ! Lutzomyia longipalpis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LuM1
AC CVCL_X013
RX PubMed=8609053;
CC Breed/subspecies: BALB/c.
DI NCIt; C120044; Mouse colon adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0240 ! MC-26
SX Female
CA Cancer cell line
//
ID LUMCi001-A
AC CVCL_9S26
SY LUMC0054iCTRL02
DR hPSCreg; LUMCi001-A
CC From: Leiden University Medical Center; Leiden; Netherlands.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID LUMCi001-A-1
AC CVCL_9S27
SY LUMC0054iCTRL03
DR hPSCreg; LUMCi001-A-1
CC From: Leiden University Medical Center; Leiden; Netherlands.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9S26 ! LUMCi001-A
SX Male
CA Induced pluripotent stem cell
//
ID LuSIV
AC CVCL_1H04
DR NIH-ARP; 5460-355
RX PubMed=10915601;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7904 ! T1
CA Hybrid cell line
//
ID LUVA
AC CVCL_5G48
SY Laboratory of University of VirginiA
RX PubMed=21281958;
WW https://www.kerafast.com/product/2020/human-mast-cell-line-luva
CC Doubling time: 54.0 +- 0.5 hours (in the absence of SCF), 43.3 +- 2.9 hours (in the presence of SCF) (PubMed=21281958).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Spontaneously immortalized cell line
//
ID LUY
AC CVCL_E761
DR dbMHC; 48957
DR ECACC; 85121705
DR IHW; IHW9070
DR IMGT/HLA; 11011
RX PubMed=8307784;
RX PubMed=11782282;
WW http://bioinformatics.hsanmartino.it/ecbr/cl70.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID LV-E
AC CVCL_0C20
RX PubMed=7736387;
RX PubMed=9815546;
RX PubMed=10037197;
RX PubMed=10100721;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LW878
AC CVCL_IV44
RX PubMed=9973220;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LWAGS
AC CVCL_E762
DR dbMHC; 48958
DR ECACC; 88052078
DR IHW; IHW9079
DR IMGT/HLA; 11013
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl79.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LWFN
AC CVCL_Z516
SY Leopard Wrass FiN
RX PubMed=23991874;
CC Group: Fish cell line.
OX NCBI_TaxID=241318; ! Macropharyngodon geoffroy
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LWSK
AC CVCL_Z517
SY Leopard Wrass SKin
RX PubMed=23991874;
CC Group: Fish cell line.
OX NCBI_TaxID=241318; ! Macropharyngodon geoffroy
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LX-1 [Human HSC]
AC CVCL_5790
SY Lieming Xu-1
DR BTO; BTO:0003515
RX PubMed=15591520;
RX PubMed=17760834;
CC Doubling time: 24 hours (PubMed=15591520).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Anecdotal: Name of the cell line is derived from the name of the first author of the original paper.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID LX-1 [Human lung carcinoma]
AC CVCL_5791
DR ChEMBL-Cells; CHEMBL3307613
DR ChEMBL-Targets; CHEMBL614389
DR CLS; 300268/NA
RX PubMed=3147984;
RX PubMed=12601555;
CC Discontinued: CLS; 300268; true.
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LX-2
AC CVCL_5792
SY Lieming Xu-2
DR BTO; BTO:0003516
DR Lonza; 616
DR Millipore; SCC064
DR PRIDE; PRD000680
DR SKY/M-FISH/CGH; 5853
RX PubMed=15591520;
RX PubMed=17760834;
RX PubMed=22694338;
RX PubMed=24116068;
CC Doubling time: ~3-4 days (PubMed=15591520).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Extracellular matrix proteome analysis.
CC Anecdotal: Name of the cell line is derived from the name of the first author of the original paper.
ST Source(s): PubMed=24116068
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,13
ST D16S539: 13
ST D18S51: 12
ST D19S433: 13,15.2
ST D21S11: 28,31
ST D2S1338: 17
ST D3S1358: 13,15
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 13
ST FGA: 21,26
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5790 ! LX-1 [Human HSC]
SX Male
CA Transformed cell line
//
ID LX821
AC CVCL_L282
RX PubMed=6413855;
CC Breed/subspecies: DBA/2.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2097 ! L-5178-Y
SX Female
CA Cancer cell line
//
ID LX827
AC CVCL_L283
RX PubMed=6413855;
CC Breed/subspecies: DBA/2.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2097 ! L-5178-Y
SX Female
CA Cancer cell line
//
ID LX830
AC CVCL_7882
SY LX-830
DR CLO; CLO_0050169
DR ChEMBL-Cells; CHEMBL3308624
DR ChEMBL-Targets; CHEMBL614695
DR RCB; RCB0138
RX PubMed=6413855;
CC Breed/subspecies: DBA/2.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2097 ! L-5178-Y
SX Female
CA Cancer cell line
//
ID LXF 289
AC CVCL_1394
SY LXF289; LXF-289; LXF 289L
DR CLO; CLO_0007424
DR EFO; EFO_0006641
DR CLDB; cl3278
DR BioSample; SAMN03473043
DR CCLE; LXF289_LUNG
DR ChEMBL-Cells; CHEMBL3307871
DR ChEMBL-Targets; CHEMBL614107
DR CLS; 300269/p529_LXF-289
DR Cosmic; 753592
DR Cosmic; 1995499
DR Cosmic-CLP; 753592
DR DSMZ; ACC-265
DR GDSC; 753592
DR GEO; GSM513972
DR GEO; GSM514324
DR GEO; GSM784227
DR GEO; GSM887285
DR GEO; GSM888360
DR GEO; GSM1670069
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'LX-289'.
ST Source(s): CLS; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 9,11
ST D16S539: 13
ST D18S51: 14
ST D21S11: 30,31
ST D3S1358: 15,18
ST D5S818: 9,10
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 24,25
ST Penta D: 10,13
ST Penta E: 10,20
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LXF 297
AC CVCL_5901
SY LXF297; LXF-297
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LXFA 629L
AC CVCL_D189
SY LXFA629; LXFA 629; LXF 629L
DR ChEMBL-Cells; CHEMBL3308621
DR ChEMBL-Targets; CHEMBL614689
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LXFL 529L
AC CVCL_D085
SY LXFL-529L; LXFL529L; LXF 529 L; LXFL-529; LXFL 529; LXFL529; LXF 529
DR EFO; EFO_0006642
DR BioSample; SAMN03472856
DR ChEMBL-Cells; CHEMBL3307537
DR ChEMBL-Cells; CHEMBL3307874
DR ChEMBL-Targets; CHEMBL614110
DR ChEMBL-Targets; CHEMBL614113
DR Cosmic; 1802292
DR Cosmic; 1870262
DR GEO; GSM206521
RX PubMed=25485619;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'LXPL 529' in ChEMBL CHEMBL614113 and CHEMBL3307874.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 10,11
ST D18S51: 13
ST D21S11: 28,29
ST D3S1358: 15,17
ST D5S818: 10,11
ST D7S820: 8,12
ST D8S1179: 11,15
ST FGA: 20,21
ST Penta D: 11,13
ST Penta E: 12
ST TH01: 9.3
ST TPOX: 9
ST vWA: 18
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID LXKC40
AC CVCL_HE56
RX PubMed=8365721;
CC Group: Human/rodent somatic cell hybrid.
CC Transformant: NCIt; C17262; X-Ray.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1R79 ! GM06318
HI CVCL_F739 ! L-M(TK-)1D
CA Hybrid cell line
//
ID LXKC50
AC CVCL_HE57
RX PubMed=8365721;
CC Group: Human/rodent somatic cell hybrid.
CC Transformant: NCIt; C17262; X-Ray.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1R79 ! GM06318
HI CVCL_F739 ! L-M(TK-)1D
CA Hybrid cell line
//
ID LXKC56
AC CVCL_HE58
RX PubMed=8365721;
CC Group: Human/rodent somatic cell hybrid.
CC Transformant: NCIt; C17262; X-Ray.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1R79 ! GM06318
HI CVCL_F739 ! L-M(TK-)1D
CA Hybrid cell line
//
ID LXVIII-1D7-B8
AC CVCL_U047
SY M-7; M7
RX PubMed=8734946;
CC Monoclonal antibody target: Leishmania mexicana.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID LXVIII-4D8-E3
AC CVCL_U037
SY M-8
DR ECACC; 08041712
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID LXXIX-1G12-G7
AC CVCL_U052
SY XXIX-1G12-G7; D-14
DR ECACC; 08041715
RX PubMed=6373932;
CC Monoclonal antibody target: Leishmania donovani.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID LXXVIII-2E5-A8
AC CVCL_U038
SY D-2; D2
RX PubMed=8734946;
CC Monoclonal antibody target: Leishmania chagasi.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID LY-336-TC
AC CVCL_F930
SY LY-336; LY336
DR TKG; TKG 0110
DR TKG; TKG 0652
RX PubMed=7829394;
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID LY-5-TC
AC CVCL_F931
SY LY-5; Ly-5
DR TKG; TKG 0102
DR TKG; TKG 0635
RX PubMed=21085;
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID LY-52-TC
AC CVCL_F932
SY LY-52
DR TKG; TKG 0105
DR TKG; TKG 0649
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID LY-54-TC
AC CVCL_F933
SY LY-54
DR TKG; TKG 0106
DR TKG; TKG 0650
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID LY-6-TC
AC CVCL_5327
SY LY-6; LY6
DR CLO; CLO_0050825
DR RCB; RCB2910
DR TKG; TKG 0103
DR TKG; TKG 0648
RX PubMed=7829394;
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID LY-7-TC
AC CVCL_F934
SY LY-7
DR TKG; TKG 0104
DR TKG; TKG 0636
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID LY-80-TC
AC CVCL_F935
SY LY-80
DR TKG; TKG 0107
DR TKG; TKG 0651
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID LY-A/hCERT
AC CVCL_L555
DR CLO; CLO_0050418
DR RCB; RCB1870
CC Transfected with: HGNC; 2205; COL4A3BP.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_J422 ! CHO-LY-A
SX Female
CA Spontaneously immortalized cell line
//
ID LY-H12
AC CVCL_1Q79
DR RCB; RCB2728
RX PubMed=17537454;
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C125415; Rat malignant peripheral nerve sheath tumor
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_1Q80 ! LY-PPB6
SX Female
CA Cancer cell line
//
ID LY-PPB6
AC CVCL_1Q80
DR RCB; RCB2729
RX PubMed=17537454;
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C125415; Rat malignant peripheral nerve sheath tumor
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_1Q79 ! LY-H12
SX Female
CA Cancer cell line
//
ID Ly46
AC CVCL_IU21
SY LY46; LY 46; LY-46; IARC/LY 46; IARC/LY46; IARC/Ly46
RX PubMed=170370;
RX PubMed=3027441;
RX PubMed=4122458;
RX PubMed=4364259;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Ly47
AC CVCL_N273
SY LY47; LY 47; IARC/LY 47; IARC/LY47; IARC/Ly47; GM08688; GM17349
DR CLO; CLO_0010611
DR CLO; CLO_0013750
DR Coriell; GM08688
DR Coriell; GM17349
RX PubMed=2847931;
RX PubMed=3027441;
RX PubMed=3035497;
RX PubMed=6806672;
CC Part of: Human variation panel.
CC Population: Africans south of the Sahara.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Ly65
AC CVCL_IU48
SY LY65; IARC/LY 65; IARC/LY65; IARC/Ly65
RX PubMed=3027441;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Ly66
AC CVCL_N274
SY LY66; IARC/LY 66; IARC/LY66; IARC/Ly66
RX PubMed=3027441;
RX PubMed=6806672;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Ly67
AC CVCL_N275
SY LY67; LY-67; LY 67; IARC/LY 67; IARC/LY67; IARC/Ly67
DR Cosmic; 931127
RX PubMed=3027441;
RX PubMed=3035497;
RX PubMed=6806672;
RX PubMed=9473234;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Ly74
AC CVCL_IU49
SY LY74; IARC/LY 74; IARC/LY74; IARC/Ly74
RX PubMed=3027441;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID LY9
AC CVCL_U065
DR ECACC; 99061826
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID Ly91
AC CVCL_N276
SY LY91; IARC/LY 91; IARC/LY91; IARC/Ly91; GM08689
DR CLO; CLO_0010425
DR Coriell; GM08689
RX PubMed=2847931;
RX PubMed=3027441;
RX PubMed=6806672;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID LyB9
AC CVCL_6232
SY Lyb9
RX PubMed=2784769;
RX PubMed=3501371;
CC Characteristics: IL3 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5433 ! LyD9
OI CVCL_6231 ! LyH7
CA Factor-dependent cell line
//
ID LYCK
AC CVCL_HP90
SY Large Yellow Croaker Kidney
RX PubMed=24773544;
CC Group: Fish cell line.
CC Doubling time: 29.5 hours (PubMed=24773544).
OX NCBI_TaxID=215358; ! Larimichthys crocea
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LYCS-1
AC CVCL_M751
SY Large Yellow Croaker Spleen; LYCS
RX DOI=10.1007/s11802-011-1778-5;
CC Group: Fish cell line.
CC Doubling time: 48.7 hours (DOI=10.1007/s11802-011-1778-5).
OX NCBI_TaxID=215358; ! Larimichthys crocea
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID LyD9
AC CVCL_5433
SY Lyd9
RX PubMed=1969653;
RX PubMed=2784769;
RX PubMed=3501371;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=LyD9
CC Characteristics: IL3 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6232 ! LyB9
OI CVCL_6231 ! LyH7
CA Factor-dependent cell line
//
ID LyD9 K-4
AC CVCL_6061
SY K-4
RX PubMed=1969653;
RX PubMed=2487673;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=K-4
CC Characteristics: IL4 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5433 ! LyD9
CA Factor-dependent cell line
//
ID LyD9 K-5
AC CVCL_6063
SY K-5
RX PubMed=2112086;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=K-5
CC Characteristics: IL5 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5433 ! LyD9
CA Factor-dependent cell line
//
ID LyD9 K-GM
AC CVCL_6086
SY K-GM
RX PubMed=2487673;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=K-GM
CC Characteristics: CSF2 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5433 ! LyD9
CA Factor-dependent cell line
//
ID LyD9 LS-1
AC CVCL_6212
SY LS-1
RX PubMed=2487673;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=LS-1
CC Characteristics: CSF2 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5433 ! LyD9
CA Factor-dependent cell line
//
ID LyH7
AC CVCL_6231
RX PubMed=3501371;
CC Characteristics: IL3 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6232 ! LyB9
OI CVCL_5433 ! LyD9
CA Factor-dependent cell line
//
ID LYK-1
AC CVCL_9194
DR CLO; CLO_0007425
DR ATCC; HB-306
RX PubMed=9070314;
CC Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LYK-10
AC CVCL_DB35
DR ATCC; HB-314
RX PubMed=9070314;
CC Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC Discontinued: ATCC; HB-314; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LYK-11
AC CVCL_DB36
DR ATCC; HB-315
RX PubMed=9070314;
CC Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC Discontinued: ATCC; HB-315; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LYK-12
AC CVCL_9195
DR CLO; CLO_0007426
DR ATCC; HB-316
RX PubMed=9070314;
CC Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LYK-16
AC CVCL_9196
DR CLO; CLO_0007427
DR ATCC; HB-319
RX PubMed=9070314;
CC Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LYK-2
AC CVCL_DB33
DR ATCC; HB-307
RX PubMed=9070314;
CC Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC Discontinued: ATCC; HB-307; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LYK-4
AC CVCL_DB34
DR ATCC; HB-309
RX PubMed=9070314;
CC Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC Discontinued: ATCC; HB-309; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LYK-5
AC CVCL_9197
DR CLO; CLO_0007428
DR ATCC; HB-310
RX PubMed=9070314;
CC Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LYK-6
AC CVCL_DB37
DR ATCC; HB-320
RX PubMed=9070314;
CC Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC Discontinued: ATCC; HB-320; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LYK-7
AC CVCL_9198
DR CLO; CLO_0007429
DR ATCC; HB-311
RX PubMed=9070314;
CC Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LYK-8
AC CVCL_9199
DR CLO; CLO_0007430
DR ATCC; HB-312
RX PubMed=9070314;
CC Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID LYK-9
AC CVCL_9200
DR CLO; CLO_0007431
DR ATCC; HB-313
RX PubMed=9070314;
CC Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Lym-1
AC CVCL_E985
DR CLO; CLO_0007432
DR ATCC; HB-8612
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID LYM-1
AC CVCL_4859
DR CLO; CLO_0050819
DR CLO; CLO_0050820
DR RCB; RCB0076
DR RCB; RCB1473
RX CelloPub=CLPUB00074;
RX PubMed=9511820;
CC Derived from metastatic site: Lymph node.
CC Breed/subspecies: JAR-2.
DI NCIt; C63864; Rat intestinal neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID LYM-1.P3
AC CVCL_U213
DR JCRB; JCRB0144.1
DR JCRB; NIHS0225
CC Discontinued: JCRB; NIHS0225; true.
CC Derived from metastatic site: Lymph node.
CC Breed/subspecies: JAR-2.
DI NCIt; C63864; Rat intestinal neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4859 ! LYM-1
CA Cancer cell line
//
ID LYM-1.P3B
AC CVCL_U214
DR JCRB; JCRB0144.1B
DR JCRB; NIHS0359
CC Discontinued: JCRB; NIHS0359; true.
CC Derived from metastatic site: Lymph node.
CC Breed/subspecies: JAR-2.
DI NCIt; C63864; Rat intestinal neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_U213 ! LYM-1.P3
CA Cancer cell line
//
ID LYM-1.P3D
AC CVCL_U215
DR JCRB; JCRB0144.1D
DR JCRB; NIHS0360
CC Discontinued: JCRB; NIHS0360; true.
CC Derived from metastatic site: Lymph node.
CC Breed/subspecies: JAR-2.
DI NCIt; C63864; Rat intestinal neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_U213 ! LYM-1.P3
CA Cancer cell line
//
ID Lym-2
AC CVCL_E986
DR CLO; CLO_0007433
DR ATCC; HB-8613
RX Patent=US4724212;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Lymph2-AD2-iPS
AC CVCL_AB84
RX PubMed=27345793;
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID Lymph8-iPS
AC CVCL_9U80
RX PubMed=27345781;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9U76 ! CON8
SX Male
CA Induced pluripotent stem cell
//
ID LZL
AC CVCL_E763
DR dbMHC; 48959
DR ECACC; 88052099
DR IHW; IHW9099
DR IMGT/HLA; 11014
WW http://bioinformatics.hsanmartino.it/ecbr/cl99.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID M [Dog melanoma]
AC CVCL_0D70
RX Patent=US3432595;
RX PubMed=14266865;
CC Breed/subspecies: Boxer.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID M [Rat]
AC CVCL_5550
DR CLO; CLO_0050607
DR CLO; CLO_0050613
DR JCRB; JCRB0152.1
DR JCRB; NIHS0228
DR RCB; RCB0067
DR RCB; RCB1472
CC Discontinued: JCRB; NIHS0228; true.
CC Breed/subspecies: JAR.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID M 111
AC CVCL_J757
SY M111; M-4
DR CLO; CLO_0007438
DR ATCC; HB-8438
RX Patent=US4806628;
RX Patent=US4808704;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID M 138
AC CVCL_J758
AS CVCL_5788
SY M138; M-24 (M138); M-24; L-138; L138
DR CLO; CLO_0007472
DR ATCC; HB-8449
DR CLS; 400384/NA
RX Patent=US4806628;
RX Patent=US4808704;
CC Discontinued: ATCC; HB-8449; probable.
CC Discontinued: CLS; 400384; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID M 144
AC CVCL_J759
SY M144; M-10
DR CLO; CLO_0007439
DR ATCC; HB-8440
RX Patent=US4806628;
RX Patent=US4808704;
CC Discontinued: ATCC; HB-8440; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID M 368
AC CVCL_C507
SY M368; M3-68; L368 M68; M-25; M25
DR CLO; CLO_0007188
DR ATCC; HB-8450
RX Patent=US4806628;
RX Patent=US4808704;
CC Discontinued: ATCC; HB-8450; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID M. dunni (Clone III8C)
AC CVCL_9125
SY M. dunni clone III8C; M.dunni(Clone III8C); Clone IIIC8
DR CLO; CLO_0007440
DR CLO; CLO_0007441
DR CLDB; cl3306
DR ATCC; CRL-2017
DR BCRC; 60203
DR ECACC; 94101211
DR JCRB; JCRB9124
RX PubMed=6092693;
OX NCBI_TaxID=254704; ! Mus terricolor
SX Female
CA Spontaneously immortalized cell line
//
ID M-07
AC CVCL_D630
SY M-O7
DR BTO; BTO:0005249
RX PubMed=3261598;
DI NCIt; C7972; Childhood acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID M-07e
AC CVCL_2106
SY M-07E; M-O7e; M07e; Mo7e; MO7e; MO7E
DR BTO; BTO:0005248
DR CLO; CLO_0007447
DR CLDB; cl3281
DR CLDB; cl7156
DR BioSample; SAMN03473408
DR CCLE; M07E_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CCRID; 3111C0001CCC000112
DR Cosmic; 787447
DR Cosmic; 975265
DR Cosmic; 999723
DR Cosmic; 1012082
DR Cosmic; 1181607
DR Cosmic; 1281323
DR Cosmic; 1524835
DR Cosmic; 1633511
DR Cosmic; 2306215
DR DSMZ; ACC-104
DR GEO; GSM236792
DR GEO; GSM236828
DR GEO; GSM887287
DR GEO; GSM888362
DR ICLC; HTL04002
DR Lonza; 485
DR NCBI_Iran; C621
RX PubMed=2273055;
RX PubMed=11414198;
RX PubMed=16408098;
RX PubMed=22460905;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MO7E
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 10,11
ST D16S539: 11
ST D5S818: 11
ST D7S820: 11
ST TH01: 6,8
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C7972; Childhood acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D630 ! M-07
SX Female
CA Cancer cell line
//
ID M-1 [Human mantle cell lymphoma]
AC CVCL_9494
RX PubMed=15360009;
DI NCIt; C4337; Mantle cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID M-1 [Mouse kidney]
AC CVCL_8786
DR CLO; CLO_0007449
DR ATCC; CRL-2038
DR BCRC; 60297
DR ECACC; 95092201
RX PubMed=1654478;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Tg(SV40E)Bri/7 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID M-17
AC CVCL_D028
DR Cosmic; 2163788
DR ESTDAB; ESTDAB-039
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,13
ST D3S1358: 17,18
ST D5S818: 11
ST D7S820: 10,13
ST FGA: 24
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID M-27
AC CVCL_M065
RX PubMed=3697987;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_M064 ! M-3LL
CA Cancer cell line
//
ID M-2E6
AC CVCL_4537
DR CLO; CLO_0007473
DR CLDB; cl5223
DR ATCC; HB-138
DR IZSLER; BS Hy 26
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID M-3LL
AC CVCL_M064
RX PubMed=3697987;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5653 ! 3LL
CA Cancer cell line
//
ID M-7
AC CVCL_6491
SY M-7 [Mutatect]
DR CLO; CLO_0007485
DR ATCC; CRL-2804
RX PubMed=14732341;
CC Breed/subspecies: C57BL/10.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4982 ! MC-TGS17-51
SX Male
CA Cancer cell line
//
ID M-FetMSC
AC CVCL_6F28
RX PubMed=25697001;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6F27 ! FetMSC
SX Male
CA Adult stem cell
//
ID m-ICcl2
AC CVCL_AW03
SY mICcl2
RX PubMed=8764149;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Misspelling: Occasionally 'm-ICc12'.
CC Breed/subspecies: (C57BL/6 x DBA) L-PK/TAg1 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID M-MOK
AC CVCL_8731
DR CLO; CLO_0051548
DR BioSample; SAMN03471920
DR Cosmic; 787456
DR Cosmic; 975273
DR Cosmic; 1281331
DR RCB; RCB2534
DR TKG; TKG 0458
RX PubMed=7589286;
ST Source(s): RCB; TKG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 10,12
ST D5S818: 9,11
ST D7S820: 10
ST TH01: 7
ST TPOX: 11,12
ST vWA: 17,18
DI NCIt; C7972; Childhood acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID M-MSV-BALB/3T3
AC CVCL_5793
SY M-MSV-Balb/3T3
DR CLO; CLO_0007805
DR CLDB; cl3295
DR CLDB; cl3296
DR ATCC; CCL-163.2
DR CLS; 400458/p480_M-MSV-Balb3T3
DR ECACC; 90030802
DR KCLB; 10163.2
CC Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0184 ! BALB/3T3 clone A31
CA Transformed cell line
//
ID M-NBT-II
AC CVCL_M906
RX PubMed=7929634;
CC Breed/subspecies: Wistar.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0453 ! NBT-II
SX Male
CA Cancer cell line
//
ID M-OS
AC CVCL_R727
RX PubMed=22833358;
CC Derived from metastatic site: Lung.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID M-TAT
AC CVCL_1Q82
RX PubMed=7961690;
RX PubMed=19344951;
DI NCIt; C3247; Myelodysplastic syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID M/K-1.9
AC CVCL_9201
SY M/K-1
DR CLO; CLO_0007442
DR ATCC; CRL-1910
RX PubMed=1713592;
CC Monoclonal antibody target: UniProtKB; P29533; Mouse Vcam1/Cd106.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID M/K-2.7
AC CVCL_9202
AS CVCL_D671
SY M/K-2; M/K2; MK2
DR CLO; CLO_0007443
DR ATCC; CRL-1909
DR BCRJ; 0150
RX PubMed=1713592;
CC Monoclonal antibody target: UniProtKB; P29533; Mouse Vcam1/Cd106.
CC Discontinued: BCRJ; 0150; probable.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID M.A.
AC CVCL_E764
DR dbMHC; 48960
DR IHW; IHW9324
DR IMGT/HLA; 11015
WW http://bioinformatics.hsanmartino.it/ecbr/cl324.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID M.M.
AC CVCL_E765
DR dbMHC; 48961
DR IHW; IHW9335
DR IMGT/HLA; 11020
WW http://bioinformatics.hsanmartino.it/ecbr/cl335.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID M.P3
AC CVCL_5551
DR JCRB; JCRB0152.2
DR JCRB; JCRB0152.3
DR JCRB; NIHS0228.1
DR JCRB; NIHS0356
CC Discontinued: JCRB; NIHS0228.1; true.
CC Discontinued: JCRB; NIHS0356; true.
CC Breed/subspecies: JAR.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5550 ! M [Rat]
CA Transformed cell line
//
ID M.R.
AC CVCL_E766
DR dbMHC; 48962
DR ECACC; 94050308
DR IHW; IHW9316
DR IMGT/HLA; 11022
WW http://bioinformatics.hsanmartino.it/ecbr/cl316.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID M0-91
AC CVCL_0086
SY MO-91; MO91; M091
DR BTO; BTO:0005491
RX PubMed=8632663;
RX PubMed=17252008;
DI NCIt; C8460; Acute myeloid leukemia with minimal differentiation
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M000216
AC CVCL_S806
RX PubMed=16827748;
CC From: URPP biobank; University of Zurich; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M000907
AC CVCL_S807
DR GEO; GSM482457
RX PubMed=16827748;
RX PubMed=18245463;
RX PubMed=22336146;
CC From: URPP biobank; University of Zurich; Switzerland.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M000921
AC CVCL_S808
DR GEO; GSM433916
DR IGRhCellID; M000921
RX PubMed=16827748;
RX PubMed=22336146;
RX PubMed=24581590;
CC From: URPP biobank; University of Zurich; Switzerland.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M010119
AC CVCL_S671
RX PubMed=16827748;
RX PubMed=24581590;
CC From: URPP biobank; University of Zurich; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M010308
AC CVCL_S809
RX PubMed=16827748;
RX PubMed=18245463;
CC From: URPP biobank; University of Zurich; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M010322
AC CVCL_S672
RX PubMed=16827748;
CC From: URPP biobank; University of Zurich; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M010718
AC CVCL_S673
RX PubMed=16827748;
CC From: URPP biobank; University of Zurich; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M010817
AC CVCL_S674
RX PubMed=16827748;
RX PubMed=22336146;
RX PubMed=24581590;
CC From: URPP biobank; University of Zurich; Switzerland.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M0505
AC CVCL_HP91
DR GEO; GSM1320306
DR GEO; GSM1320307
DR GEO; GSM1320308
RX PubMed=24672774;
CC Doubling time: 48 hours (PubMed=24672774).
CC Omics: Transcriptome analysis.
CC Breed/subspecies: FVB/N.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Finite cell line
//
ID M050829
AC CVCL_AT59
RX PubMed=22336146;
CC From: URPP biobank; University of Zurich; Switzerland.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M059J
AC CVCL_0400
SY Mo 59J; MO59J
DR CLO; CLO_0007445
DR EFO; EFO_0005697
DR MCCL; MCC:0000294
DR ATCC; CRL-2366
DR BCRC; 60382
DR BCRJ; 0151
DR BioSample; SAMN03471832
DR BioSample; SAMN03473044
DR ChEMBL-Cells; CHEMBL3308113
DR ChEMBL-Targets; CHEMBL1075494
DR Cosmic; 949094
DR Cosmic; 1746953
DR Cosmic; 2367537
DR Cosmic-CLP; 949094
DR ENCODE; ENCBS062ILC
DR ENCODE; ENCBS235AAA
DR ENCODE; ENCBS304XWS
DR ENCODE; ENCBS370AFW
DR GDSC; 949094
DR GEO; GSM326251
DR GEO; GSM1374640
DR GEO; GSM1670070
RX PubMed=8316628;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/M059J_Stam_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y (ATCC; Cosmic-CLP)
ST Amelogenin: X (PubMed=25877200)
ST CSF1PO: 10,12 (ATCC; Cosmic-CLP)
ST CSF1PO: 10 (PubMed=25877200)
ST D13S317: 14
ST D16S539: 10,12
ST D18S51: 15,19
ST D21S11: 30,31.2
ST D3S1358: 14
ST D5S818: 11,12 (ATCC; Cosmic-CLP)
ST D5S818: 12 (PubMed=25877200)
ST D7S820: 10,12 (ATCC; Cosmic-CLP)
ST D7S820: 10 (PubMed=25877200)
ST D8S1179: 15
ST FGA: 20
ST Penta D: 12,13
ST Penta E: 7
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0401 ! M059K
SX Male
CA Cancer cell line
//
ID M059K
AC CVCL_0401
DR CLO; CLO_0007446
DR EFO; EFO_0006451
DR MCCL; MCC:0000295
DR ATCC; CRL-2365
DR BCRC; 60381
DR BioSample; SAMN03473046
DR CCLE; M059K_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 897445
DR Cosmic; 1237543
DR GEO; GSM887286
DR GEO; GSM888361
DR GEO; GSM1374641
DR GEO; GSM1670071
RX PubMed=8316628;
RX PubMed=21406405;
RX PubMed=22460905;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 14
ST D16S539: 10,12
ST D18S51: 15,19
ST D21S11: 30,31.2
ST D3S1358: 14,15
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 15
ST FGA: 20,26
ST Penta D: 12,13
ST Penta E: 7,15
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0400 ! M059J
SX Male
CA Cancer cell line
//
ID M060125
AC CVCL_AT44
RX PubMed=22336146;
RX PubMed=24581590;
CC From: URPP biobank; University of Zurich; Switzerland.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M060621
AC CVCL_AT45
RX PubMed=24581590;
CC From: URPP biobank; University of Zurich; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M061103
AC CVCL_AT60
RX PubMed=22336146;
CC From: URPP biobank; University of Zurich; Switzerland.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M070112
AC CVCL_AT46
RX PubMed=24581590;
CC From: URPP biobank; University of Zurich; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M080201
AC CVCL_AT61
RX PubMed=22336146;
CC From: URPP biobank; University of Zurich; Switzerland.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M080214
AC CVCL_AT62
RX PubMed=22336146;
CC From: URPP biobank; University of Zurich; Switzerland.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M080221
AC CVCL_AT47
RX PubMed=24581590;
CC From: URPP biobank; University of Zurich; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M080228
AC CVCL_AT48
RX PubMed=24581590;
CC From: URPP biobank; University of Zurich; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M080306
AC CVCL_AT49
RX PubMed=24581590;
CC From: URPP biobank; University of Zurich; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M080310
AC CVCL_AT63
RX PubMed=22336146;
CC From: URPP biobank; University of Zurich; Switzerland.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M080326
AC CVCL_AT50
RX PubMed=24581590;
CC From: URPP biobank; University of Zurich; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M080423
AC CVCL_AT51
RX PubMed=22336146;
RX PubMed=24581590;
CC From: URPP biobank; University of Zurich; Switzerland.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M080729
AC CVCL_AT52
RX PubMed=24581590;
CC From: URPP biobank; University of Zurich; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID M080904
AC CVCL_AT53
RX PubMed=24581590;
CC From: URPP biobank; University of Zurich; Switzerland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AT54 ! M080904B
CA Cancer cell line
- 公告/新闻
